<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName archivearticle3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bipolar Disord</journal-id><journal-id journal-id-type="iso-abbrev">Bipolar Disord</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1399-5618</journal-id><journal-id journal-id-type="publisher-id">BDI</journal-id><journal-title-group><journal-title>Bipolar Disorders</journal-title></journal-title-group><issn pub-type="ppub">1398-5647</issn><issn pub-type="epub">1399-5618</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5716873</article-id><article-id pub-id-type="doi">10.1111/bdi.12556</article-id><article-id pub-id-type="publisher-id">BDI12556</article-id><article-categories><subj-group subj-group-type="overline"><subject>Task Force Papers</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Articles</subject><subj-group subj-group-type="heading"><subject>Reviews</subject></subj-group></subj-group></article-categories><title-group><article-title>The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research</article-title><alt-title alt-title-type="left-running-head">GOLDSTEIN et&#x000a0;al.</alt-title></title-group><contrib-group><contrib id="bdi12556-cr-0001" contrib-type="author" corresp="yes"><name><surname>Goldstein</surname><given-names>Benjamin I</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0340-349X</contrib-id><address><email>benjamin.goldstein@sunnybrook.ca</email></address><xref ref-type="aff" rid="bdi12556-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="bdi12556-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="bdi12556-cr-0002" contrib-type="author"><name><surname>Birmaher</surname><given-names>Boris</given-names></name><xref ref-type="aff" rid="bdi12556-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="bdi12556-cr-0003" contrib-type="author"><name><surname>Carlson</surname><given-names>Gabrielle A</given-names></name><xref ref-type="aff" rid="bdi12556-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="bdi12556-cr-0004" contrib-type="author"><name><surname>DelBello</surname><given-names>Melissa P</given-names></name><xref ref-type="aff" rid="bdi12556-aff-0005">
<sup>5</sup>
</xref></contrib><contrib id="bdi12556-cr-0005" contrib-type="author"><name><surname>Findling</surname><given-names>Robert L</given-names></name><xref ref-type="aff" rid="bdi12556-aff-0006">
<sup>6</sup>
</xref></contrib><contrib id="bdi12556-cr-0006" contrib-type="author"><name><surname>Fristad</surname><given-names>Mary</given-names></name><xref ref-type="aff" rid="bdi12556-aff-0007">
<sup>7</sup>
</xref></contrib><contrib id="bdi12556-cr-0007" contrib-type="author"><name><surname>Kowatch</surname><given-names>Robert A</given-names></name><xref ref-type="aff" rid="bdi12556-aff-0007">
<sup>7</sup>
</xref></contrib><contrib id="bdi12556-cr-0008" contrib-type="author"><name><surname>Miklowitz</surname><given-names>David J</given-names></name><xref ref-type="aff" rid="bdi12556-aff-0008">
<sup>8</sup>
</xref></contrib><contrib id="bdi12556-cr-0009" contrib-type="author"><name><surname>Nery</surname><given-names>Fabiano G</given-names></name><xref ref-type="aff" rid="bdi12556-aff-0005">
<sup>5</sup>
</xref></contrib><contrib id="bdi12556-cr-0010" contrib-type="author"><name><surname>Perez&#x02010;Algorta</surname><given-names>Guillermo</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6610-4951</contrib-id><xref ref-type="aff" rid="bdi12556-aff-0009">
<sup>9</sup>
</xref></contrib><contrib id="bdi12556-cr-0011" contrib-type="author"><name><surname>Van Meter</surname><given-names>Anna</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0012-206X</contrib-id><xref ref-type="aff" rid="bdi12556-aff-0010">
<sup>10</sup>
</xref></contrib><contrib id="bdi12556-cr-0012" contrib-type="author"><name><surname>Zeni</surname><given-names>Cristian P</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9810-3929</contrib-id><xref ref-type="aff" rid="bdi12556-aff-0011">
<sup>11</sup>
</xref></contrib><contrib id="bdi12556-cr-0013" contrib-type="author"><name><surname>Correll</surname><given-names>Christoph U</given-names></name><xref ref-type="aff" rid="bdi12556-aff-0012">
<sup>12</sup>
</xref><xref ref-type="aff" rid="bdi12556-aff-0013">
<sup>13</sup>
</xref></contrib><contrib id="bdi12556-cr-0014" contrib-type="author"><name><surname>Kim</surname><given-names>Hyo&#x02010;Won</given-names></name><xref ref-type="aff" rid="bdi12556-aff-0014">
<sup>14</sup>
</xref></contrib><contrib id="bdi12556-cr-0015" contrib-type="author"><name><surname>Wozniak</surname><given-names>Janet</given-names></name><xref ref-type="aff" rid="bdi12556-aff-0015">
<sup>15</sup>
</xref></contrib><contrib id="bdi12556-cr-0016" contrib-type="author"><name><surname>Chang</surname><given-names>Kiki D</given-names></name><xref ref-type="aff" rid="bdi12556-aff-0016">
<sup>16</sup>
</xref></contrib><contrib id="bdi12556-cr-0017" contrib-type="author"><name><surname>Hillegers</surname><given-names>Manon</given-names></name><xref ref-type="aff" rid="bdi12556-aff-0017">
<sup>17</sup>
</xref></contrib><contrib id="bdi12556-cr-0018" contrib-type="author"><name><surname>Youngstrom</surname><given-names>Eric A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2251-6860</contrib-id><xref ref-type="aff" rid="bdi12556-aff-0018">
<sup>18</sup>
</xref></contrib></contrib-group><aff id="bdi12556-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Centre for Youth Bipolar Disorder</named-content>
<institution>Sunnybrook Health Sciences Centre</institution>
<named-content content-type="city">Toronto</named-content>
<country country="CA">Canada</country>
</aff><aff id="bdi12556-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Departments of Psychiatry and Pharmacology</named-content>
<institution>University of Toronto</institution>
<named-content content-type="city">Toronto</named-content>
<country country="CA">Canada</country>
</aff><aff id="bdi12556-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Psychiatry</named-content>
<institution>University of Pittsburgh School of Medicine</institution>
<named-content content-type="city">Pittsburgh</named-content>
<named-content content-type="country-part">PA</named-content>
<country country="US">USA</country>
</aff><aff id="bdi12556-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Psychiatry</named-content>
<institution>Stony Brook University School of Medicine</institution>
<named-content content-type="city">Stony Brook</named-content>
<named-content content-type="country-part">NY</named-content>
<country country="US">USA</country>
</aff><aff id="bdi12556-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Department of Psychiatry &#x00026; Behavioral Neuroscience</named-content>
<institution>University of Cincinnati</institution>
<named-content content-type="city">Cincinnati</named-content>
<named-content content-type="country-part">OH</named-content>
<country country="US">USA</country>
</aff><aff id="bdi12556-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">Department of Psychiatry &#x00026; Behavioral Sciences</named-content>
<institution>The Johns Hopkins University</institution>
<named-content content-type="city">Baltimore</named-content>
<named-content content-type="country-part">MD</named-content>
<country country="US">USA</country>
</aff><aff id="bdi12556-aff-0007">
<label><sup>7</sup></label>
<institution>Ohio State University Wexner Medical Center/Nationwide Children's Hospital</institution>
<named-content content-type="city">Columbus</named-content>
<named-content content-type="country-part">OH</named-content>
<country country="US">USA</country>
</aff><aff id="bdi12556-aff-0008">
<label><sup>8</sup></label>
<named-content content-type="organisation-division">Department of Psychiatry</named-content>
<institution>UCLA</institution>
<named-content content-type="city">Los Angeles</named-content>
<named-content content-type="country-part">CA</named-content>
<country country="US">USA</country>
</aff><aff id="bdi12556-aff-0009">
<label><sup>9</sup></label>
<named-content content-type="organisation-division">Division of Health Research</named-content>
<institution>Lancaster University</institution>
<named-content content-type="city">Lancaster</named-content>
<country country="GB">UK</country>
</aff><aff id="bdi12556-aff-0010">
<label><sup>10</sup></label>
<named-content content-type="organisation-division">Ferkauf Graduate School of Psychology</named-content>
<institution>Yeshiva University</institution>
<named-content content-type="city">Bronx</named-content>
<named-content content-type="country-part">NY</named-content>
<country country="US">USA</country>
</aff><aff id="bdi12556-aff-0011">
<label><sup>11</sup></label>
<named-content content-type="organisation-division">Department of Psychiatry</named-content>
<institution>University of Texas</institution>
<named-content content-type="city">Houston</named-content>
<named-content content-type="country-part">TX</named-content>
<country country="US">USA</country>
</aff><aff id="bdi12556-aff-0012">
<label><sup>12</sup></label>
<named-content content-type="organisation-division">The Zucker Hillside Hospital</named-content>
<named-content content-type="organisation-division">Department of Psychiatry</named-content>
<institution>Northwell Health</institution>
<named-content content-type="city">Glen Oaks</named-content>
<named-content content-type="country-part">NY</named-content>
<country country="US">USA</country>
</aff><aff id="bdi12556-aff-0013">
<label><sup>13</sup></label>
<named-content content-type="organisation-division">Department of Psychiatry and Molecular Medicine</named-content>
<institution>Hofstra Northwell School of Medicine</institution>
<named-content content-type="city">Hempstead</named-content>
<named-content content-type="country-part">NY</named-content>
<country country="US">USA</country>
</aff><aff id="bdi12556-aff-0014">
<label><sup>14</sup></label>
<named-content content-type="organisation-division">Department of Psychiatry</named-content>
<institution>University of Ulsan College of Medicine</institution>
<institution>Asan Medical Center</institution>
<named-content content-type="city">Seoul</named-content>
<country country="KP">Korea</country>
</aff><aff id="bdi12556-aff-0015">
<label><sup>15</sup></label>
<named-content content-type="organisation-division">Clinical and Research Program in Pediatric Psychopharmacology</named-content>
<institution>Massachusetts General Hospital</institution>
<institution>Harvard Medical School</institution>
<named-content content-type="city">Boston</named-content>
<named-content content-type="country-part">MA</named-content>
<country country="US">USA</country>
</aff><aff id="bdi12556-aff-0016">
<label><sup>16</sup></label>
<named-content content-type="organisation-division">Department of Psychiatry</named-content>
<institution>Stanford University</institution>
<named-content content-type="city">Palo Alto</named-content>
<named-content content-type="country-part">CA</named-content>
<country country="US">USA</country>
</aff><aff id="bdi12556-aff-0017">
<label><sup>17</sup></label>
<named-content content-type="organisation-division">Department of Child and Adolescent Psychiatry and Psychology</named-content>
<institution>Erasmus Medical Center&#x02010;Sophia</institution>
<named-content content-type="city">Rotterdam</named-content>
<country country="NL">The Netherlands</country>
</aff><aff id="bdi12556-aff-0018">
<label><sup>18</sup></label>
<named-content content-type="organisation-division">Department of Psychology and Neuroscience</named-content>
<institution>University of North Carolina</institution>
<named-content content-type="city">Chapel Hill</named-content>
<named-content content-type="country-part">NC</named-content>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Benjamin I Goldstein, Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, Toronto, Canada.<break/>
Email: <email>benjamin.goldstein@sunnybrook.ca</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>9</month><year>2017</year></pub-date><pub-date pub-type="ppub"><month>11</month><year>2017</year></pub-date><volume>19</volume><issue>7</issue><issue-id pub-id-type="doi">10.1111/bdi.2017.19.issue-7</issue-id><fpage>524</fpage><lpage>543</lpage><history><date date-type="received"><day>05</day><month>4</month><year>2017</year></date><date date-type="accepted"><day>14</day><month>8</month><year>2017</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2017 John Wiley & Sons A/S <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2017 The Authors <italic>Bipolar Disorders</italic> Published by John Wiley &#x00026; Sons Ltd</copyright-statement><license license-type="creativeCommonsBy-nc"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution&#x02010;NonCommercial</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:BDI-19-524.pdf"/><abstract id="bdi12556-abs-0001"><sec id="bdi12556-sec-0001"><title>Objectives</title><p>Over the past two decades, there has been tremendous growth in research regarding bipolar disorder (<styled-content style="fixed-case">BD</styled-content>) among children and adolescents (ie, pediatric <styled-content style="fixed-case">BD</styled-content> [<styled-content style="fixed-case">PBD</styled-content>]). The primary purpose of this article is to distill the extant literature, dispel myths or exaggerated assertions in the field, and disseminate clinically relevant findings.</p></sec><sec id="bdi12556-sec-0002"><title>Methods</title><p>An international group of experts completed a selective review of the literature, emphasizing areas of consensus, identifying limitations and gaps in the literature, and highlighting future directions to mitigate these gaps.</p></sec><sec id="bdi12556-sec-0003"><title>Results</title><p>Substantial, and increasingly international, research has accumulated regarding the phenomenology, differential diagnosis, course, treatment, and neurobiology of <styled-content style="fixed-case">PBD</styled-content>. Prior division around the role of irritability and of screening tools in diagnosis has largely abated. Gold&#x02010;standard pharmacologic trials inform treatment of manic/mixed episodes, whereas fewer data address bipolar depression and maintenance/continuation treatment. Adjunctive psychosocial treatment provides a forum for psychoeducation and targets primarily depressive symptoms. Numerous neurocognitive and neuroimaging studies, and increasing peripheral biomarker studies, largely converge with prior findings from adults with <styled-content style="fixed-case">BD</styled-content>.</p></sec><sec id="bdi12556-sec-0004"><title>Conclusions</title><p>As data have accumulated and controversy has dissipated, the field has moved past existential questions about <styled-content style="fixed-case">PBD</styled-content> toward defining and pursuing pressing clinical and scientific priorities that remain. The overall body of evidence supports the position that perceptions about marked international (US vs elsewhere) and developmental (pediatric vs adult) differences have been overstated, although additional research on these topics is warranted. Traction toward improved outcomes will be supported by continued emphasis on pathophysiology and novel therapeutics.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="bdi12556-kwd-0001">adolescent</kwd><kwd id="bdi12556-kwd-0002">bipolar disorder</kwd><kwd id="bdi12556-kwd-0003">child</kwd><kwd id="bdi12556-kwd-0004">pediatric</kwd><kwd id="bdi12556-kwd-0005">youth</kwd></kwd-group><funding-group><award-group><funding-source>National Institute of Mental Health</funding-source></award-group><award-group><funding-source>Random House, Inc.</funding-source></award-group><award-group><funding-source>Lippincott Williams &#x00026; Wilkins</funding-source></award-group><award-group><funding-source>APA Press</funding-source></award-group><award-group><funding-source>UpToDate</funding-source></award-group><award-group><funding-source>Patient Centered Outcomes Research Institute (PCORI)</funding-source></award-group><award-group><funding-source>Merck</funding-source></award-group><award-group><funding-source>NIDDK</funding-source></award-group><award-group><funding-source>Otsuka</funding-source></award-group><award-group><funding-source>Lundbeck</funding-source></award-group><award-group><funding-source>Sunovion</funding-source></award-group><award-group><funding-source>Pfizer</funding-source></award-group><award-group><funding-source>Johnson and Johnson</funding-source></award-group><award-group><funding-source>Supernus</funding-source></award-group><award-group><funding-source>Amarex</funding-source></award-group><award-group><funding-source>Shire</funding-source></award-group><award-group><funding-source>Takeda</funding-source></award-group><award-group><funding-source>Neuronetics</funding-source></award-group><award-group><funding-source>Akili</funding-source></award-group><award-group><funding-source>Actavis</funding-source></award-group><award-group><funding-source>Alcobra</funding-source></award-group><award-group><funding-source>American Academy of Child &#x00026; Adolescent Psychiatry</funding-source></award-group><award-group><funding-source>American Psychiatric Press</funding-source></award-group><award-group><funding-source>Bracket</funding-source></award-group><award-group><funding-source>CogCubed</funding-source></award-group><award-group><funding-source>Cognition Group</funding-source></award-group><award-group><funding-source>Coronado Biosciences</funding-source></award-group><award-group><funding-source>Elsevier</funding-source></award-group><award-group><funding-source>Epharma Solutions</funding-source></award-group><award-group><funding-source>Forest</funding-source></award-group><award-group><funding-source>Genentech</funding-source></award-group><award-group><funding-source>Guilford Press</funding-source></award-group><award-group><funding-source>Ironshore</funding-source></award-group><award-group><funding-source>Johns Hopkins University Press</funding-source></award-group><award-group><funding-source>KemPharm</funding-source></award-group><award-group><funding-source>Medgenics</funding-source></award-group><award-group><funding-source>NIH</funding-source></award-group><award-group><funding-source>Neurim</funding-source></award-group><award-group><funding-source>Novartis</funding-source></award-group><award-group><funding-source>Physicians Postgraduate Press</funding-source></award-group><award-group><funding-source>Purdue</funding-source></award-group><award-group><funding-source>Rhodes Pharmaceuticals</funding-source></award-group><award-group><funding-source>Roche</funding-source></award-group><award-group><funding-source>Sage</funding-source></award-group><award-group><funding-source>Syneurx</funding-source></award-group><award-group><funding-source>Teva</funding-source></award-group><award-group><funding-source>Tris</funding-source></award-group><award-group><funding-source>Validus</funding-source></award-group><award-group><funding-source>WebMD</funding-source></award-group><award-group><funding-source>Janssen</funding-source></award-group><award-group><funding-source>John Wiley &#x00026; Sons</funding-source></award-group><award-group><funding-source>UCB Pharma</funding-source></award-group><award-group><funding-source>NeuroMetrix</funding-source></award-group><award-group><funding-source>Luitpold</funding-source></award-group></funding-group><counts><fig-count count="1"/><table-count count="1"/><page-count count="20"/><word-count count="18284"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>bdi12556</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>November 2017</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.2.8 mode:remove_FC converted:12.12.2017</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="bdi12556-cit-1001">
<string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>, <string-name>
<surname>Birmaher</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Carlson</surname>
<given-names>GA</given-names>
</string-name>, et&#x000a0;al. <article-title>The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research</article-title>. <source>Bipolar Disord</source>. <year>2017</year>;<volume>19</volume>:<fpage>524</fpage>&#x02013;<lpage>543</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/bdi.12556">https://doi.org/10.1111/bdi.12556</ext-link>
<pub-id pub-id-type="pmid">28944987</pub-id></mixed-citation>
</p><fn-group id="bdi12556-ntgp-0101"><fn id="bdi12556-note-1001"><p>[Correction added on 6 October 2017, after first online publication: Copyright License changed.]</p></fn></fn-group></notes></front><body><sec id="bdi12556-sec-0005"><label>1</label><title>INTRODUCTION</title><p>Over the past two decades, there has been tremendous growth in the scientific literature regarding bipolar disorder (BD) among children and adolescents (ie, pediatric BD [PBD]) (Figure&#x000a0;<xref rid="bdi12556-fig-0001" ref-type="fig">1</xref>). The literature now contains numerous gold&#x02010;standard clinical trials of pharmacologic agents for mania, an increasing evidence base for adjunctive psychosocial treatments, several large&#x02010;scale prospective clinical cohort studies, representative epidemiologic studies (particularly focused on adolescents) with international representation, numerous neurocognitive and neuroimaging studies, and an accelerating number of biomarker studies. Despite the volume, quality, and international spectrum of available literature, and regardless of the general consensus about some of the field's previously most divisive and controversial topics, there remains a perspective in the popular press, other branches of medicine, and even within mental health that the field of PBD lacks evidence and is replete with controversy. Therefore, the primary purpose of this article is to <italic>distill</italic> the extant literature, <italic>dispel</italic> myths or exaggerated assertions in the field, and <italic>disseminate</italic> clinically relevant findings. In this paper, an international group of experts completed a selective review of the extant literature (including PubMed and Web of Science/PsycINFO searches, querying other databases or conference proceedings and unpublished reports on an ad hoc basis), emphasizing areas of established findings and consensus, identifying limitations and gaps in the literature, and highlighting future directions to mitigate these gaps.</p><fig fig-type="Figure" xml:lang="en" id="bdi12556-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Articles about pediatric bipolar disorder indexed in PubMed each year. Search terms were (&#x0201c;bipolar disorder&#x0201d; or mania or manic) and (child or adole* or pediatric or juvenile)</p></caption><graphic id="nlm-graphic-1" xlink:href="BDI-19-524-g001"/></fig></sec><sec id="bdi12556-sec-0006"><label>2</label><title>EPIDEMIOLOGY</title><sec id="bdi12556-sec-0007"><label>2.1</label><title>Established findings and consensus</title><p>In community samples around the world, it is now well established that bipolar spectrum disorders&#x02014;an umbrella that covers bipolar I disorder, bipolar II disorder, cyclothymic disorder [CycD], bipolar disorder not otherwise specified (NOS) and other specified bipolar and related disorders (OS&#x02010;BRD)&#x02014;occur in youths. The update of a published meta&#x02010;analysis of epidemiologic studies<xref rid="bdi12556-bib-0001" ref-type="ref">1</xref> using an identical search strategy identified six new studies satisfying inclusion criteria. The update includes 17 studies (seven from the USA) with 31&#x000a0;443 youth aged 7&#x02010;21&#x000a0;years, 576 of whom met criteria for bipolar spectrum disorders.<xref rid="bdi12556-bib-0002" ref-type="ref">2</xref>, <xref rid="bdi12556-bib-0003" ref-type="ref">3</xref>, <xref rid="bdi12556-bib-0004" ref-type="ref">4</xref>, <xref rid="bdi12556-bib-0005" ref-type="ref">5</xref>, <xref rid="bdi12556-bib-0006" ref-type="ref">6</xref>, <xref rid="bdi12556-bib-0007" ref-type="ref">7</xref>, <xref rid="bdi12556-bib-0008" ref-type="ref">8</xref>, <xref rid="bdi12556-bib-0009" ref-type="ref">9</xref>, <xref rid="bdi12556-bib-0010" ref-type="ref">10</xref>, <xref rid="bdi12556-bib-0011" ref-type="ref">11</xref>, <xref rid="bdi12556-bib-0012" ref-type="ref">12</xref>, <xref rid="bdi12556-bib-0013" ref-type="ref">13</xref>, <xref rid="bdi12556-bib-0014" ref-type="ref">14</xref>, <xref rid="bdi12556-bib-0015" ref-type="ref">15</xref>, <xref rid="bdi12556-bib-0016" ref-type="ref">16</xref>, <xref rid="bdi12556-bib-0017" ref-type="ref">17</xref> The updated weighted average prevalence rate of bipolar spectrum disorders is 2.06% (95% confidence interval [CI] 1.44%&#x02010;2.95%).</p><p>There was substantial heterogeneity across studies, but it was not explained by year of data collection, lifetime prevalence (vs other time periods), or sex. Studies that included more adolescents had significantly higher prevalence estimates. Differences in the definition of BD explained the largest portion of variance between studies. As expected, broader definitions (ie, including NOS or CycD) had the highest rates while narrow definitions (ie, BD&#x02010;I and &#x02010;II only) had lower rates, but even this was not a complete explanation. The weighted average prevalence of BD&#x02010;I was 0.49% (95% CI 0.22%&#x02010;1.09%), with four of 12 studies reporting no BD&#x02010;I cases. Although there is no epidemiologic study on PBD in Asia, several studies from clinical samples reported that PBD is also prevalent in Asia.<xref rid="bdi12556-bib-0018" ref-type="ref">18</xref>, <xref rid="bdi12556-bib-0019" ref-type="ref">19</xref>, <xref rid="bdi12556-bib-0020" ref-type="ref">20</xref>
</p><p>Community rates are not higher in the USA, nor do rates appear to be increasing over time. In contrast, billing and services data show a marked increase in rates of diagnoses in the USA over a 20&#x02010;year period.<xref rid="bdi12556-bib-0021" ref-type="ref">21</xref>, <xref rid="bdi12556-bib-0022" ref-type="ref">22</xref> Differences in training, conceptualization of cases and insurance demands appear more of a factor<xref rid="bdi12556-bib-0023" ref-type="ref">23</xref> than underlying differences in prevalence.</p><p>In summary, PBD prevalence rates appear relatively stable across studies. PBD is more common than autism or schizophrenia and much less common than depression or attention deficit hyperactivity disorder (ADHD) in the community; more data are available with post&#x02010;pubertal samples, and they find higher rates than before puberty.<xref rid="bdi12556-bib-0024" ref-type="ref">24</xref>
</p></sec><sec id="bdi12556-sec-0008"><label>2.2</label><title>Limitations, gaps, and future directions</title><p>New epidemiologic studies need to systematically assess hypomania and mania and differentiate them from other non&#x02010;mood psychopathology. Even the newest epidemiologic data were collected at least 10&#x000a0;years ago (range 1986&#x02010;2005), and fewer than 1% of indexed papers on pediatric epidemiology include data about BD.<xref rid="bdi12556-bib-0001" ref-type="ref">1</xref> Documenting age of onset of the first mood episode of each type will be vital, with more studies including prepubertal children, to clarify onset and course. If depression manifests first, it may not be clear that it is following a bipolar course until later. Onset age may be bimodal<xref rid="bdi12556-bib-0025" ref-type="ref">25</xref>, <xref rid="bdi12556-bib-0026" ref-type="ref">26</xref> and American youth may be at higher risk for very early onset.<xref rid="bdi12556-bib-0027" ref-type="ref">27</xref> Existing literature confounds age and informant effects: studies with older participants are less likely to include interviews of parents. Studies relying only on retrospective self&#x02010;report are likely to underestimate hypomania or mania, as people forget or minimize the events, whereas depression may be more salient. Using more consistent criteria across studies will reduce the largest source of variance identified in extant meta&#x02010;analyses.</p></sec></sec><sec id="bdi12556-sec-0009"><label>3</label><title>INTERNATIONAL FINDINGS</title><sec id="bdi12556-sec-0010"><label>3.1</label><title>Established findings and consensus</title><p>Prior studies in adults suggested that, although BD occurs worldwide, there could be international differences in the clinical characteristics of BD, including age of onset, comorbidity, early adversity, and familiality.<xref rid="bdi12556-bib-0028" ref-type="ref">28</xref>, <xref rid="bdi12556-bib-0029" ref-type="ref">29</xref> Although international differences in BD are less well studied in youth as compared to adults, there now are PBD data from multiple countries including Australia/New Zealand, Brazil, China, France, India, Italy, South Korea, Spain, the Netherlands, Turkey, and the UK.<xref rid="bdi12556-bib-0030" ref-type="ref">30</xref> In addition to the epidemiologic studies reviewed above, international BD data now include phenomenological,<xref rid="bdi12556-bib-0019" ref-type="ref">19</xref>, <xref rid="bdi12556-bib-0031" ref-type="ref">31</xref>, <xref rid="bdi12556-bib-0032" ref-type="ref">32</xref>, <xref rid="bdi12556-bib-0033" ref-type="ref">33</xref> comorbidity,<xref rid="bdi12556-bib-0019" ref-type="ref">19</xref>, <xref rid="bdi12556-bib-0034" ref-type="ref">34</xref> longitudinal,<xref rid="bdi12556-bib-0035" ref-type="ref">35</xref>, <xref rid="bdi12556-bib-0036" ref-type="ref">36</xref> treatment,<xref rid="bdi12556-bib-0037" ref-type="ref">37</xref>, <xref rid="bdi12556-bib-0038" ref-type="ref">38</xref> neuroimaging and biomarker,<xref rid="bdi12556-bib-0039" ref-type="ref">39</xref>, <xref rid="bdi12556-bib-0040" ref-type="ref">40</xref>, <xref rid="bdi12556-bib-0041" ref-type="ref">41</xref> and high&#x02010;risk studies.<xref rid="bdi12556-bib-0042" ref-type="ref">42</xref>, <xref rid="bdi12556-bib-0043" ref-type="ref">43</xref> Numerous commentaries discuss purported international differences in the prevalence of PBD, which may be attributable to including more subtypes,<xref rid="bdi12556-bib-0001" ref-type="ref">1</xref> differences in the interview method,<xref rid="bdi12556-bib-0044" ref-type="ref">44</xref> training,<xref rid="bdi12556-bib-0023" ref-type="ref">23</xref>, <xref rid="bdi12556-bib-0045" ref-type="ref">45</xref> or the type of sample studied (predominantly manic, depressive, treatment&#x02010;seeking or registry), or a combination of these.<xref rid="bdi12556-bib-0046" ref-type="ref">46</xref>
</p><p>Some findings converge with US data. For example, Brazilian families with PBD also show lower positive regard and higher negative expressed emotion (EE) compared to control families.<xref rid="bdi12556-bib-0047" ref-type="ref">47</xref> There are, however, examples of non&#x02010;replication. In contrast to US data, a recent Brazilian imaging study did not find white matter microstructure differences between PBD youth, healthy bipolar offspring and healthy controls,<xref rid="bdi12556-bib-0048" ref-type="ref">48</xref> and parent report of youth mood symptoms showed much lower discriminative validity than parent report in other countries.<xref rid="bdi12556-bib-0049" ref-type="ref">49</xref> However, it is unclear whether this a true international difference or a difference owing to methodologic factors.</p><p>A recent study directly compared Dutch and US samples of offspring of parents with BD.<xref rid="bdi12556-bib-0050" ref-type="ref">50</xref> Both projects used the Achenbach Child Behavior Checklist (CBCL)<xref rid="bdi12556-bib-0051" ref-type="ref">51</xref> as well as similar semi&#x02010;structured interviews (eg, the Kiddie Schedule for Affective Disorders and Schizophrenia).<xref rid="bdi12556-bib-0052" ref-type="ref">52</xref> After controlling for age, rates of DSM&#x02010;IV BD&#x02010;I (2.2% in the US sample and 1.5% in the Dutch sample) and BD&#x02010;II (2% and 1%, respectively) were similar. In contrast, other disorders were significantly more common in the US sample, including depressive disorders (13% vs 4% in the Dutch sample), anxiety disorders (31% vs 9%, respectively), ADHD (22% vs 8%, respectively), and disruptive behavior disorder (19% vs 6%, respectively). CBCL Externalizing scores were higher in the US sample (mean + standard deviation 15.0&#x000a0;+&#x000a0;9.7 vs 10.8&#x000a0;+&#x000a0;7.6, respectively, <italic>P</italic>&#x000a0;=&#x000a0;.03). However, Internalizing scores did not differ between samples (raw <italic>M&#x000a0;</italic>~&#x000a0;15), despite higher rates of anxiety and depressive disorders in the US sample. In the US, fewer parents had BD&#x02010;I, affected parents were younger at their own illness onset, parental substance abuse rates were higher, and rates of parental employment and youth living with both biological parents were lower. These stressors may have contributed to the greater rates of problems in the US sample. The differences also illustrate the importance of the psychopathology of the parent bipolar sample to understanding rates of offspring psychopathology. The internalizing findings also suggest that there could be differences in clinical interpretation of similar levels of pathology, even using semi&#x02010;structured approaches.</p></sec><sec id="bdi12556-sec-0011"><label>3.2</label><title>Limitations, gaps, and future directions</title><p>Future work needs to determine whether there are meaningful international differences in the prevalence, phenomenology, course, treatment, and biology of PBD. Translating scales into multiple languages and pursuing cross&#x02010;cultural validation are accelerating progress by using consistent definitions,<xref rid="bdi12556-bib-0050" ref-type="ref">50</xref> revealing considerable continuity in phenomenology.<xref rid="bdi12556-bib-0053" ref-type="ref">53</xref> Combining data sets internationally would help calibrate definitions and examine common risk factors.</p></sec></sec><sec id="bdi12556-sec-0012"><label>4</label><title>CLINICAL CHARACTERISTICS, DIFFERENTIAL DIAGNOSES, AND COURSE</title><sec id="bdi12556-sec-0013"><label>4.1</label><title>Established findings and consensus</title><sec id="bdi12556-sec-0014"><label>4.1.1</label><title>Clinical characteristics</title><p>Interest in BD phenotypes spans decades. Over 25&#x000a0;years ago, the issue of severe chronic irritability as part of the bipolar spectrum polarized the field; this issue is now largely resolved.<xref rid="bdi12556-bib-0046" ref-type="ref">46</xref>, <xref rid="bdi12556-bib-0054" ref-type="ref">54</xref>, <xref rid="bdi12556-bib-0055" ref-type="ref">55</xref> With regard to symptom presentations, one position held that elation and/or grandiosity was required for a diagnosis of BD in youth.<xref rid="bdi12556-bib-0056" ref-type="ref">56</xref> There now is substantial consensus that chronic irritability, regardless of explosiveness or severity, is not sufficient for a diagnosis of BD, in contrast with formulations that focused on rages or severe aggression.<xref rid="bdi12556-bib-0057" ref-type="ref">57</xref> However, irritability is commonly present in youth with BD. Counting irritability as part of the diagnostic criteria for a manic or hypomanic episode requires that the irritability either begins or significantly increases in intensity <italic>in conjunction with</italic> the presence of accompanying manic (DSM Criterion B) symptoms. Thus, a youth with BPD <italic>may</italic> have chronic irritability, but the diagnosis would not be made based on that mood state.<xref rid="bdi12556-bib-0058" ref-type="ref">58</xref>, <xref rid="bdi12556-bib-0059" ref-type="ref">59</xref>, <xref rid="bdi12556-bib-0060" ref-type="ref">60</xref>, <xref rid="bdi12556-bib-0061" ref-type="ref">61</xref> Although severe irritability and emotional dysregulation are not proxies for BD, they are also not mutually exclusive of episodic, DSM&#x02010;adherent BD. Irritability that waxes and wanes spontaneously or in conjunction with other episodic changes in energy or sleep is much more suggestive of a mood disorder than other pathology.</p><p>While calls to include severe, chronic irritability as a developmental type of BD among youth have waned, substantial data have accrued concerning repeated brief discrete episodes of hypomania for less than 4&#x000a0;days as part of the BD spectrum. As among adults,<xref rid="bdi12556-bib-0062" ref-type="ref">62</xref> youth manifest CycD<xref rid="bdi12556-bib-0063" ref-type="ref">63</xref> and episodic OS&#x02010;BRD, as well as BD&#x02010;I and BD&#x02010;II. However, as described below, youth with brief but well&#x02010;defined episodes of mania or hypomania are at very high risk to switch into BD&#x02010;I or BD&#x02010;II (particularly if they have a family history of BD),<xref rid="bdi12556-bib-0064" ref-type="ref">64</xref> and they have as much psychosocial impairment, suicidality, comorbidity (eg, substance abuse), and family history of BD as those with BD&#x02010;I.<xref rid="bdi12556-bib-0065" ref-type="ref">65</xref> Less research has specifically addressed CycD, which is often subsumed within the BD&#x02010;NOS category due to lack of operationalized criteria.<xref rid="bdi12556-bib-0001" ref-type="ref">1</xref>, <xref rid="bdi12556-bib-0063" ref-type="ref">63</xref>, <xref rid="bdi12556-bib-0066" ref-type="ref">66</xref>
</p><p>Ultra&#x02010;rapid or &#x0201c;ultradian&#x0201d; cycling also has been associated with pediatric (as well as adult) BD.<xref rid="bdi12556-bib-0067" ref-type="ref">67</xref> Although youth with BD, particularly younger children, often have more mood fluctuations than adults, it appears that &#x0201c;ultra&#x02010;rapid cycles&#x0201d; describes mood fluctuation within an episode, and they are not themselves distinct episodes.<xref rid="bdi12556-bib-0068" ref-type="ref">68</xref>
</p><p>Similar to adult BD, PBD has extensive comorbidity, both in representative epidemiologic studies with largely untreated samples<xref rid="bdi12556-bib-0017" ref-type="ref">17</xref>, <xref rid="bdi12556-bib-0069" ref-type="ref">69</xref>, <xref rid="bdi12556-bib-0070" ref-type="ref">70</xref> and in clinical samples.<xref rid="bdi12556-bib-0071" ref-type="ref">71</xref> With the exception of developmental disorders like ADHD and autism spectrum disorders, the patterns of comorbidity are broadly consistent between youth and adult presentations.<xref rid="bdi12556-bib-0071" ref-type="ref">71</xref>, <xref rid="bdi12556-bib-0072" ref-type="ref">72</xref> Apparent differences may partly reflect limited assessment of ADHD and autism spectrum disorders in adult samples rather than a true difference in comorbidities between these age groups, although some studies also suggest an association between ADHD and earlier age of onset of bipolar illness in adult samples.<xref rid="bdi12556-bib-0073" ref-type="ref">73</xref>, <xref rid="bdi12556-bib-0074" ref-type="ref">74</xref> The presence of comorbid disorders worsens the course and outcome of PBD, indicating the need for their identification and treatment. When determining comorbid diagnoses, it is important not to &#x0201c;double&#x02010;count&#x0201d; overlapping diagnostic symptoms (eg, hyperactivity in ADHD and irritability in multiple disorders), as this leads to artificially high rates of comorbidity. Identifying discrete mood episodes and ensuring that overlapping symptoms are (i) over and above what can be expected from the individual's baseline and (ii) concurrent with mood episodes helps disentangle clinical presentations. Conversely, symptoms that persist in periods of euthymia suggest a non&#x02010;mood etiology, and thus a &#x0201c;true&#x0201d; comorbidity. Finally, there is increasing evidence that medical comorbidity is relevant to PBD, both in terms of the association of physical health characteristics such as obesity with suicidality, neurocognition, and other markers of psychiatric symptom burden, and in terms of future premature cardiovascular disease.<xref rid="bdi12556-bib-0075" ref-type="ref">75</xref>, <xref rid="bdi12556-bib-0076" ref-type="ref">76</xref>, <xref rid="bdi12556-bib-0077" ref-type="ref">77</xref>, <xref rid="bdi12556-bib-0078" ref-type="ref">78</xref>, <xref rid="bdi12556-bib-0079" ref-type="ref">79</xref> Medical comorbidity is closely related to both the mood symptoms and related lifestyle behaviors such as sedentary lifestyle and binge&#x02010;eating in PBD.<xref rid="bdi12556-bib-0080" ref-type="ref">80</xref>, <xref rid="bdi12556-bib-0081" ref-type="ref">81</xref>
</p></sec><sec id="bdi12556-sec-0015"><label>4.1.2</label><title>Differential diagnosis</title><p>Diagnosing PBD requires changes in mood and behavior that are uncharacteristic of the individual and more extreme than developmentally appropriate, persist long enough to satisfy duration criteria, and have a clear impact on functioning. If comorbid disorders are present, mood symptoms need to be above and beyond the regular symptoms for the other disorder. For example, if symptoms of ADHD get worse episodically, and during these episodes the youth presents symptoms more specific to mania (eg, decreased need for sleep), a PBD diagnosis should be considered. Symptom sequence may help differentiate BD from some other disorders: a teen with BD might first experience symptoms of hypomania and depression and then begin using substances, in contrast to another teen who experimented with drugs first and then began showing irritability. However, it can be difficult to separate onset of a comorbid disorder from onset of manic/hypomanic symptoms.</p><p>Although the new and controversial DSM&#x02010;5 diagnosis of disruptive mood dysregulation disorder (DMDD) cannot formally be diagnosed if the youth has BD,<xref rid="bdi12556-bib-0082" ref-type="ref">82</xref> the phenotype commonly overlaps with those of all BD subtypes<xref rid="bdi12556-bib-0060" ref-type="ref">60</xref>, <xref rid="bdi12556-bib-0083" ref-type="ref">83</xref>, <xref rid="bdi12556-bib-0084" ref-type="ref">84</xref> as well as other conditions, particularly oppositional defiant disorder (ODD).<xref rid="bdi12556-bib-0085" ref-type="ref">85</xref>, <xref rid="bdi12556-bib-0086" ref-type="ref">86</xref> Thus, one must evaluate the potential presence of BD even if DMDD is identified, and vice versa. The reliability of DMDD diagnoses was low in the DSM&#x02010;5 field trials, suggesting that it may be challenging to accurately identify clinically.</p></sec><sec id="bdi12556-sec-0016"><label>4.1.3</label><title>Course</title><p>Multiple longitudinal studies have prospectively followed cohorts of youths for 4 or more years. Consistent findings include (i) high rates of progression from BD&#x02010;NOS or CycD to BD&#x02010;I or BD&#x02010;II (eg, 43%),<xref rid="bdi12556-bib-0064" ref-type="ref">64</xref> particularly in youth with a family history of BD; (ii) high rates of recovery from episodes, particularly with treatment (eg, 81.5%);<xref rid="bdi12556-bib-0087" ref-type="ref">87</xref>, <xref rid="bdi12556-bib-0088" ref-type="ref">88</xref> (iii) high rates of recurrence of depression, hypomania, or mania (eg, 62.5%);<xref rid="bdi12556-bib-0064" ref-type="ref">64</xref>, <xref rid="bdi12556-bib-0087" ref-type="ref">87</xref>, <xref rid="bdi12556-bib-0089" ref-type="ref">89</xref>, <xref rid="bdi12556-bib-0090" ref-type="ref">90</xref> and (iv) patterns of comorbidity<xref rid="bdi12556-bib-0091" ref-type="ref">91</xref> and treatment response congruent with adult BD.<xref rid="bdi12556-bib-0092" ref-type="ref">92</xref> The prodrome of BD&#x02010;I or BD&#x02010;II, often identified retrospectively in adult studies, commonly involves attenuated mood symptoms; and sleep disturbance may be a marker clinically (see reference for detailed discussion of prodrome).<xref rid="bdi12556-bib-0093" ref-type="ref">93</xref>
</p></sec></sec><sec id="bdi12556-sec-0017"><label>4.2</label><title>Limitations, gaps, and future directions</title><p>Remaining controversies include whether ADHD might be a prodrome for BD. Some studies suggest that ADHD might be a prodrome,<xref rid="bdi12556-bib-0094" ref-type="ref">94</xref>, <xref rid="bdi12556-bib-0095" ref-type="ref">95</xref> although some used interviews that blurred the distinction between mood episodes and more chronic presentations.<xref rid="bdi12556-bib-0044" ref-type="ref">44</xref> Longitudinal studies of ADHD cohorts tend to find no or only small increases in risk of BD.<xref rid="bdi12556-bib-0096" ref-type="ref">96</xref> Adding the DMDD diagnosis to DSM&#x02010;5 created several gaps in terms of evidence&#x02010;based assessment methods to differentiate DMDD from mood disorders, and lack of clarity regarding effective treatments. DMDD has its own definitional problems, as irritability includes both mood (often loses temper) and behavior (what happens when temper is lost).<xref rid="bdi12556-bib-0046" ref-type="ref">46</xref> The next version of ICD will not add DMDD as a diagnosis, instead making a mood disturbance specifier for ODD.<xref rid="bdi12556-bib-0097" ref-type="ref">97</xref> Research needs to evaluate the relative effectiveness of psychosocial (eg, parent training; emotion regulation strategies) and pharmacologic interventions for DMDD.<xref rid="bdi12556-bib-0061" ref-type="ref">61</xref>, <xref rid="bdi12556-bib-0098" ref-type="ref">98</xref> Longitudinal data also raise interesting questions about the possibility of remission of DMDD and bipolar disorders,<xref rid="bdi12556-bib-0055" ref-type="ref">55</xref>, <xref rid="bdi12556-bib-0099" ref-type="ref">99</xref> a topic that warrants further study.</p></sec></sec><sec id="bdi12556-sec-0018"><label>5</label><title>MEASUREMENT</title><sec id="bdi12556-sec-0019"><label>5.1</label><title>Established findings and consensus</title><p>There has been a large increase in the number of scales available and supported by data to measure different aspects of PBD. Myths ready for retirement include: (i) there is no validated rating scale or checklist for assessing manic symptoms in youth, (ii) a profile of scores on the CBCL<xref rid="bdi12556-bib-0051" ref-type="ref">51</xref> can be used as a proxy for a diagnosis of PBD, and (iii) thinking in polarized terms about the value of a particular informant perspective in the evaluation of PBD (see Table&#x000a0;<xref rid="bdi12556-tbl-0001" ref-type="table-wrap">1</xref>). Common (and mistaken) beliefs include &#x0201c;teacher report is essential for confirming a diagnosis of mania,&#x0201d; vs &#x0201c;teacher report is useless in the evaluation of PBD&#x0201d;, or &#x0201c;parents&#x02019; perspective is always right&#x0201d; vs &#x0201c;parents&#x02019; perspective is hopelessly contaminated by their own mood or agenda.&#x0201d;</p><table-wrap id="bdi12556-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Summary of myths, consensus, and next actions for research on pediatric bipolar disorder</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Area</th><th align="left" valign="top" rowspan="1" colspan="1">Myths</th><th align="left" valign="top" rowspan="1" colspan="1">Data</th><th align="left" valign="top" rowspan="1" colspan="1">Five&#x02010;year needs</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1. Epidemiology</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0001"><list-item><p>Doesn't happen in children</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0002"><list-item><p>Evident in epidemiologic samples in ages 5 years and higher</p></list-item><list-item><p>Convergent adolescent data</p></list-item><list-item><p>No difference in overall or BD&#x02010;I/II rates</p></list-item><list-item><p>Inconsistent inclusion and/or definition of NOS/OS&#x02010;BRD</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0003"><list-item><p>Include full age range</p></list-item><list-item><p>Use consistent definition of BD spectrum (NOS and OS&#x02010;BRD)</p></list-item><list-item><p>Examine BMI, pubertal status, and comorbidity</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">2. International perspectives</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0004"><list-item><p>No evidence outside of&#x000a0;US</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0005"><list-item><p>Evidence base includes multiple non&#x02010;US studies covering assessment, genetics, treatment, imaging, outcome, and comorbidity</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0006"><list-item><p>Ensure valid translation available in multiple languages</p></list-item><list-item><p>Move toward Kessler/Harvard/Michigan&#x02010;team model (WHO) using CIDI, to allow data integration and direct comparisons</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">3. Clinical characteristics, differential diagnoses, and&#x000a0;course</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0007"><list-item><p>Adult criteria do not apply</p></list-item><list-item><p>Can forego the requirement for episodes</p></list-item><list-item><p>Predominantly chronic, and characterized by irritability without elation</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0008"><list-item><p>Most youth have both irritability and elation at&#x000a0;most severe episode</p></list-item><list-item><p>Applying adult criteria yields convergent findings&#x000a0;with adult BD</p></list-item><list-item><p>Irritable&#x02010;only (hypo)mania is uncommon but otherwise symptomatically similar to other types&#x000a0;of PBD</p></list-item><list-item><p>Most research defines BD based on DSM, and requires episodes</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0009"><list-item><p>Study ADHD and related neurocognitive profiles as indicators of risk for BD</p></list-item><list-item><p>Examine comorbid DMDD&#x02010;type phenotype in terms of prognostication and treatment</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">4. Measurement</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0010"><list-item><p>Screeners are not helpful</p></list-item><list-item><p>CBCL is sufficient</p></list-item><list-item><p>One type of informant is&#x000a0;inherently superior (teacher, parent, or child)</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0011"><list-item><p>Multiple published measures report high validity&#x000a0;coefficients</p></list-item><list-item><p>CBCL is a poor proxy for diagnosis</p></list-item><list-item><p>Screeners can be part of evidence&#x02010;based medicine approach to diagnosis, and inform next&#x000a0;steps</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0012"><list-item><p>Examine incremental value of biomarkers, imaging, and cognitive testing for diagnostic accuracy</p></list-item><list-item><p>Test measures in samples that allow meaningful comparison groups to BD (eg, ADHD and depression, rather than healthy controls)</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">5. Course, outcome, and comorbidity</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0013"><list-item><p>Chronic, non&#x02010;episodic</p></list-item><list-item><p>No evidence of diagnostic continuity into&#x000a0;adulthood</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0014"><list-item><p>When defined based on episodicity, continues to&#x000a0;evince episodicity prospectively</p></list-item><list-item><p>Comorbidity largely dependent on age</p></list-item><list-item><p>Comorbidity by late adolescence is similar to that in adulthood (higher rates of SUD and anxiety; lower rates of ADHD)</p></list-item><list-item><p>Overlapping symptoms of mania and ADHD should not be simply double counted</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0015"><list-item><p>Include cognition, imaging, and biomarkers in prospective studies to inform staging models</p></list-item><list-item><p>Be consistent about hierarchical exclusions (CD vs ODD)</p></list-item><list-item><p>Examine DMDD with/without BD exclusions</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">6. Pharmacologic treatment</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0016"><list-item><p>SGAs effective</p></list-item><list-item><p>Youth extra&#x02010;sensitive to metabolic side effects</p></list-item><list-item><p>Mood&#x02010;stabilizers less efficacious than in adults</p></list-item><list-item><p>Stimulants for comorbid ADHD, in the context of a mood stabilizer, are usually safe and efficacious</p></list-item><list-item><p>Adjunctive nutritional interventions show promise</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0017"><list-item><p>Determine if early stimulant or antidepressant treatment for ADHD and depression/anxiety, respectively, precipitates BD</p></list-item><list-item><p>Explore treatment for bipolar depression and maintenance</p></list-item><list-item><p>Study clinical staging using low&#x02010;risk interventions for high&#x02010;risk youth</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">7. Psychosocial treatment</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0018"><list-item><p>No validated treatments</p></list-item><list-item><p>Specific elements of treatment not relevant</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0019"><list-item><p>Family psychoeducation plus skill building is a well&#x02010;established category of psychotherapy</p></list-item><list-item><p>High EE predicts response to different treatments</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0020"><list-item><p>Determine core components linked to positive outcome</p></list-item><list-item><p>Match patients to treatments based on EE, etc.</p></list-item><list-item><p>Develop novel methods to access psychotherapy content</p></list-item><list-item><p>Study dissemination and implementation strategies</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">8. Imaging and neurocognition</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0021"><list-item><p>No specific findings; overlap with ADHD/ODD</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0022"><list-item><p>Several distinguishing features, but also overlapping findings with SMD/ADHD</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0023"><list-item><p>Complete larger, repeated&#x02010;measures studies</p></list-item><list-item><p>Use multimodal imaging</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">9. Biomarkers</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0024"><list-item><p>Few data</p></list-item></list>
</td><td align="left" rowspan="1" colspan="1">
<list list-type="order" id="bdi12556-list-0025"><list-item><p>Increase uptake of biomarker research</p></list-item><list-item><p>Use multimethod research (eg, integrate imaging)</p></list-item></list>
</td></tr></tbody></table><table-wrap-foot><fn id="bdi12556-note-0001"><p>ADHD, attention deficit hyperactivity disorder; BD, bipolar disorder; BMI, body mass index; CBCL, Achenbach Child Behavior Checklist; CD, conduct disorder; CIDI, Composite International Diagnostic Interview; DMDD, disruptive mood dysregulation disorder; EE, expressed emotion; NOS, not otherwise specified; PBD, pediatric bipolar disorder; ODD, oppositional defiant disorder; OS&#x02010;BRD, other specified bipolar and related disorders; SGA, second&#x02010;generation antipsychotic; SMD, severe mood dysregulation; WHO, World Health Organization.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><sec id="bdi12556-sec-0020"><label>5.1.1</label><title>Current state of assessment</title><p>The current generation of practitioners completed their training before the bulk of research on PBD was available. Consequently, agreement between clinicians about the presence or absence of PBD in a particular case is poor.<xref rid="bdi12556-bib-0100" ref-type="ref">100</xref>, <xref rid="bdi12556-bib-0101" ref-type="ref">101</xref> Agreement also tends to be worse around CycD and OS&#x02010;BRD,<xref rid="bdi12556-bib-0023" ref-type="ref">23</xref>, <xref rid="bdi12556-bib-0102" ref-type="ref">102</xref> which is unfortunate given that these may be more common than BD&#x02010;I.<xref rid="bdi12556-bib-0001" ref-type="ref">1</xref>, <xref rid="bdi12556-bib-0066" ref-type="ref">66</xref>
</p></sec><sec id="bdi12556-sec-0021"><label>5.1.2</label><title>Cross&#x02010;informant report on checklists</title><p>Multiple studies have evaluated parent, youth, and teacher report on both broad symptom checklists, such as the Achenbach System of Empirically Based Assessment,<xref rid="bdi12556-bib-0051" ref-type="ref">51</xref> and manic symptom scales. Agreement between informants on ratings of the youth's mood symptoms tends to be only &#x0201c;fair,&#x0201d; ie, in the <italic>r&#x000a0;</italic>=<italic>&#x000a0;</italic>.2 to .3 range, consistent with meta&#x02010;analyses of agreement about youth mood and behavior in general.<xref rid="bdi12556-bib-0103" ref-type="ref">103</xref>
</p><p>Checklists can detect cases needing more in&#x02010;depth evaluation for potential PBD. A recent meta&#x02010;analysis found 63 effect sizes&#x02014;38 based on caregiver, 14 on youth, and 11 on teacher report, with eight checklists providing at least two different effect sizes. Teacher and youth reports had medium effect sizes, and parent/caregiver reports had the largest effect sizes. The Achenbach Externalizing Scale outperformed the putative &#x0201c;bipolar&#x0201d; profile, consistent with findings that the &#x0201c;bipolar&#x0201d; profile is not specific to PBD.<xref rid="bdi12556-bib-0104" ref-type="ref">104</xref>, <xref rid="bdi12556-bib-0105" ref-type="ref">105</xref> Manic symptom scales fared better at identifying PBD, with three top tier options: The Parent General Behavior Inventory<xref rid="bdi12556-bib-0106" ref-type="ref">106</xref> and its 10&#x02010;item mania short form,<xref rid="bdi12556-bib-0107" ref-type="ref">107</xref> the Child Mania Rating Scale<xref rid="bdi12556-bib-0108" ref-type="ref">108</xref> and its 10&#x02010;item short form,<xref rid="bdi12556-bib-0109" ref-type="ref">109</xref> and the parent version of the Mood Disorder Questionnaire.<xref rid="bdi12556-bib-0110" ref-type="ref">110</xref>
</p><p>These scales are not accurate enough to justify their use as universal screening devices or as substitutes for a (semi&#x02010;)structured diagnostic interview. However, they can change the probability of a PBD diagnosis within an evidence&#x02010;based medicine or Bayesian decision&#x02010;making framework<xref rid="bdi12556-bib-0111" ref-type="ref">111</xref>, <xref rid="bdi12556-bib-0112" ref-type="ref">112</xref> and substantially improve the accuracy of clinical interpretation and agreement about next clinical action.<xref rid="bdi12556-bib-0102" ref-type="ref">102</xref>, <xref rid="bdi12556-bib-0112" ref-type="ref">112</xref> Some checklists have also shown sensitivity to treatment effects in masked randomized controlled trials (RCTs), with effect sizes equal to those based on direct interview of the youth and primary caregiver.<xref rid="bdi12556-bib-0113" ref-type="ref">113</xref>, <xref rid="bdi12556-bib-0114" ref-type="ref">114</xref> Checklists can improve diagnostic decision making in a range of clinical settings, as well as measuring treatment response.<xref rid="bdi12556-bib-0090" ref-type="ref">90</xref>, <xref rid="bdi12556-bib-0100" ref-type="ref">100</xref>, <xref rid="bdi12556-bib-0101" ref-type="ref">101</xref>, <xref rid="bdi12556-bib-0102" ref-type="ref">102</xref>
</p></sec><sec id="bdi12556-sec-0022"><label>5.1.3</label><title>Diagnostic and severity interviews</title><p>Semi&#x02010;structured or structured diagnostic interviews that systematically evaluate mood symptoms remain the best available method to establish PBD diagnoses<xref rid="bdi12556-bib-0052" ref-type="ref">52</xref>, <xref rid="bdi12556-bib-0115" ref-type="ref">115</xref> as well as symptom severity. The Young Mania Rating Scale (YMRS)<xref rid="bdi12556-bib-0116" ref-type="ref">116</xref> and Child Depression Rating Scale Revised<xref rid="bdi12556-bib-0117" ref-type="ref">117</xref> have been the industry standard interviews to quantify severity. Newer alternatives were designed for pediatric patients, with developmentally appropriate anchors and complete coverage of DSM mood symptoms.<xref rid="bdi12556-bib-0118" ref-type="ref">118</xref> Psychometric differences between severity interviews are small,<xref rid="bdi12556-bib-0119" ref-type="ref">119</xref>, <xref rid="bdi12556-bib-0120" ref-type="ref">120</xref> so the choice is more conceptual than statistical. Interview length and training requirements are barriers to routine clinical use.<xref rid="bdi12556-bib-0044" ref-type="ref">44</xref> More structured methods are faster and easier to use consistently, and are surprisingly popular with patients.<xref rid="bdi12556-bib-0121" ref-type="ref">121</xref> It is important to check for mood episodes in the context of developmental history at the outset of the interview. Few methods provide a clear algorithm for CycD or OS&#x02010;BRD&#x02014;a key omission given the data on prevalence and burden.</p></sec><sec id="bdi12556-sec-0023"><label>5.1.4</label><title>Risk factors as part of clinical evaluation</title><p>Risk factors inform the initial diagnostic evaluation process, and may guide treatment selection. Family history of mood disorders&#x02014;and BD in particular&#x02014;is the best&#x02010;validated risk factor, recommended for routine clinical evaluation, while keeping in mind that the majority of youth with a family history will not necessarily develop BD. Brief screening tools make adding family history clinically feasible.<xref rid="bdi12556-bib-0122" ref-type="ref">122</xref> High EE (ie, criticism, hostility, and emotional overinvolvement) and high family conflict are risk factors for treatment drop&#x02010;out and more rapid relapse.<xref rid="bdi12556-bib-0090" ref-type="ref">90</xref> High&#x02010;EE families may show larger responses to family&#x02010;focused psychotherapeutic interventions.<xref rid="bdi12556-bib-0123" ref-type="ref">123</xref>
</p></sec></sec><sec id="bdi12556-sec-0024"><label>5.2</label><title>Limitations, gaps, and future directions</title><p>Although considerable advances have been made in the use of rating scales, checklists, and structured diagnostic interviews, little work has been done with neurocognitive or neuroimaging methods using clinically generalizable comparison groups to establish whether these methods have diagnostic specificity. Productive next steps in assessment research would be to examine hybrid batteries that combine checklists and neurocognitive measures, biomarkers, or imaging to test incremental validity (ie, the degree to which each measure improves diagnostic accuracy) in order to guide the most cost&#x02010;effective test sequences. Better assessment of developmental phenomenology would be valuable to clarify prodromal presentations and trajectories. Structured interviews could be redesigned to better capture duration, potential prodrome, and trajectories. Rapid changes in Internet&#x02010;based and smartphone delivery of clinical assessments need to be integrated with traditional assessment and treatment. Finally, feasibility, acceptability and utility of translation of research tools into real&#x02010;world measurement&#x02010;based care need to be studied.</p></sec></sec><sec id="bdi12556-sec-0025"><label>6</label><title>PHARMACOLOGIC TREATMENT</title><sec id="bdi12556-sec-0026"><label>6.1</label><title>Established findings and consensus</title><p>This section summarizes extant literature about pharmacologic treatment of PBD, emphasizing RCTs. For additional detail, the reader is referred to recent reviews on this topic.<xref rid="bdi12556-bib-0037" ref-type="ref">37</xref>, <xref rid="bdi12556-bib-0124" ref-type="ref">124</xref>, <xref rid="bdi12556-bib-0125" ref-type="ref">125</xref>, <xref rid="bdi12556-bib-0126" ref-type="ref">126</xref>, <xref rid="bdi12556-bib-0127" ref-type="ref">127</xref>, <xref rid="bdi12556-bib-0128" ref-type="ref">128</xref>, <xref rid="bdi12556-bib-0129" ref-type="ref">129</xref>
</p><sec id="bdi12556-sec-0027"><label>6.1.1</label><title>Manic/mixed episodes</title><p>Second&#x02010;generation antipsychotics (SGAs) approved by the United States Food and Drug Administration (FDA) for the treatment of acute mania and/or mixed mania in children and adolescents (10&#x02010;17&#x000a0;years) include risperidone, aripiprazole and quetiapine, olanzapine, and asenapine<xref rid="bdi12556-bib-0013" ref-type="ref">13</xref>, <xref rid="bdi12556-bib-0014" ref-type="ref">14</xref>, <xref rid="bdi12556-bib-0015" ref-type="ref">15</xref>, <xref rid="bdi12556-bib-0016" ref-type="ref">16</xref>, <xref rid="bdi12556-bib-0017" ref-type="ref">17</xref> (<ext-link ext-link-type="uri" xlink:href="http://www.accessdata.fda.gov/scripts/cder/daf/">http://www.accessdata.fda.gov/scripts/cder/daf/</ext-link>). Lithium has FDA indication for the treatment and recurrence prevention of mania in youths aged 12 years and older, bolstered by a recently published positive 8&#x02010;week RCT for youths 7&#x02010;17&#x000a0;years old with BD&#x02010;I manic/mixed episodes.<xref rid="bdi12556-bib-0130" ref-type="ref">130</xref> In that study, change in mania symptom scores was significantly larger in lithium&#x02010;treated participants, as was global improvement at week 8, compared to placebo&#x02010;treated participants.</p><p>A large (n<italic>&#x000a0;</italic>=<italic>&#x000a0;</italic>153) 8&#x02010;week National Institute of Mental Health (NIMH)&#x02010;funded RCT compared lithium vs divalproex vs placebo in youths aged 7&#x02010;17&#x000a0;years with BD&#x02010;I mania.<xref rid="bdi12556-bib-0127" ref-type="ref">127</xref> Participants randomized to divalproex had a significantly larger reduction in YMRS scores (&#x00394;<italic>M&#x000a0;</italic>=&#x000a0;8.3) from baseline compared to those randomized to placebo (&#x00394;<italic>M&#x000a0;</italic>=&#x000a0;5.3) (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.04). There was not a statistically significant difference in YMRS scores for subjects randomized to lithium (7.2) compared to placebo (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.19), or divalproex vs lithium (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.35). However, another 4&#x02010;week RCT of divalproex extended&#x02010;release was negative when comparing an active group (n&#x000a0;=&#x000a0;74) to placebo (n&#x000a0;=&#x000a0;70).<xref rid="bdi12556-bib-0131" ref-type="ref">131</xref> In this investigation, treatment with divalproex extended release (ER) promoted a mean reduction of 8.8 points in the YMRS, and the placebo group presented a mean reduction of mania of 7.9 points (<italic>P</italic>&#x000a0;=&#x000a0;.6). In an open extension of this trial with divalproex ER, where only 26 of 66 patients completed a 6&#x02010;month follow&#x02010;up, the mean YMRS score decreased by 2.2 points from a baseline of 20.3.</p><p>An early meta&#x02010;analysis on the treatment of PBD (N<italic>&#x000a0;</italic>=<italic>&#x000a0;</italic>2666 participants across 46 trials) reported that SGAs were highly efficacious and superior to the modest anti&#x02010;manic effects for traditional mood&#x02010;stabilizing agents, such as lithium carbonate, divalproex sodium, and carbamazepine, when used as monotherapy.<xref rid="bdi12556-bib-0129" ref-type="ref">129</xref> Another meta&#x02010;analysis of double&#x02010;masked placebo&#x02010;controlled RCTs of treatment for BD&#x02010;I mania among youth (n<italic>&#x000a0;</italic>=<italic>&#x000a0;</italic>1609) and adults (n<italic>&#x000a0;</italic>=<italic>&#x000a0;</italic>6501) found that SGAs were more efficacious but more metabolically burdensome compared to traditional mood stabilizers among youth, but showed no such differences among adults.<xref rid="bdi12556-bib-0132" ref-type="ref">132</xref> However, these meta&#x02010;analyses predated recent studies supporting the efficacy of lithium.</p><p>The anticonvulsants divalproex sodium and carbamazepine have not fared well head&#x02010;to&#x02010;head with SGAs. In two meta&#x02010;analyses, treatment effect was less robust with anticonvulsants than with SGAs.<xref rid="bdi12556-bib-0105" ref-type="ref">105</xref>, <xref rid="bdi12556-bib-0106" ref-type="ref">106</xref> An RCT of divalproex extended release was negative,<xref rid="bdi12556-bib-0131" ref-type="ref">131</xref> as was a large RCT of oxcarbazepine,<xref rid="bdi12556-bib-0110" ref-type="ref">110</xref> and a topiramate RCT in youth was interrupted prior to its completion due to negative results in adult studies; it failed to show efficacy in youth given inadequate power.<xref rid="bdi12556-bib-0133" ref-type="ref">133</xref> A study of 10 outpatients with BD (11&#x02010;17&#x000a0;years old) whose weight increased by &#x0003e; 5% during treatment with mood&#x02010;stabilizer or antipsychotic monotherapy were switched to topiramate; reductions in manic symptoms and weight were observed.<xref rid="bdi12556-bib-0133" ref-type="ref">133</xref>, <xref rid="bdi12556-bib-0134" ref-type="ref">134</xref>
</p><p>In the &#x0201c;Treatment of Early Age Mania&#x0201d; 8&#x02010;week trial, which included 290 youths aged 6&#x02010;15&#x000a0;years with BD&#x02010;I manic or mixed episodes, response rates were 68% for risperidone, 35% for lithium, and 24% for divalproex sodium.<xref rid="bdi12556-bib-0135" ref-type="ref">135</xref> The advantage of risperidone vs lithium was greater for youth with ADHD (vs non&#x02010;ADHD) and non&#x02010;obese (vs obese) youth.<xref rid="bdi12556-bib-0136" ref-type="ref">136</xref> However, rates of comorbid ADHD in this study were &#x0003e; 90%, limiting power for ADHD vs no&#x02010;ADHD comparisons, and some sites showed similar response rates for risperidone and lithium. Concerns have been raised regarding several characteristics in this sample, including prolonged episodes, very early childhood onset, and high rates of rapid cycling, constraining comparisons with adult studies.<xref rid="bdi12556-bib-0137" ref-type="ref">137</xref>
</p></sec><sec id="bdi12556-sec-0028"><label>6.1.2</label><title>Bipolar depression</title><p>The combination of olanzapine and fluoxetine has an FDA indication for BD depression in youth aged 10&#x02010;17&#x000a0;years old.<xref rid="bdi12556-bib-0138" ref-type="ref">138</xref> In a recently presented RCT of 347 youth 10&#x02013;17 years old, lurasidone was associated with significantly greater improvement in depression symptoms at 6 weeks as compared to placebo (effect size, 0.45). <xref rid="bdi12556-bib-0139" ref-type="ref">139</xref> There have been two negative RCTs of quetiapine for bipolar depression.<xref rid="bdi12556-bib-0140" ref-type="ref">140</xref>, <xref rid="bdi12556-bib-0141" ref-type="ref">141</xref> In a sample of 193 adolescents (10&#x02010;17 years old) with BD&#x02010;I or BD&#x02010;II who received quetiapine or placebo for 8&#x000a0;weeks, although nonsignificant differences were observed between the responses in the placebo and quetiapine groups (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.63), high rates of response were observed in both groups (placebo: 55%, and quetiapine ER: 63%).<xref rid="bdi12556-bib-0127" ref-type="ref">127</xref> A smaller trial of 32 adolescents (12&#x02010;18 years old) with BD&#x02010;I where subjects were randomized for 8&#x000a0;weeks to placebo (n<italic>&#x000a0;</italic>=<italic>&#x000a0;</italic>15) or quetiapine (n<italic>&#x000a0;</italic>=<italic>&#x000a0;</italic>17) revealed no statistically significant differences in response rates between the placebo (67%) and quetiapine (71%) groups.<xref rid="bdi12556-bib-0128" ref-type="ref">128</xref> Positive preliminary open trials<xref rid="bdi12556-bib-0142" ref-type="ref">142</xref>, <xref rid="bdi12556-bib-0143" ref-type="ref">143</xref> or chart reviews<xref rid="bdi12556-bib-0144" ref-type="ref">144</xref> of lithium and lamotrigine warrant future RCTs. However, high placebo response rates in depression studies require larger samples than mania trials or blinded placebo lead&#x02010;in. Although the precise frequency of antidepressant&#x02010;induced mania is uncertain,<xref rid="bdi12556-bib-0145" ref-type="ref">145</xref>, <xref rid="bdi12556-bib-0146" ref-type="ref">146</xref> practice parameters and guidelines suggest avoiding antidepressant monotherapy; this approach is supported by pharmaco&#x02010;epidemiologic data.<xref rid="bdi12556-bib-0147" ref-type="ref">147</xref>
</p></sec><sec id="bdi12556-sec-0029"><label>6.1.3</label><title>Maintenance/continuation treatment</title><p>There have been few maintenance/continuation treatment studies in youth, most of which have been previously reviewed.<xref rid="bdi12556-bib-0125" ref-type="ref">125</xref> An early observational study of continuation treatment with lithium found an increased risk of relapse among adolescents who were not treated with lithium following hospitalization for mania.<xref rid="bdi12556-bib-0148" ref-type="ref">148</xref> A subsequent study of children and adolescents with BD who had been stabilized on the combination of lithium and divalproex found a similar survival time to recurrence among those randomized to continuation treatment with monotherapy with lithium or divalproex.<xref rid="bdi12556-bib-0149" ref-type="ref">149</xref> In a larger continuation study of 226 youth with BD (mean duration 124.4&#x000a0;days), YMRS scores decreased a further 12.4 points.<xref rid="bdi12556-bib-0150" ref-type="ref">150</xref> In a 72&#x02010;week maintenance study, 96 outpatient children, 4&#x02010;9&#x000a0;years old, with PBD who had been stabilized on aripiprazole (mean dose 6.4&#x000a0;mg) were randomized to continuation with aripiprazole or placebo (n<italic>&#x000a0;</italic>=<italic>&#x000a0;</italic>30/group).<xref rid="bdi12556-bib-0151" ref-type="ref">151</xref> Although children randomized to aripiprazole, vs placebo, were enrolled significantly longer until time to discontinuation for a mood event or for any reason, the study was constrained by high drop&#x02010;out rates within the first 4&#x000a0;weeks (50% for the aripiprazole group; 90% for the placebo group), understood by the authors as a nocebo effect. No significant between&#x02010;group treatment effects on symptom rating or changes over time were observed for mania, depression, general impression, or global assessment. Another placebo&#x02010;controlled continuation study of aripiprazole (10&#x000a0;mg or 30&#x000a0;mg) in youths (10&#x02010;17&#x000a0;years old) with manic/mixed episodes followed participants for 26&#x000a0;weeks under double&#x02010;blind conditions after a 4&#x02010;week acute treatment phase.<xref rid="bdi12556-bib-0152" ref-type="ref">152</xref> For both aripiprazole dosages, there were greater reductions in YMRS symptoms (in last observation carried forward analyses only) and time to all&#x02010;cause discontinuation was longer for both aripiprazole dosages compared to placebo. There were also higher response rates, greater improvements in global functioning, and greater reductions in clinical global impression bipolar severity for each of the aripiprazole groups vs placebo. Another recent study of 301 children and adolescents with BD&#x02010;I stabilized for at least 6&#x000a0;weeks on adjunctive lamotrigine, in combination with up to two mood stabilizers or antipsychotics, randomized participants to 36 weeks of either continuation treatment with lamotrigine or placebo.<xref rid="bdi12556-bib-0153" ref-type="ref">153</xref> Although the primary analysis was negative, continuation with lamotrigine was superior to placebo (hazard ratio 0.46) in 13&#x02010;17&#x02010;year&#x02010;olds, but not in 10&#x02010;12&#x02010;year&#x02010;olds (hazard ratio 0.94). Although reasons for this discrepancy are uncertain, it may relate to higher rates of ADHD in the younger group. Finally, a 50&#x02010;week open&#x02010;label, flexible&#x02010;dose extension study of 321 youth, 10&#x02010;17&#x000a0;years old, with BD&#x02010;I (lead&#x02010;in study treatment: placebo, n&#x000a0;=&#x000a0;80; asenapine, n&#x000a0;=&#x000a0;241) reported that: (i) there was a mean 9.2&#x02010;point reduction in YMRS at week 50; (ii) 79.2% were considered responders based on 50% reduction in YMRS relative to acute trial baseline; (iii) somnolence/sedation/hypersomnia (42.4%) and significant weight gain (34.8%) were very common.<xref rid="bdi12556-bib-0154" ref-type="ref">154</xref>
</p></sec><sec id="bdi12556-sec-0030"><label>6.1.4</label><title>Comorbidity</title><p>Positive results have been reported regarding the treatment of comorbid ADHD with mixed amphetamine salts and methylphenidate, albeit in modest&#x02010;sized samples, particularly in euthymic youth.<xref rid="bdi12556-bib-0037" ref-type="ref">37</xref>, <xref rid="bdi12556-bib-0155" ref-type="ref">155</xref>, <xref rid="bdi12556-bib-0156" ref-type="ref">156</xref> Aripiprazole did not differ from placebo in ADHD symptom reduction.<xref rid="bdi12556-bib-0157" ref-type="ref">157</xref> Preliminary findings from open trials and case reports suggest promise for adjunctive atomoxetine.<xref rid="bdi12556-bib-0158" ref-type="ref">158</xref> Although stimulants, as well as antidepressants, hold some risk of precipitating mania, precise estimates of this risk are lacking, both with and without ongoing mood stabilizer cotreatment.<xref rid="bdi12556-bib-0145" ref-type="ref">145</xref> A single small RCT found that lithium improved mood symptoms and comorbid substance use disorder among adolescents with, or at risk for, BD.<xref rid="bdi12556-bib-0159" ref-type="ref">159</xref>
</p></sec><sec id="bdi12556-sec-0031"><label>6.1.5</label><title>Nutritional interventions</title><p>Four open&#x02010;label nutritional trials, three of Omega 3 (&#x003a9;3) monotherapy (n&#x000a0;=&#x000a0;3) and one of a commercially available multinutrient, in youth with BPSD provide preliminary evidence of potential benefits in terms of manic and depressive symptoms, global functioning, and parent&#x02010;rated internalizing and externalizing behaviors.<xref rid="bdi12556-bib-0160" ref-type="ref">160</xref>, <xref rid="bdi12556-bib-0161" ref-type="ref">161</xref>, <xref rid="bdi12556-bib-0162" ref-type="ref">162</xref> A 12&#x02010;week pilot RCT (N&#x000a0;=&#x000a0;23 youth with BD&#x02010;NOS or CycD) found that the combination of &#x003a9;3 and psychoeducation was superior to placebo and active monitoring.<xref rid="bdi12556-bib-0163" ref-type="ref">163</xref> An RCT of flax seed oil (alpha&#x02010;linolenic acid [ALA]) in youth with BD&#x02010;I/BD&#x02010;II was negative.<xref rid="bdi12556-bib-0164" ref-type="ref">164</xref>
</p></sec></sec><sec id="bdi12556-sec-0032"><label>6.2</label><title>Limitations, gaps, and future directions</title><p>Positive RCTs for maintenance treatment and bipolar depression are lacking, although preliminary positive open trials hold promise. Pharmacologic treatment of comorbidities other than ADHD is another gap. Given concerns about heterogeneity of longitudinal course, it would be helpful to examine whether subtype of BD or age of onset moderates treatment response. Future studies should include neuroimaging, neurocognition, and peripheral biomarkers as moderators and predictors of treatment response. Large&#x02010;scale RCTs of nutritional interventions are warranted, based on positive pilot RCTs and open&#x02010;label trials. Studies concentrating on CycD and OS&#x02010;BRD are crucial to address the need for titrated and evidence&#x02010;based options, along with more masked maintenance studies to look at altering trajectories, and head&#x02010;to&#x02010;head trials and trials of combinations with non&#x02010;pharmacologic treatments. Although systematically addressing the topic of offspring of parents with BD was beyond the scope of this article, it is important to note that there is also a need for large&#x02010;scale RCTs examining the relative efficacy, tolerability, and safety of antidepressants vs mood stabilizers for anxiety and/or depression, and the efficacy, tolerability, and safety of stimulants for ADHD, among BD offspring.</p></sec></sec><sec id="bdi12556-sec-0033"><label>7</label><title>PSYCHOSOCIAL TREATMENTS</title><sec id="bdi12556-sec-0034"><label>7.1</label><title>Established findings and consensus</title><p>Adult psychotherapy trials provide substantial evidence for the effectiveness of family&#x02010;focused therapy (FFT),<xref rid="bdi12556-bib-0165" ref-type="ref">165</xref> group psychoeducation,<xref rid="bdi12556-bib-0166" ref-type="ref">166</xref>, <xref rid="bdi12556-bib-0167" ref-type="ref">167</xref>, <xref rid="bdi12556-bib-0168" ref-type="ref">168</xref> and interpersonal and social rhythm therapy<xref rid="bdi12556-bib-0169" ref-type="ref">169</xref> in improving symptoms, reducing rates of recurrence, and hastening recovery in adults with BD. In recent years, an accumulating body of evidence similarly supports the use of manualized psychotherapies for the treatment of PBD. A recent review highlighted 13 unique studies<xref rid="bdi12556-bib-0170" ref-type="ref">170</xref> and three studies published since that review further strengthen the evidence base,<xref rid="bdi12556-bib-0171" ref-type="ref">171</xref>, <xref rid="bdi12556-bib-0172" ref-type="ref">172</xref>, <xref rid="bdi12556-bib-0173" ref-type="ref">173</xref>, <xref rid="bdi12556-bib-0174" ref-type="ref">174</xref> whereas one additional study offers mixed evidence.<xref rid="bdi12556-bib-0175" ref-type="ref">175</xref> The category of family psychoeducation plus skill building can be considered as a <italic>well&#x02010;established</italic> treatment, meaning that two or more research groups have, via independent RCTs, demonstrated efficacy.<xref rid="bdi12556-bib-0176" ref-type="ref">176</xref> Dialectical behavior therapy<xref rid="bdi12556-bib-0171" ref-type="ref">171</xref> can be considered <italic>possibly efficacious</italic>, based on a single RCT or multiple studies by the same group, while interpersonal and social rhythm therapy<xref rid="bdi12556-bib-0177" ref-type="ref">177</xref> remains <italic>experimental</italic> in youths at this time. Effectiveness trials suggest that family psychoeducation plus skill&#x02010;building approaches have excellent acceptability and sustainability in community settings.<xref rid="bdi12556-bib-0178" ref-type="ref">178</xref>, <xref rid="bdi12556-bib-0179" ref-type="ref">179</xref>
</p><p>Treatment <italic>mediator analyses</italic> suggest that psychoeducation leads families to improve the quality of services they utilize, mediated by parental treatment beliefs; improved quality of services, in turn, mediates improved outcomes.<xref rid="bdi12556-bib-0180" ref-type="ref">180</xref> Improved parenting skills and coping, family flexibility and family positive reframing are linked to improved mood and global functioning in youth with PBD.<xref rid="bdi12556-bib-0181" ref-type="ref">181</xref> Treatment <italic>moderators</italic> include youth impairment<xref rid="bdi12556-bib-0182" ref-type="ref">182</xref> and family EE,<xref rid="bdi12556-bib-0123" ref-type="ref">123</xref> along with comorbid disorders, youth age, and family socioeconomic status (SES). <italic>Predictors</italic> of better treatment response include greater impairment, more stress/trauma history for the child, less Cluster B personality symptoms in parents,<xref rid="bdi12556-bib-0182" ref-type="ref">182</xref> and comorbid anxiety disorders.<xref rid="bdi12556-bib-0131" ref-type="ref">131</xref>
</p><p>With regard to secondary outcomes other than mood, family psychoeducation plus skill building are also associated with a reduction in behavioral symptoms.<xref rid="bdi12556-bib-0183" ref-type="ref">183</xref> In an open trial of an adaptation of family psychoeducation and skill building, benefits were observed for adolescents with BD and comorbid substance use disorders.<xref rid="bdi12556-bib-0184" ref-type="ref">184</xref> While no dismantling studies have been conducted, therapeutic ingredients common to the psychotherapy category <italic>family psychoeducation and skill building</italic> should be used. These include family involvement; psychoeducation about etiology, symptoms, course, medications, risk and protective factors, and effective treatment of BD; skill building (especially communication, problem&#x02010;solving, and emotion regulation skills); and relapse and recurrence prevention.<xref rid="bdi12556-bib-0170" ref-type="ref">170</xref>
</p><p>In regard to prevention, or delay of onset, two RCTs have examined the impact of family psychoeducation plus skill building in youth at high risk for developing BD. Youth who received FFT had more rapid recovery from their initial mood symptoms, experienced more weeks in remission, and had lower YMRS scores over 1&#x000a0;year compared to youth who received enhanced care.<xref rid="bdi12556-bib-0185" ref-type="ref">185</xref> In a second study, youth with depression and transient manic symptoms were 4 times less likely to convert to BPSD at 12&#x02010;month follow&#x02010;up if they received multi&#x02010;family psychoeducational psychotherapy plus treatment as usual (TAU) compared to the group who received only TAU.<xref rid="bdi12556-bib-0186" ref-type="ref">186</xref>
</p></sec><sec id="bdi12556-sec-0035"><label>7.2</label><title>Limitations, gaps, and future directions</title><p>More work is needed to (i) determine the impact of low&#x02010;risk interventions (eg, psychosocial treatments and nutritional interventions) in preventing or delaying the onset of BD in high&#x02010;risk youth; (ii) test psychotherapies in diverse populations, including different SES and cultural backgrounds; (iii) determine what modifications are appropriate based on age or treatment format (eg, group or individual/family); (iv) determine the impact of psychotherapy on functional and quality of life outcomes as well as symptoms; (v) develop efficient ways to train large numbers of clinicians in these treatments; (vi) identify mechanisms of change and essential treatment components;<xref rid="bdi12556-bib-0170" ref-type="ref">170</xref> (vii) examine the potential benefits of smartphone or Internet&#x02010;based delivery; (viii) evaluate combinations of pharmacotherapy and psychotherapy; and (ix) determine how best to disseminate manual&#x02010;based psychotherapies into health care settings.</p></sec></sec><sec id="bdi12556-sec-0036"><label>8</label><title>NEUROIMAGING AND NEUROCOGNITION</title><sec id="bdi12556-sec-0037"><label>8.1</label><title>Established findings and consensus</title><p>Prevailing pathophysiologic models of BD implicate abnormalities in brain regions that regulate emotion and attention, namely the emotional control network (ECN).<xref rid="bdi12556-bib-0187" ref-type="ref">187</xref> The ECN is comprised of ventrolateral and ventromedial prefrontal networks, which modulate the limbic system, specifically the amygdala, in conjunction with subcortical nuclei, such as the thalamus and striatum.<xref rid="bdi12556-bib-0187" ref-type="ref">187</xref>, <xref rid="bdi12556-bib-0188" ref-type="ref">188</xref> Increasing evidence suggests that there are anatomical, neurochemical, functional and cognitive abnormalities within the ECN in PBD.<xref rid="bdi12556-bib-0188" ref-type="ref">188</xref>, <xref rid="bdi12556-bib-0189" ref-type="ref">189</xref> Pathophysiologic abnormalities underlying other cognitive functions that are altered in BD, such as reward processing, have also been studied.<xref rid="bdi12556-bib-0190" ref-type="ref">190</xref>
</p><sec id="bdi12556-sec-0038"><label>8.1.1</label><title>Neuroimaging</title><sec id="bdi12556-sec-0039"><title>Brain structure</title><p>Within the ECN, the amygdala plays a central role in emotional regulation. Two meta&#x02010;analyses of magnetic resonance imaging (MRI) studies reported that youth with PBD present with smaller amygdala volumes compared with controls.<xref rid="bdi12556-bib-0191" ref-type="ref">191</xref>, <xref rid="bdi12556-bib-0192" ref-type="ref">192</xref> One prospective study that evaluated youth after their first manic episode showed that amygdala volumes failed to show a normal increase with aging in patients, whereas this did not occur in controls or in youth with ADHD, suggesting that hampered neurodevelopment of the amygdala may underlie the dysfunctional emotional processing present in the ventral&#x02010;limbic pathway.<xref rid="bdi12556-bib-0193" ref-type="ref">193</xref> Diffusion tensor imaging (DTI) studies have investigated abnormalities in the white matter microstructure of youth with PBD. Preliminary findings suggest the presence of abnormal white matter microstructure in superior frontal regions,<xref rid="bdi12556-bib-0194" ref-type="ref">194</xref>, <xref rid="bdi12556-bib-0195" ref-type="ref">195</xref> and inferior/ventral frontal areas, such as the orbitofrontal or anterior cingulate cortex, and anterior regions of the corpus callosum<xref rid="bdi12556-bib-0196" ref-type="ref">196</xref>, <xref rid="bdi12556-bib-0197" ref-type="ref">197</xref>, <xref rid="bdi12556-bib-0198" ref-type="ref">198</xref>, <xref rid="bdi12556-bib-0199" ref-type="ref">199</xref>, <xref rid="bdi12556-bib-0200" ref-type="ref">200</xref> compared to controls. One study found even greater reduction in white matter integrity in the anterior limb of the internal capsule in PBD vs adult BD.<xref rid="bdi12556-bib-0201" ref-type="ref">201</xref> Most of these studies had very small sample sizes, but, together, they are consistent with a hypothesis of structural connectivity deficits between prefrontal&#x02010;subcortical areas that underlie the prefrontal&#x02010;limbic dysfunction in PBD.</p></sec><sec id="bdi12556-sec-0040"><title>Brain function</title><p>Meta&#x02010;analyses of over 20 task&#x02010;based functional MRI (fMRI) studies with approximately 500 youth concluded that BD involves hypoactivation of prefrontal areas and hyperactivation of limbic areas.<xref rid="bdi12556-bib-0202" ref-type="ref">202</xref>, <xref rid="bdi12556-bib-0203" ref-type="ref">203</xref> Weigbreit et&#x000a0;al (2014) included more emotional (emotional face processing) than non&#x02010;emotional (or cognitive) tasks whereas Lee et&#x000a0;al (2014) did not discriminate the effects of emotional vs cognitive tasks. PBD presents with greater activation in the right amygdala, parahippocampal gyrus, and left putamen, and lower activation in the right ventrolateral and dorsolateral prefrontal cortices compared with controls in paradigms that involve emotional stimuli.<xref rid="bdi12556-bib-0202" ref-type="ref">202</xref>, <xref rid="bdi12556-bib-0203" ref-type="ref">203</xref> These findings suggest that prefrontal regions are unable to modulate hyperactive limbic regions,<xref rid="bdi12556-bib-0203" ref-type="ref">203</xref> due either to a primary prefrontal dysfunction or to altered connectivity between prefrontal and limbic regions. Studies using non&#x02010;emotional tasks (eg, reversal learning and reward anticipation) also showed abnormal functional activity of prefrontal areas, such as the dorsolateral prefrontal cortex, parietal regions, such as the temporal gyrus, and subcortical regions, such as the thalamus, during processing of the tasks.<xref rid="bdi12556-bib-0204" ref-type="ref">204</xref>, <xref rid="bdi12556-bib-0205" ref-type="ref">205</xref>, <xref rid="bdi12556-bib-0206" ref-type="ref">206</xref> fMRI studies using tasks of attention and response inhibition have also found that prefrontal areas involved in attention and inhibitory control (namely the ventrolateral prefrontal cortex) are hypoactive while processing a continuous performance task in patients with PBD and comorbid ADHD, while posterior parietal and temporal areas are hyperactive, possibly as a compensatory mechanism.<xref rid="bdi12556-bib-0207" ref-type="ref">207</xref> Other studies using continuous performance task and response inhibition also have found underactivation of the ventrolateral prefrontal cortex.<xref rid="bdi12556-bib-0208" ref-type="ref">208</xref>, <xref rid="bdi12556-bib-0209" ref-type="ref">209</xref> The few resting state fMRI studies in PBD show that youth with PBD present with fronto&#x02010;temporal, amygdala&#x02010;hippocampus and amygdala&#x02010;precuneus functional connectivity alterations,<xref rid="bdi12556-bib-0210" ref-type="ref">210</xref>, <xref rid="bdi12556-bib-0211" ref-type="ref">211</xref>, <xref rid="bdi12556-bib-0212" ref-type="ref">212</xref> with similar alterations observed during bipolar depression.<xref rid="bdi12556-bib-0213" ref-type="ref">213</xref> Together, these studies suggest that PBD is characterized by abnormal prefrontal&#x02010;limbic functional connectivity in the processing of emotion, attention, and reward. Although still too preliminary to allow any definitive conclusions about the neurophysiology of PBD, these findings converge with adult BD findings.</p></sec><sec id="bdi12556-sec-0041"><title>Brain chemistry</title><p>Proton magnetic resonance spectroscopy studies are particularly important to help understand two current neurobiological hypotheses of BD, ie, glutamatergic dysfunction and mitochondrial dysfunction or energy metabolism dysfunction. Several studies in PBD have shown abnormalities in glutamate or glutamine levels in prefrontal brain areas.<xref rid="bdi12556-bib-0214" ref-type="ref">214</xref>, <xref rid="bdi12556-bib-0215" ref-type="ref">215</xref> Abnormal levels of metabolites that are considered to be biomarkers of mitochondrial dysfunction or cell energy metabolism, such as decreased N&#x02010;acetyl&#x02010;aspartate or increased myo&#x02010;inositol levels, were found in dorsal and ventral areas of the prefrontal cortex in PBD.<xref rid="bdi12556-bib-0216" ref-type="ref">216</xref>, <xref rid="bdi12556-bib-0217" ref-type="ref">217</xref>, <xref rid="bdi12556-bib-0218" ref-type="ref">218</xref>, <xref rid="bdi12556-bib-0219" ref-type="ref">219</xref>, <xref rid="bdi12556-bib-0220" ref-type="ref">220</xref>, <xref rid="bdi12556-bib-0221" ref-type="ref">221</xref>, <xref rid="bdi12556-bib-0222" ref-type="ref">222</xref>, <xref rid="bdi12556-bib-0223" ref-type="ref">223</xref>, <xref rid="bdi12556-bib-0224" ref-type="ref">224</xref>
</p><p>Although very valuable given the possibility of in vivo measurement of metabolites that might relate to pathophysiologic processes of neuronal integrity/viability, glutamatergic neurotransmission, and cell energy metabolism, the exact meaning of these results is poorly understood, partly because they are difficult to replicate or to predict. For instance, although several proton spectroscopy studies reported positive results for specific metabolite differences between patients and controls (eg, N&#x02010;acetyl&#x02010;aspartate or glutamine),<xref rid="bdi12556-bib-0215" ref-type="ref">215</xref>, <xref rid="bdi12556-bib-0220" ref-type="ref">220</xref>, <xref rid="bdi12556-bib-0223" ref-type="ref">223</xref>, <xref rid="bdi12556-bib-0224" ref-type="ref">224</xref> within the same experiment, results are often negative for other metabolites (eg, creatine, myo&#x02010;inositol and choline).<xref rid="bdi12556-bib-0215" ref-type="ref">215</xref>
</p></sec></sec></sec><sec id="bdi12556-sec-0042"><label>8.2</label><title>Neuroimaging in relation to treatment</title><p>There is a preliminary literature regarding neuroimaging studies in relation to treatment of PBD. For instance, an association between change in prefrontal glutamate concentrations and change in manic symptoms was reported in patients who achieved remission of mania after treatment with divalproex sodium.<xref rid="bdi12556-bib-0225" ref-type="ref">225</xref> Remission of mania after olanzapine treatment was associated with an increase in ventromedial prefrontal N&#x02010;acetyl aspartate and choline levels.<xref rid="bdi12556-bib-0226" ref-type="ref">226</xref> Quetiapine treatment for bipolar depression may lead to decreased neural activity in the left occipital cortex, and increased neural activity in the left insula, left cerebellum, and right ventrolateral prefrontal cortex during performance of a face emotion recognition task.<xref rid="bdi12556-bib-0227" ref-type="ref">227</xref> Treatment of mania with ziprasidone was associated with an increase in activation in the right ventrolateral prefrontal cortex in response to a sustained attention task, which suggests that the ziprasidone antimanic effect is associated with improved prefrontal modulation of emotional regulation.<xref rid="bdi12556-bib-0228" ref-type="ref">228</xref> Carbamazepine treatment of mania was also associated with increased activation in Brodmann area 10 of the right prefrontal cortex in a small sample of 11 adolescents,<xref rid="bdi12556-bib-0229" ref-type="ref">229</xref> further suggesting that mood stabilizers might exert their beneficial effects by improving the top&#x02010;down prefrontal modulation of limbic areas. Treatment response to risperidone and divalproex sodium for mania may lead to increased functional connectivity of the amygdala within the ECN.<xref rid="bdi12556-bib-0230" ref-type="ref">230</xref> These preliminary findings offer insights regarding putative mechanisms of action of these medications. One recent study provided evidence that some psychotherapy modalities, such as FFT, improve dorsolateral prefrontal cortex activation and decrease amygdala activation in youth with mood dysregulation at familial risk for BD,<xref rid="bdi12556-bib-0231" ref-type="ref">231</xref> which is consistent with the putative treatment effects of mood stabilizers (ie, improved prefrontal modulation of limbic areas, or better &#x0201c;top&#x02010;down control&#x0201d;). Additional studies are necessary to better understand the physiology of treatment response and guide improved therapeutic strategies.</p><sec id="bdi12556-sec-0043"><label>8.2.1</label><title>Neurocognition</title><p>PBD is associated with impairment in several cognitive domains.<xref rid="bdi12556-bib-0232" ref-type="ref">232</xref> A meta&#x02010;analysis of 10 cognitive studies reported overall cognitive deficits in PBD (n<italic>&#x000a0;</italic>=<italic>&#x000a0;</italic>352) compared to healthy controls (HCs; n<italic>&#x000a0;</italic>=<italic>&#x000a0;</italic>439) with mean effect sizes that are: large in verbal memory; moderate to large in attention and working memory; moderate in executive functioning, visual perceptual skills, and visual memory; and small to moderate in motor speed, reading achievement, full&#x02010;scale IQ, and verbal fluency.<xref rid="bdi12556-bib-0232" ref-type="ref">232</xref> A prospective study showed that youth with PBD may exhibit a delay in cognitive development compared with controls in some cognitive domains (eg, executive functioning and verbal memory), despite optimal pharmacologic management.<xref rid="bdi12556-bib-0233" ref-type="ref">233</xref> Thus, it is essential to investigate therapeutic strategies, such as cognitive remediation<xref rid="bdi12556-bib-0234" ref-type="ref">234</xref> and/or optimizing cardiometabolic health,<xref rid="bdi12556-bib-0078" ref-type="ref">78</xref> that might be useful to restore these cognitive deficits and improve academic, social and functional impairments in youth with PBD.</p><p>In summary, in the last two decades, many neuroimaging and cognition studies have demonstrated anomalous brain structure, brain function, and cognition, alongside preliminary evidence of lagging neurocognitive development in PBD, mainly relating to the ECN.</p></sec></sec><sec id="bdi12556-sec-0044"><label>8.3</label><title>Limitations, gaps, and future directions</title><p>Further studies are necessary to understand whether abnormal neurodevelopment is present across other brain regions and to what extent abnormal neurostructure is related to abnormal brain function, behavioral aspects of the disease, and alterations in cognitive, social and functional development. Essential questions that remain unanswered concern how these abnormalities predict clinical course or the social, academic, personal, and functional impairments present in PBD. Additionally, it is largely unknown which brain abnormalities represent risk factors, resilience factors, early disease markers, or some combination of these. Studies that integrate information from different imaging modalities and theoretical perspectives should help parse these effects. Longitudinal studies will be crucial to help to discern developmental and progressive neurophysiological aspects of PBD. Finally, future studies need to parse the independent and interactive effects of PBD in relation to treatment effects and response markers, as well as common comorbidities such as ADHD, anxiety, and substance use disorders.</p></sec></sec><sec id="bdi12556-sec-0045"><label>9</label><title>PERIPHERAL BIOMARKERS</title><sec id="bdi12556-sec-0046"><label>9.1</label><title>Established findings and consensus</title><p>Numerous studies over the past decade have examined peripheral biomarkers among adults with BD, focusing most consistently on a pattern of increased inflammatory and oxidative stress markers and decreased neurotrophic markers, particularly during acute mood episodes.<xref rid="bdi12556-bib-0235" ref-type="ref">235</xref>, <xref rid="bdi12556-bib-0236" ref-type="ref">236</xref>, <xref rid="bdi12556-bib-0237" ref-type="ref">237</xref>, <xref rid="bdi12556-bib-0238" ref-type="ref">238</xref> Peripheral biomarkers, particularly those that fluctuate in relation to symptoms, have the potential for clinical application such as in the selection, prediction, and assessment of treatments. In contrast to the relatively broad literature on neuroimaging and neurocognition, there is a relative dearth of studies on peripheral biomarkers among youth with BD. However, in recent years there has been growing interest in this topic. Given the nascent literature, the following is a synopsis rather than a conclusive demonstration of replicated findings.</p><p>In a study of 30 adolescents with PBD, hypomanic symptoms were associated with levels of high&#x02010;sensitivity c reactive protein (hsCRP). Brain&#x02010;derived neurotrophic factor (BDNF) and interleukin 6 (IL&#x02010;6) were negatively associated with each other, and cardiovascular high&#x02010;risk levels of hsCRP were observed in 40% of the sample.<xref rid="bdi12556-bib-0239" ref-type="ref">239</xref> A subsequent larger study on the topic based on 123 young adults in the Course and Outcome of Bipolar Youth study found that, controlling for comorbidity and treatment, tumor necrosis factor alpha (TNF&#x02010;&#x003b1;) was associated with the proportion of time with psychosis, IL&#x02010;6 was associated with the proportion of time with subthreshold mood symptoms and with any suicide attempt, and hsCRP was associated with maximum depression severity over the preceding 6&#x000a0;months.<xref rid="bdi12556-bib-0240" ref-type="ref">240</xref>
</p><p>Two controlled studies of adolescents with PBD provide support for elevated inflammation. The first study (18 BD patients, 13 major depressive disorder [MDD] patients and 20 HCs) found significantly higher levels of nuclear factor kappa beta (NF&#x02010;&#x003ba;&#x003b2;) in peripheral blood mononuclear cells, monocytes, and lymphocytes, higher IL&#x02010;1&#x003b2; plasma levels, and greater TNF&#x02010;&#x003b1;&#x02010;induced elevations in NF&#x02010;&#x003ba;&#x003b2; in adolescents with mood disorders than in HCs.<xref rid="bdi12556-bib-0241" ref-type="ref">241</xref> The second study (40 BD patients and 20 HCs) found elevated IL&#x02010;6 and TNF&#x02010;&#x003b1; levels among adolescents with PBD.<xref rid="bdi12556-bib-0242" ref-type="ref">242</xref>
</p><p>A recent study of 30 adolescents with BD found that oxidative stress markers were lower as compared to adults with BD, and lipid hydroperoxide (LPH) levels were associated with a proxy measure of atherosclerosis but not with mood symptoms or medications.<xref rid="bdi12556-bib-0243" ref-type="ref">243</xref> A population&#x02010;based study of young adults found that those with BPSD, but not those with MDD, had increased protein oxidative damage compared to HCs.<xref rid="bdi12556-bib-0244" ref-type="ref">244</xref> A study of adolescents with or at risk for PBD found that adolescents with PBD had significantly lower LPH vs controls, with non&#x02010;symptomatic adolescents at familial risk falling between the other groups.<xref rid="bdi12556-bib-0245" ref-type="ref">245</xref> Finally, a study of 29 adolescents with PBD and 25 HCs found that LPH&#x02212;BDNF correlations were significantly different between adolescents with PBD and HCs, and that, among adolescents with PBD in the top half of the distribution of BDNF levels, greater LPH levels were associated with poorer executive function.<xref rid="bdi12556-bib-0246" ref-type="ref">246</xref>
</p><p>In an early biomarker study, platelet&#x02010;derived BDNF protein and lymphocyte&#x02010;derived BDNF mRNA levels were reduced among 26 medication&#x02010;free youth with PBD compared to HCs; mRNA BDNF levels increased significantly in a subset of 19 participants after 8&#x000a0;weeks of treatment.<xref rid="bdi12556-bib-0247" ref-type="ref">247</xref> A study of 30 adolescents with BD found a significant association between BDNF levels and amygdala volumes,<xref rid="bdi12556-bib-0248" ref-type="ref">248</xref> whereas other findings from the same sample indicated no association between neurotrophic factors and hippocampal volumes.<xref rid="bdi12556-bib-0249" ref-type="ref">249</xref>
</p><p>Similar to blood&#x02010;based biomarkers, the literature regarding the genetics of PBD is sparse. A family&#x02010;based association study found that genes coding for the serotonin transporter (solute carrier family 6 member 4), BDNF, and catechol&#x02010;O&#x02010;methyltransferase (COMT) were not significantly associated with PBD,<xref rid="bdi12556-bib-0250" ref-type="ref">250</xref> whereas a prior study based on the same sample found that four of 28 single nucleotide polymorphisms (SNPs) in the dopamine transporter gene (SLC6A3) were associated with PBD, of which only rs40184 remained significant after correction for multiple comparisons.<xref rid="bdi12556-bib-0251" ref-type="ref">251</xref> Another family&#x02010;based association study found that two SNPs in early growth gene 3 (EGR3) were nominally significantly associated with PBD,<xref rid="bdi12556-bib-0252" ref-type="ref">252</xref> as were glutamate decarboxylase 1 (GAD1)<xref rid="bdi12556-bib-0253" ref-type="ref">253</xref> and BDNF val66 alleles.<xref rid="bdi12556-bib-0254" ref-type="ref">254</xref> Most recently, a genetic study based on participants in the Treatment of Early Age Mania study found that a calcium channel, voltage&#x02010;dependent, L type, alpha 1c subunit (CACNA1C) haplotype was associated with PBD. Whereas the CACNA1C rs1006737 SNP has been previously associated with adult BD in genome&#x02010;wide association studies,<xref rid="bdi12556-bib-0255" ref-type="ref">255</xref> it was the rs10848632 CACNA1C SNP that was nominally associated with PBD in SNP analyses.<xref rid="bdi12556-bib-0256" ref-type="ref">256</xref>
</p></sec><sec id="bdi12556-sec-0047"><label>9.2</label><title>Limitations, gaps, and future directions</title><p>Despite the substantial increase in research findings in this area over the past 5&#x000a0;years, important limitations and gaps remain. Most studies have been constrained by small samples, limited covariate modeling, and cross&#x02010;sectional design. Ultimately, the clinical application of peripheral biomarkers will require that findings are significant in the heterogeneous samples in which these biomarkers would be employed, as reflected by a variety of comorbidities, different subtypes of PBD, and varying medication regimens. Studies using repeated measures afford the advantage of within&#x02010;subject analyses, which mitigate the impact of heterogeneity and state&#x02010;related changes. With regard to genetics, larger studies are needed, as are studies examining the link between genetic markers and intermediate phenotypes, such as neuroimaging, in PBD. In addition to these considerations, studies that incorporate biomarkers as objective predictors, treatment targets, and/or correlates of treatment response are warranted.</p></sec></sec><sec id="bdi12556-sec-0048"><label>10</label><title>CONCLUSIONS</title><p>There has been substantial progress in the area of PBD over the past 20&#x000a0;years. As data have accumulated and controversy has dissipated, the field has moved past existential questions about PBD toward defining and pursuing pressing clinical and scientific priorities that remain. The overall body of evidence supports the position that perceptions about marked international and developmental differences have been overstated, albeit that additional research on these topics is warranted. Traction toward improved outcomes will be supported by continued emphasis on phenomenology, prospective clinical epidemiology, pathophysiology, measurement&#x02010;based quantitative approaches including digital phenotyping, and novel therapeutics.</p><p>Despite the substantial increase in consensus regarding phenomenology and epidemiology, there remain outstanding questions about the prevalence of PBD in pre&#x02010;pubertal children. Whereas the existence of PBD in pre&#x02010;pubertal children has long been recognized, and indeed described in Kraepelin's seminal text,<xref rid="bdi12556-bib-0257" ref-type="ref">257</xref> reliable and valid estimates of the epidemiologic and clinical prevalence of PBD in pre&#x02010;pubertal children are lacking. With the progress that has been made, in terms of parsing PBD from chronic irritability without episodic mania/hypomania, in terms of increased recognition of PBD, and in terms of screening and diagnostic instruments, the field is now better positioned to examine this topic than it was as recently as a decade ago.</p><p>In terms of pathophysiology, it is important to consider the context of the Research Domain Criteria (RDoC) initiative, which suggests the value of integrating dimensional liability traits alongside DSM&#x02010;driven diagnoses and diagnostic criteria. In addition to all the inherent complexity of BD in adults, including differences across mood states, comorbidities, and BD subtypes, among others, research focusing on youth includes the added challenge of developmental differences. Future research should focus on age effects on the biology, manifestations, and treatment of PBD.</p><p>Future research should also focus on meaningfully integrating multiple methodologic levels of analysis. Thus far, there is a paucity of research that combines, for example, multiple neuroimaging approaches, neuroimaging and/or neurocognition with biomarkers, and/or neurobiology and clinical epidemiology. To the extent that the field can apply the large sample sizes and prospective measures of cohort studies toward improved understanding of the neurobiology of PBD, findings will become increasingly clinically and heuristically relevant.</p><p>From a treatment perspective, it will be important to begin addressing functional outcomes, rather than simply focusing on symptom reduction. Even during recovery, youth with PBD demonstrate impaired psychosocial functioning. Improved understanding of the factors underlying these impairments will allow for targeted preventive and treatment approaches. More studies with longer periods of acute treatment and maintenance studies will both help to clarify stabilization and relapse prevention. Representative <italic>epidemiologic</italic>, not just clinical, PBD samples show very high rates of suicidality and multi&#x02010;comorbidity alongside very low rates of treatment, even though &#x0201c;over&#x02010;treatment&#x0201d; and &#x0201c;over&#x02010;diagnosis&#x0201d; garner more attention.<xref rid="bdi12556-bib-0258" ref-type="ref">258</xref>, <xref rid="bdi12556-bib-0259" ref-type="ref">259</xref> The high degree of complexity and severity of PBD, even in the relatively early years of the disease, is in part an outcome of delaying or avoiding treatment altogether. It is crucial that the clinical and scientific community continues collaborative efforts, together with consumers, families, schools, and other stakeholders, toward public education and stigma reduction.</p><p>Finally, prevention strategies must be an area of emphasis in the decade ahead. Findings suggest that some psychotherapies and perhaps nutritional interventions might be low&#x02010;risk options for early stage/prodromal intervention. Here, prevention refers not only to the prevention of BD, which is an important but relatively distal goal, but also to the prevention of comorbidity accumulation (eg, substance use disorders), suicidality, treatment refractoriness, neurocognitive and functional impairment, and adverse physical health outcomes. Indeed, the physical implications of BD, particularly in terms of future cardiovascular disease, are increasingly recognized.<xref rid="bdi12556-bib-0079" ref-type="ref">79</xref> Just as it is important for primary care providers to recognize the increased cardiovascular risk associated with PBD, it is important for our own field to begin integrating brain&#x02212;body considerations in the assessment and treatment of PBD. The therapeutic and preventive potential of physical exercise for PBD, for example, is an almost entirely untouched topic.<xref rid="bdi12556-bib-0260" ref-type="ref">260</xref>, <xref rid="bdi12556-bib-0261" ref-type="ref">261</xref>
</p><p>While many questions remain unanswered, or insufficiently answered, we are hopeful that progress over the next decade will be far less constrained by controversies that, although critical in defining the directions of the field, also slowed progress and limited collaboration. At a time when clinically relevant psychiatric research faces the ironically dichotomous pressures of the RDoC era (ie, choosing between DSM and RDoC), it is important to retain focus on the importance of the categorical BD diagnosis in terms of treatment selection, clinical course, and familial risk. We are optimistic that liberally applied integration strategies (ie, dimensional as well as categorical views, neurobiology alongside clinical epidemiology, and pharmacologic alongside psychosocial interventions) will best serve the needs of our field and our constituents.</p></sec><sec id="bdi12556-sec-0049"><title>DISCLOSURES</title><p>Dr Birmaher receives funds for research from the National Institute of Mental Health. He receives royalties for publications from: Random House, Inc., Lippincott Williams &#x00026; Wilkins, APA Press, and UpToDate. Dr. Carlson receives funds for research from the NIMH and Patient Centered Outcomes Research Institute (PCORI). Dr. Chang is an unpaid consultant for GSK, Lilly, and BMS. He is on the DSMB for Sunovion. In the past 3&#x000a0;years he has received research support from GSK and Merck, and has been a consultant for Actavis and Janssen. Dr. DelBello has received research support from NIMH, NIDDK, and PCORI, as well as Otsuka, Lundbeck, Sunovion, Pfizer, Johnson and Johnson, Supernus, Amarex, and Shire; and has received consulting/advisory board fees/honoraria from Pfizer, Lundbeck, Sunovion, Supernus, Takeda, Johnson and Johnson, Neuronetics, and Akili. Dr. Findling receives or has received research support from, acted as a consultant for and/or served on a speaker's bureau for Actavis, Akili, Alcobra, American Academy of Child &#x00026; Adolescent Psychiatry, American Psychiatric Press, Bracket, CogCubed, Cognition Group, Coronado Biosciences, Elsevier, Epharma Solutions, Forest, Genentech, GlaxoSmithKline, Guilford Press, Ironshore, Johns Hopkins University Press, KemPharm, Lundbeck, Medgenics, Merck, NIH, Neurim, Novartis, Otsuka, PCORI, Pfizer, Physicians Postgraduate Press, Purdue, Rhodes Pharmaceuticals, Roche, Sage, Shire, Sunovion, Supernus Pharmaceuticals, Syneurx, Takeda, Teva, Tris, Validus, and WebMD. Dr. Fristad receives research funds from Janssen, publication royalties from Guilford Press, American Psychiatric Press and Child &#x00026; Family Psychological Services, and honoraria from Physician's Post&#x02010;Graduate Press. Dr. Goldstein has nothing to disclose. Dr. Hillegers has nothing to disclose. Dr. Kim has nothing to disclose. Dr. Kowatch is a consultant on data&#x02010;safety monitoring boards for Forest and Pfizer; he is faculty for the REACH Institute. Dr. Miklowitz receives funds for research from the NIMH and royalties from Guilford Press and John Wiley &#x00026; Sons. Dr. Nery's spouse is an employee of Eli Lilly &#x00026; Company. Dr. Perez Algorta has no disclosures/conflicts of interest. Dr. Van Meter has no disclosures/conflicts of interest. Dr. Wozniak has nothing to disclose personally; her spouse has received speaker honoraria from Otsuka, royalties from UptoDate, consultation fees from Advance Medical, FlexPharma, and Merck; and research support from UCB Pharma, NeuroMetrix, and Luitpold. Dr. Youngstrom has consulted with Pearson, Otsuka, Lundbeck, Joe Startup Technologies, and Western Psychological Services about psychological assessment, and receives funding from NIMH.</p></sec></body><back><ref-list content-type="cited-references" id="bdi12556-bibl-0001"><title>REFERENCES</title><ref id="bdi12556-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="bdi12556-cit-0001">
<string-name>
<surname>Van Meter</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Moreira</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>. <article-title>Meta&#x02010;analysis of epidemiological studies of bipolar disorder</article-title>. <source>J Clin Psychiatry</source>. <year>2011</year>;<volume>72</volume>:<fpage>1250</fpage>&#x02010;<lpage>1256</lpage>.<pub-id pub-id-type="pmid">21672501</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="bdi12556-cit-0002">
<string-name>
<surname>Andrade</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Hishinuma</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>McDermott</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>The National Center on Indigenous Hawaiian Behavioral Health Study of Prevalence of Psychiatric Disorders in Native Hawaiian Adolescents</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2006</year>;<volume>45</volume>:<fpage>26</fpage>&#x02010;<lpage>36</lpage>.<pub-id pub-id-type="pmid">16327578</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="bdi12556-cit-0003">
<string-name>
<surname>Anselmi</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Fleitlich&#x02010;Bilyk</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Menezes</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ara&#x000fa;jo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Rohde</surname>
<given-names>L</given-names>
</string-name>. <article-title>Prevalence of psychiatric disorders in a Brazilian birth cohort of 11&#x02010;year&#x02010;olds</article-title>. <source>Soc Psychiatry Psychiatr Epidemiol</source>. <year>2010</year>;<volume>45</volume>:<fpage>135</fpage>&#x02010;<lpage>142</lpage>.<pub-id pub-id-type="pmid">19381426</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="bdi12556-cit-0004">
<string-name>
<surname>Benjet</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Borges</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Medina&#x02010;Mora</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Zambrano</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Aguilar&#x02010;Gaxiola</surname>
<given-names>S</given-names>
</string-name>. <article-title>Youth mental health in a populous city of the developing world: results from the Mexican Adolescent Mental Health Survey</article-title>. <source>J Child Psychol Psychiatry</source>. <year>2009</year>;<volume>50</volume>:<fpage>386</fpage>&#x02010;<lpage>395</lpage>.<pub-id pub-id-type="pmid">19040499</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="bdi12556-cit-0005">
<string-name>
<surname>Canals</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Domenech</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Carbajo</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Blade</surname>
<given-names>J</given-names>
</string-name>. <article-title>Prevalence of DSM&#x02010;III&#x02010;R and ICD&#x02010;10 psychiatric disorders in a Spanish population of 18&#x02010;year&#x02010;olds</article-title>. <source>Acta Psychiatr Scand</source>. <year>1997</year>;<volume>96</volume>:<fpage>287</fpage>&#x02010;<lpage>294</lpage>.<pub-id pub-id-type="pmid">9350958</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="bdi12556-cit-0006">
<string-name>
<surname>Costello</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Angold</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Burns</surname>
<given-names>BJ</given-names>
</string-name>, et&#x000a0;al. <article-title>The Great Smoky Mountains Study of Youth: goals, design, methods, and the prevalence of DSM&#x02010;III&#x02010;R disorders</article-title>. <source>Arch Gen Psychiatry</source>. <year>1996</year>;<volume>53</volume>:<fpage>1129</fpage>&#x02010;<lpage>1136</lpage>.<pub-id pub-id-type="pmid">8956679</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="bdi12556-cit-0007">
<string-name>
<surname>Gould</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>King</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Greenwald</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Psychopathology associated with suicidal ideation and attempts among children and adolescents</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>1998</year>;<volume>37</volume>:<fpage>915</fpage>&#x02010;<lpage>923</lpage>.<pub-id pub-id-type="pmid">9735611</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="bdi12556-cit-0008">
<string-name>
<surname>Kessler</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Avenevoli</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Green</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>National Comorbidity Survey Replication Adolescent Supplement (NCS&#x02010;A): III. Concordance of DSM&#x02010;IV/CIDI diagnoses with clinical reassessments</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2009</year>;<volume>48</volume>:<fpage>386</fpage>&#x02010;<lpage>399</lpage>.<pub-id pub-id-type="pmid">19252450</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="bdi12556-cit-0009">
<string-name>
<surname>Kim&#x02010;Cohen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Caspi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Moffitt</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Harrington</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Milne</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Poulton</surname>
<given-names>R</given-names>
</string-name>. <article-title>Prior juvenile diagnoses in adults with mental disorder: developmental follow&#x02010;back of a prospective&#x02010;longitudinal cohort</article-title>. <source>Arch Gen Psychiatry</source>. <year>2003</year>;<volume>60</volume>:<fpage>709</fpage>&#x02010;<lpage>717</lpage>.<pub-id pub-id-type="pmid">12860775</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="bdi12556-cit-0010">
<string-name>
<surname>Lewinsohn</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Seeley</surname>
<given-names>J</given-names>
</string-name>. <article-title>Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>1995</year>;<volume>34</volume>:<fpage>454</fpage>&#x02010;<lpage>463</lpage>.<pub-id pub-id-type="pmid">7751259</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="bdi12556-cit-0011">
<string-name>
<surname>Lynch</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Mills</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Daly</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Fitzpatrick</surname>
<given-names>C</given-names>
</string-name>. <article-title>Challenging times: prevalence of psychiatric disorders and suicidal behaviours in Irish adolescents</article-title>. <source>J Adolesc</source>. <year>2006</year>;<volume>29</volume>:<fpage>555</fpage>&#x02010;<lpage>573</lpage>.<pub-id pub-id-type="pmid">16202448</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="bdi12556-cit-0012">
<string-name>
<surname>P&#x000e4;&#x000e4;ren</surname>
<given-names>A</given-names>
</string-name>. <article-title>Hypomania spectrum disorder in adolescence: a 15&#x02010;year follow&#x02010;up of non&#x02010;mood morbidity in adulthood</article-title>. <source>BMC Psychiatry</source>. <year>2014</year>;<volume>14</volume>:<fpage>9</fpage>.<pub-id pub-id-type="pmid">24428938</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="bdi12556-cit-0013">
<string-name>
<surname>Pan</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Salum</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Gadelha</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Manic symptoms in youth: dimensions, latent classes, and associations with parental psychopathology</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2014</year>;<volume>53</volume>:<fpage>625</fpage>&#x02010;<lpage>634</lpage>.<pub-id pub-id-type="pmid">24839881</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="bdi12556-cit-0014">
<string-name>
<surname>Stringaris</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Santosh</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Leibenluft</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Goodman</surname>
<given-names>R</given-names>
</string-name>. <article-title>Youth meeting symptom and impairment criteria for mania&#x02010;like episodes lasting less than four days: an epidemiological enquiry</article-title>. <source>J Child Psychol Psychiatry</source>. <year>2009</year>;<volume>51</volume>:<fpage>31</fpage>&#x02010;<lpage>38</lpage>.<pub-id pub-id-type="pmid">19686330</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="bdi12556-cit-0015">
<string-name>
<surname>Tijssen</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Van Os</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wittchen</surname>
<given-names>HU</given-names>
</string-name>, <string-name>
<surname>Lieb</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Beesdo</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wichers</surname>
<given-names>M</given-names>
</string-name>. <article-title>Risk factors predicting onset and persistence of subthreshold expression of bipolar psychopathology among youth from the community</article-title>. <source>Acta Psychiatr Scand</source>. <year>2010</year>;<volume>122</volume>:<fpage>255</fpage>&#x02010;<lpage>266</lpage>.<pub-id pub-id-type="pmid">20199490</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="bdi12556-cit-0016">
<string-name>
<surname>Verhulst</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Van der Ende</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ferdinand</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kasius</surname>
<given-names>M</given-names>
</string-name>. <article-title>The prevalence of DSM&#x02010;III&#x02010;R diagnoses in a national sample of Dutch adolescents</article-title>. <source>Arch Gen Psychiatry</source>. <year>1997</year>;<volume>54</volume>:<fpage>329</fpage>&#x02010;<lpage>336</lpage>.<pub-id pub-id-type="pmid">9107149</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="bdi12556-cit-0017">
<string-name>
<surname>Kozloff</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Cheung</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Schaffer</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Bipolar disorder among adolescents and young adults: results from an epidemiological sample</article-title>. <source>J Affect Disord</source>. <year>2010</year>;<volume>125</volume>:<fpage>350</fpage>&#x02010;<lpage>354</lpage>.<pub-id pub-id-type="pmid">20226535</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="bdi12556-cit-0018">
<string-name>
<surname>Oh</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Cheon</surname>
<given-names>KA</given-names>
</string-name>. <article-title>Comparison of aripiprazole and other atypical antipsychotics for pediatric bipolar disorder: a retrospective chart review of efficacy and tolerability</article-title>. <source>Clin Psychopharmacol Neurosci</source>. <year>2013</year>;<volume>11</volume>:<fpage>72</fpage>&#x02010;<lpage>79</lpage>.<pub-id pub-id-type="pmid">24023551</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="bdi12556-cit-0019">
<string-name>
<surname>Shon</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Joo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>HW</given-names>
</string-name>. <article-title>Comparison of clinical characteristics of bipolar and depressive disorders in Korean clinical sample of youth: a retrospective chart review</article-title>. <source>Eur Child Adolesc Psychiatry</source>. <year>2013</year>;<volume>23</volume>:<fpage>307</fpage>&#x02010;<lpage>316</lpage>.<pub-id pub-id-type="pmid">23963644</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="bdi12556-cit-0020">
<string-name>
<surname>Oh</surname>
<given-names>H&#x02010;J</given-names>
</string-name>, <string-name>
<surname>Glutting</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>McDermott</surname>
<given-names>PA</given-names>
</string-name>. <article-title>An epidemiological&#x02010;cohort study of DAS processing speed factor: how well does it identify concurrent achievement and behavior problems?</article-title>
<source>J Psychoeduc Assess</source>. <year>1999</year>;<volume>17</volume>:<fpage>362</fpage>&#x02010;<lpage>375</lpage>.</mixed-citation></ref><ref id="bdi12556-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="bdi12556-cit-0021">
<string-name>
<surname>Moreno</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Laje</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Blanco</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Schmidt</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Olfson</surname>
<given-names>M</given-names>
</string-name>. <article-title>National trends in the outpatient diagnosis and treatment of bipolar disorder in youth</article-title>. <source>Arch Gen Psychiatry</source>. <year>2007</year>;<volume>64</volume>:<fpage>1032</fpage>&#x02010;<lpage>1039</lpage>.<pub-id pub-id-type="pmid">17768268</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="bdi12556-cit-0022">
<string-name>
<surname>Blader</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Carlson</surname>
<given-names>GA</given-names>
</string-name>. <article-title>Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996&#x02010;2004</article-title>. <source>Biol Psychiat</source>. <year>2007</year>;<volume>62</volume>:<fpage>107</fpage>&#x02010;<lpage>114</lpage>.<pub-id pub-id-type="pmid">17306773</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="bdi12556-cit-0023">
<string-name>
<surname>Dubicka</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Carlson</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Vail</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Harrington</surname>
<given-names>R</given-names>
</string-name>. <article-title>Prepubertal mania: diagnostic differences between US and UK clinicians</article-title>. <source>Eur Child Adolesc Psychiatry</source>. <year>2008</year>;<volume>17</volume>:<fpage>153</fpage>&#x02010;<lpage>161</lpage>.<pub-id pub-id-type="pmid">17876503</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="bdi12556-cit-0024">
<string-name>
<surname>Costello</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Egger</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Angold</surname>
<given-names>A</given-names>
</string-name>. <article-title>10&#x02010;year research update review: the epidemiology of child and adolescent psychiatric disorders: I. Methods and public health burden</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2005</year>;<volume>44</volume>:<fpage>972</fpage>&#x02010;<lpage>986</lpage>.<pub-id pub-id-type="pmid">16175102</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="bdi12556-cit-0025">
<string-name>
<surname>Correll</surname>
<given-names>CU</given-names>
</string-name>, <string-name>
<surname>Hauser</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Penzner</surname>
<given-names>JB</given-names>
</string-name>, et&#x000a0;al. <article-title>Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episode</article-title>. <source>Bipolar Disord</source>. <year>2014</year>;<volume>16</volume>:<fpage>478</fpage>&#x02010;<lpage>492</lpage>.<pub-id pub-id-type="pmid">24597782</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="bdi12556-cit-0026">
<string-name>
<surname>Post</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Ballenger</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Rey</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Bunney</surname>
<given-names>WE</given-names>
<suffix>Jr</suffix>
</string-name>. <article-title>Slow and rapid onset of manic episodes: implications for underlying biology</article-title>. <source>Psychiatry Res</source>. <year>1981</year>;<volume>4</volume>:<fpage>229</fpage>&#x02010;<lpage>237</lpage>.<pub-id pub-id-type="pmid">6939012</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="bdi12556-cit-0027">
<string-name>
<surname>Bellivier</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Etain</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Malafosse</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Age at onset in bipolar I affective disorder in the USA and Europe</article-title>. <source>World J Biol Psychiatry</source>. <year>2014</year>;<volume>15</volume>:<fpage>369</fpage>&#x02010;<lpage>376</lpage>.<pub-id pub-id-type="pmid">22188366</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="bdi12556-cit-0028">
<string-name>
<surname>Post</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Luckenbaugh</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Leverich</surname>
<given-names>GS</given-names>
</string-name>, et&#x000a0;al. <article-title>Incidence of childhood&#x02010;onset bipolar illness in the USA and Europe</article-title>. <source>Br J Psychiatry</source>. <year>2008</year>;<volume>192</volume>:<fpage>150</fpage>&#x02010;<lpage>151</lpage>.<pub-id pub-id-type="pmid">18245035</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="bdi12556-cit-0029">
<string-name>
<surname>Post</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Leverich</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Kupka</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>Increased parental history of bipolar disorder in the United States: association with early age of onset</article-title>. <source>Acta Psychiatr Scand</source>. <year>2014</year>;<volume>129</volume>:<fpage>375</fpage>&#x02010;<lpage>382</lpage>.<pub-id pub-id-type="pmid">24138298</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0030"><label>30</label><mixed-citation publication-type="book" id="bdi12556-cit-0030">
<string-name>
<surname>Diler</surname>
<given-names>RS</given-names>
</string-name>. <source>Pediatric Bipolar Disorder: A Global Perspective</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Nova Science</publisher-name>; <year>2007</year>.</mixed-citation></ref><ref id="bdi12556-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="bdi12556-cit-0031">
<string-name>
<surname>Masi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Perugi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Millepiedi</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Clinical implications of DSM&#x02010;IV subtyping of bipolar disorders in referred children and adolescents</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2007</year>;<volume>46</volume>:<fpage>1299</fpage>&#x02010;<lpage>1306</lpage>.<pub-id pub-id-type="pmid">17885571</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="bdi12556-cit-0032">
<string-name>
<surname>Diler</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Uguz</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Seydaoglu</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Erol</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Avci</surname>
<given-names>A</given-names>
</string-name>. <article-title>Differentiating bipolar disorder in Turkish prepubertal children with attention&#x02010;deficit hyperactivity disorder</article-title>. <source>Bipolar Disord</source>. <year>2007</year>;<volume>9</volume>:<fpage>243</fpage>&#x02010;<lpage>251</lpage>.<pub-id pub-id-type="pmid">17430299</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="bdi12556-cit-0033">
<string-name>
<surname>Benarous</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Mikita</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Goodman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Stringaris</surname>
<given-names>A</given-names>
</string-name>. <article-title>Distinct relationships between social aptitude and dimensions of manic&#x02010;like symptoms in youth</article-title>. <source>Eur Child Adolesc Psychiatry</source>. <year>2016</year>;<volume>25</volume>:<fpage>831</fpage>&#x02010;<lpage>842</lpage>.<pub-id pub-id-type="pmid">26650482</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="bdi12556-cit-0034">
<string-name>
<surname>Masi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Toni</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Perugi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Mucci</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Millepiedi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Akiskal</surname>
<given-names>HS</given-names>
</string-name>. <article-title>Anxiety disorders in children and adolescents with bipolar disorder: a neglected comorbidity</article-title>. <source>Can J Psychiatry</source>. <year>2001</year>;<volume>46</volume>:<fpage>797</fpage>&#x02010;<lpage>802</lpage>.<pub-id pub-id-type="pmid">11761630</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="bdi12556-cit-0035">
<string-name>
<surname>Jairam</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Srinath</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Girimaji</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Seshadri</surname>
<given-names>SP</given-names>
</string-name>. <article-title>A prospective 4&#x02010;5&#x000a0;year follow&#x02010;up of juvenile onset bipolar disorder</article-title>. <source>Bipolar Disord</source>. <year>2004</year>;<volume>6</volume>:<fpage>386</fpage>&#x02010;<lpage>394</lpage>.<pub-id pub-id-type="pmid">15383131</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="bdi12556-cit-0036">
<string-name>
<surname>Srinath</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Janardhan Reddy</surname>
<given-names>YC</given-names>
</string-name>, <string-name>
<surname>Girimaji</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Seshadri</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Subbakrishna</surname>
<given-names>DK</given-names>
</string-name>. <article-title>A prospective study of bipolar disorder in children and adolescents from India</article-title>. <source>Acta Psychiatr Scand</source>. <year>1998</year>;<volume>98</volume>:<fpage>437</fpage>&#x02010;<lpage>442</lpage>.<pub-id pub-id-type="pmid">9879784</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="bdi12556-cit-0037">
<string-name>
<surname>Zeni</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Tramontina</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ketzer</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Pheula</surname>
<given-names>GF</given-names>
</string-name>, <string-name>
<surname>Rohde</surname>
<given-names>LA</given-names>
</string-name>. <article-title>Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention&#x02010; deficit/hyperactivity disorder: a randomized crossover trial</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2009</year>;<volume>19</volume>:<fpage>553</fpage>&#x02010;<lpage>561</lpage>.<pub-id pub-id-type="pmid">19877980</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="bdi12556-cit-0038">
<string-name>
<surname>Masi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Perugi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Millepiedi</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Pharmacological response in juvenile bipolar disorder subtypes: a naturalistic retrospective examination</article-title>. <source>Psychiatry Res</source>. <year>2010</year>;<volume>177</volume>:<fpage>192</fpage>&#x02010;<lpage>198</lpage>.<pub-id pub-id-type="pmid">20381170</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="bdi12556-cit-0039">
<string-name>
<surname>Zeni</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Tramontina</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zeni</surname>
<given-names>TA</given-names>
</string-name>, et&#x000a0;al. <article-title>The Val66Met polymorphism at the BDNF gene does not influence Wisconsin Card Sorting Test results in children and adolescents with bipolar disorder</article-title>. <source>Rev Bras Psiquiatr</source>. <year>2013</year>;<volume>35</volume>:<fpage>44</fpage>&#x02010;<lpage>50</lpage>.<pub-id pub-id-type="pmid">23567599</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="bdi12556-cit-0040">
<string-name>
<surname>Lauxen Peruzzolo</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Anes</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kohmann Ade</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Correlation between peripheral levels of brain&#x02010;derived neurotrophic factor and hippocampal volume in children and adolescents with bipolar disorder</article-title>. <source>Neural Plast</source>. <year>2015</year>;<volume>2015</volume>:<fpage>324825</fpage>.<pub-id pub-id-type="pmid">26075097</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="bdi12556-cit-0041">
<string-name>
<surname>Zeni</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Tramontina</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aguiar</surname>
<given-names>BW</given-names>
</string-name>, et&#x000a0;al. <article-title>BDNF Val66Met polymorphism and peripheral protein levels in pediatric bipolar disorder and attention&#x02010;deficit/hyperactivity disorder</article-title>. <source>Acta Psychiatr Scand</source>. <year>2016</year>;<volume>134</volume>:<fpage>268</fpage>&#x02010;<lpage>274</lpage>.<pub-id pub-id-type="pmid">27209073</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="bdi12556-cit-0042">
<string-name>
<surname>Manon</surname>
<given-names>HJH</given-names>
</string-name>, <string-name>
<surname>Catrien</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Marjolein</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Frank</surname>
<given-names>CV</given-names>
</string-name>, <string-name>
<surname>Johan</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Willem</surname>
<given-names>AN</given-names>
</string-name>. <article-title>Five&#x02010;year prospective outcome of psychopathology in the adolescent offspring of bipolar parents</article-title>. <source>Bipolar Disord</source>. <year>2005</year>;<volume>7</volume>:<fpage>344</fpage>&#x02010;<lpage>350</lpage>.<pub-id pub-id-type="pmid">16026487</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="bdi12556-cit-0043">
<string-name>
<surname>Grigoroiu&#x02010;Serbanescu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Christodorescu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Jipescu</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Totoescu</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Marinescu</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ardelean</surname>
<given-names>V</given-names>
</string-name>. <article-title>Psychopathology in children aged 10&#x02010;17 of bipolar parents: psychopathology rate and correlates of the severity of the psychopathology</article-title>. <source>J Affect Disord</source>. <year>1989</year>;<volume>16</volume>:<fpage>167</fpage>&#x02010;<lpage>179</lpage>.<pub-id pub-id-type="pmid">2522116</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="bdi12556-cit-0044">
<string-name>
<surname>Galanter</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Hundt</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Goyal</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Le</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fisher</surname>
<given-names>PW</given-names>
</string-name>. <article-title>Variability among research diagnostic interview instruments in the application of DSM&#x02010;IV&#x02010;TR criteria for pediatric bipolar disorder</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2012</year>;<volume>51</volume>:<fpage>605</fpage>&#x02010;<lpage>621</lpage>.<pub-id pub-id-type="pmid">22632620</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="bdi12556-cit-0045">
<string-name>
<surname>Galanter</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>VL</given-names>
</string-name>. <article-title>Medical decision making: a selective review for child psychiatrists and psychologists</article-title>. <source>J Child Psychol Psychiatry</source>. <year>2005</year>;<volume>46</volume>:<fpage>675</fpage>&#x02010;<lpage>689</lpage>.<pub-id pub-id-type="pmid">15972065</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="bdi12556-cit-0046">
<string-name>
<surname>Carlson</surname>
<given-names>GA</given-names>
</string-name>. <article-title>Disruptive mood dysregulation disorder: where did it come from and where is it going</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2016</year>;<volume>26</volume>:<fpage>90</fpage>&#x02010;<lpage>93</lpage>.<pub-id pub-id-type="pmid">27007451</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="bdi12556-cit-0047">
<string-name>
<surname>Nader</surname>
<given-names>EG</given-names>
</string-name>, <string-name>
<surname>Kleinman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gomes</surname>
<given-names>BC</given-names>
</string-name>, et&#x000a0;al. <article-title>Negative expressed emotion best discriminates families with bipolar disorder children</article-title>. <source>J Affect Disord</source>. <year>2013</year>;<volume>148</volume>:<fpage>418</fpage>&#x02010;<lpage>423</lpage>.<pub-id pub-id-type="pmid">23218896</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="bdi12556-cit-0048">
<string-name>
<surname>Teixeira</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Kleinman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Zanetti</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Preserved white matter in unmedicated pediatric bipolar disorder</article-title>. <source>Neurosci Lett</source>. <year>2014</year>;<volume>579</volume>:<fpage>41</fpage>&#x02010;<lpage>45</lpage>.<pub-id pub-id-type="pmid">25017827</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="bdi12556-cit-0049">
<string-name>
<surname>Lee</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Joo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Yum</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>HW</given-names>
</string-name>. <article-title>Diagnostic validity and reliability of a Korean version of the Parent and Adolescent General Behavior Inventories</article-title>. <source>Compr Psychiatry</source>. <year>2014</year>;<volume>55</volume>:<fpage>1730</fpage>&#x02010;<lpage>1737</lpage>.<pub-id pub-id-type="pmid">24962447</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="bdi12556-cit-0050">
<string-name>
<surname>Mesman</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Birmaher</surname>
<given-names>BB</given-names>
</string-name>, <string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>, et&#x000a0;al. <article-title>Categorical and dimensional psychopathology in Dutch and US offspring of parents with bipolar disorder: a preliminary cross&#x02010;national comparison</article-title>. <source>J Affect Disord</source>. <year>2016</year>;<volume>205</volume>:<fpage>95</fpage>&#x02010;<lpage>102</lpage>.<pub-id pub-id-type="pmid">27423424</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0051"><label>51</label><mixed-citation publication-type="book" id="bdi12556-cit-0051">
<string-name>
<surname>Achenbach</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Rescorla</surname>
<given-names>LA</given-names>
</string-name>. <source>Manual for the ASEBA School&#x02010;Age Forms &#x00026; Profiles</source>. <publisher-loc>Burlington, VT</publisher-loc>: <publisher-name>University of Vermont</publisher-name>; <year>2001</year>.</mixed-citation></ref><ref id="bdi12556-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="bdi12556-cit-0052">
<string-name>
<surname>Kaufman</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Birmaher</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Brent</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>Schedule for Affective Disorders and Schizophrenia for School&#x02010;Age Children&#x02010;Present and Lifetime version (K&#x02010;SADS&#x02010;PL): initial reliability and validity data</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>1997</year>;<volume>36</volume>:<fpage>980</fpage>&#x02010;<lpage>988</lpage>.<pub-id pub-id-type="pmid">9204677</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="bdi12556-cit-0053">
<string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Genzlinger</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Egerton</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Van Meter</surname>
<given-names>AR</given-names>
</string-name>. <article-title>Multivariate meta&#x02010;analysis of the discriminative validity of caregiver, youth, and teacher rating scales for pediatric bipolar disorder: mother knows best about mania</article-title>. <source>Arch Sci Psychol</source>. <year>2015</year>;<volume>3</volume>:<fpage>112</fpage>&#x02010;<lpage>137</lpage>.</mixed-citation></ref><ref id="bdi12556-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="bdi12556-cit-0054">
<string-name>
<surname>Leibenluft</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Charney</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Towbin</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Bhangoo</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Pine</surname>
<given-names>DS</given-names>
</string-name>. <article-title>Defining clinical phenotypes of juvenile mania</article-title>. <source>Am J Psychiatry</source>. <year>2003</year>;<volume>160</volume>:<fpage>430</fpage>&#x02010;<lpage>437</lpage>.<pub-id pub-id-type="pmid">12611821</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="bdi12556-cit-0055">
<string-name>
<surname>Axelson</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Birmaher</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>, et&#x000a0;al. <article-title>Concerns regarding the inclusion of temper dysregulation disorder with dysphoria in the diagnostic and statistical manual of mental disorders, fifth edition</article-title>. <source>J Clin Psychiatry</source>. <year>2011</year>;<volume>72</volume>:<fpage>1257</fpage>&#x02010;<lpage>1262</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4088/jcp.10com06220:e1-e6">https://doi.org/10.4088/jcp.10com06220:e1-e6</ext-link>.<pub-id pub-id-type="pmid">21672494</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="bdi12556-cit-0056">
<string-name>
<surname>Geller</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Craney</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Bolhofner</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>DelBello</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zimerman</surname>
<given-names>B</given-names>
</string-name>. <article-title>One&#x02010;year recovery and relapse rates of children with a prepubertal and early adolescent bipolar disorder phenotype</article-title>. <source>Am J Psychiatry</source>. <year>2001</year>;<volume>158</volume>:<fpage>303</fpage>&#x02010;<lpage>305</lpage>.<pub-id pub-id-type="pmid">11156815</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="bdi12556-cit-0057">
<string-name>
<surname>Carlson</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>DN</given-names>
</string-name>. <article-title>How to understand divergent views on bipolar disorder in youth</article-title>. <source>Annu Rev Clin Psychol</source>. <year>2014</year>;<volume>10</volume>:<fpage>529</fpage>&#x02010;<lpage>551</lpage>.<pub-id pub-id-type="pmid">24387237</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="bdi12556-cit-0058">
<string-name>
<surname>Hunt</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Birmaher</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Leonard</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Irritability without elation in a large bipolar youth sample: frequency and clinical description</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2009</year>;<volume>48</volume>:<fpage>730</fpage>&#x02010;<lpage>739</lpage>.<pub-id pub-id-type="pmid">19465878</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="bdi12556-cit-0059">
<string-name>
<surname>Fonseka</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Swampillai</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Timmins</surname>
<given-names>V</given-names>
</string-name>, et&#x000a0;al. <article-title>Significance of borderline personality&#x02010;spectrum symptoms among adolescents with bipolar disorder</article-title>. <source>J Affect Disord</source>. <year>2015</year>;<volume>170</volume>:<fpage>39</fpage>&#x02010;<lpage>45</lpage>.<pub-id pub-id-type="pmid">25233237</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="bdi12556-cit-0060">
<string-name>
<surname>Mitchell</surname>
<given-names>RHB</given-names>
</string-name>, <string-name>
<surname>Timmins</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Collins</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Scavone</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Iskric</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>. <article-title>Prevalence and correlates of disruptive mood dysregulation disorder among adolescents with bipolar disorder</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2016</year>;<volume>26</volume>:<fpage>147</fpage>&#x02010;<lpage>153</lpage>.<pub-id pub-id-type="pmid">26844707</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="bdi12556-cit-0061">
<string-name>
<surname>Fristad</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Wolfson</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Algorta</surname>
<given-names>GP</given-names>
</string-name>, et&#x000a0;al. <article-title>Disruptive mood dysregulation disorder and bipolar disorder not otherwise specified: fraternal or identical twins?</article-title>
<source>J Child Adolesc Psychopharmacol</source>. <year>2016</year>;<volume>26</volume>:<fpage>138</fpage>&#x02010;<lpage>146</lpage>.<pub-id pub-id-type="pmid">26859630</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="bdi12556-cit-0062">
<string-name>
<surname>Merikangas</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>J&#x02010;P</given-names>
</string-name>, et&#x000a0;al. <article-title>Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative</article-title>. <source>Arch Gen Psychiatry</source>. <year>2011</year>;<volume>68</volume>:<fpage>241</fpage>&#x02010;<lpage>251</lpage>.<pub-id pub-id-type="pmid">21383262</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="bdi12556-cit-0063">
<string-name>
<surname>Van Meter</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>. <article-title>Cyclothymic disorder: a critical review</article-title>. <source>Clin Psychol Rev</source>. <year>2012</year>;<volume>32</volume>:<fpage>229</fpage>&#x02010;<lpage>243</lpage>.<pub-id pub-id-type="pmid">22459786</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="bdi12556-cit-0064">
<string-name>
<surname>Axelson</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Birmaher</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Strober</surname>
<given-names>MA</given-names>
</string-name>, et&#x000a0;al. <article-title>Course of subthreshold bipolar disorder in youth: diagnostic progression from bipolar disorder not otherwise specified</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2011</year>;<volume>50</volume>:<fpage>1001</fpage>&#x02010;<lpage>1016</lpage>.<pub-id pub-id-type="pmid">21961775</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="bdi12556-cit-0065">
<string-name>
<surname>Axelson</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Birmaher</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Strober</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Phenomenology of children and adolescents with bipolar spectrum disorders</article-title>. <source>Arch Gen Psychiatry</source>. <year>2006</year>;<volume>63</volume>:<fpage>1139</fpage>&#x02010;<lpage>1148</lpage>.<pub-id pub-id-type="pmid">17015816</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="bdi12556-cit-0066">
<string-name>
<surname>Van Meter</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Demeter</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>. <article-title>Examining the validity of cyclothymic disorder in a youth sample: replication and extension</article-title>. <source>J Abnorm Child Psychol</source>. <year>2013</year>;<volume>41</volume>:<fpage>367</fpage>&#x02010;<lpage>378</lpage>.<pub-id pub-id-type="pmid">22968491</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="bdi12556-cit-0067">
<string-name>
<surname>Geller</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Zimerman</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2000</year>;<volume>10</volume>:<fpage>157</fpage>&#x02010;<lpage>164</lpage>.<pub-id pub-id-type="pmid">11052405</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="bdi12556-cit-0068">
<string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Birmaher</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>. <article-title>Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis</article-title>. <source>Bipolar Disord</source>. <year>2008</year>;<volume>10</volume>:<fpage>194</fpage>&#x02010;<lpage>214</lpage>.<pub-id pub-id-type="pmid">18199237</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="bdi12556-cit-0069">
<string-name>
<surname>Merikangas</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>J&#x02010;p</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Burstein</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication&#x02010;Adolescent Supplement (NCS&#x02010;A)</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2010</year>;<volume>49</volume>:<fpage>980</fpage>&#x02010;<lpage>989</lpage>.<pub-id pub-id-type="pmid">20855043</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="bdi12556-cit-0070">
<string-name>
<surname>Wittchen</surname>
<given-names>HU</given-names>
</string-name>, <string-name>
<surname>Frohlich</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Behrendt</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10&#x02010;year prospective&#x02010;longitudinal community study in adolescents</article-title>. <source>Drug Alcohol Depend</source>. <year>2007</year>;<volume>88</volume>(<issue>Suppl 1</issue>):<fpage>S60</fpage>&#x02010;<lpage>S70</lpage>.<pub-id pub-id-type="pmid">17257779</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="bdi12556-cit-0071">
<string-name>
<surname>Van Meter</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Burke</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kowatch</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>. <article-title>Ten&#x02010;year updated meta&#x02010;analysis of the clinical characteristics of pediatric mania and hypomania</article-title>. <source>Bipolar Disord</source>. <year>2016</year>;<volume>18</volume>:<fpage>19</fpage>&#x02010;<lpage>32</lpage>.<pub-id pub-id-type="pmid">26748678</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="bdi12556-cit-0072">
<string-name>
<surname>Birmaher</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Axelson</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Strober</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Clinical course of children and adolescents with bipolar spectrum disorders</article-title>. <source>Arch Gen Psychiatry</source>. <year>2006</year>;<volume>63</volume>:<fpage>175</fpage>&#x02010;<lpage>183</lpage>.<pub-id pub-id-type="pmid">16461861</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="bdi12556-cit-0073">
<string-name>
<surname>Sachs</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Baldassano</surname>
<given-names>CF</given-names>
</string-name>, <string-name>
<surname>Truman</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Guille</surname>
<given-names>C</given-names>
</string-name>. <article-title>Comorbidity of attention deficit hyperactivity disorder with early&#x02010; and late&#x02010;onset bipolar disorder</article-title>. <source>Am J Psychiatry</source>. <year>2000</year>;<volume>157</volume>:<fpage>466</fpage>&#x02010;<lpage>468</lpage>.<pub-id pub-id-type="pmid">10698829</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="bdi12556-cit-0074">
<string-name>
<surname>Nierenberg</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Miyahara</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Spencer</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>Clinical and diagnostic implications of lifetime attention&#x02010;deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP&#x02010;BD participants</article-title>. <source>Biol Psychiat</source>. <year>2005</year>;<volume>57</volume>:<fpage>1467</fpage>&#x02010;<lpage>1473</lpage>.<pub-id pub-id-type="pmid">15950022</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="bdi12556-cit-0075">
<string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>, <string-name>
<surname>Blanco</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>J&#x02010;P</given-names>
</string-name>, <string-name>
<surname>Merikangas</surname>
<given-names>K</given-names>
</string-name>. <article-title>Correlates of overweight and obesity among adolescents with bipolar disorder in the National Comorbidity Survey&#x02010;Adolescent Supplement (NCS&#x02010;A)</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2016</year>;<volume>55</volume>:<fpage>1020</fpage>&#x02010;<lpage>1026</lpage>.<pub-id pub-id-type="pmid">27871636</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="bdi12556-cit-0076">
<string-name>
<surname>Shapiro</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mindra</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Timmins</surname>
<given-names>V</given-names>
</string-name>, et&#x000a0;al. <article-title>Controlled study of obesity among adolescents with bipolar disorder</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2016</year>;<volume>27</volume>:<fpage>95</fpage>&#x02010;<lpage>100</lpage>.<pub-id pub-id-type="pmid">26771226</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="bdi12556-cit-0077">
<string-name>
<surname>Naiberg</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Newton</surname>
<given-names>DF</given-names>
</string-name>, <string-name>
<surname>Collins</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Bowie</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>. <article-title>Impulsivity is associated with blood pressure and waist circumference among adolescents with bipolar disorder</article-title>. <source>J Psychiatr Res</source>. <year>2016</year>;<volume>83</volume>:<fpage>230</fpage>&#x02010;<lpage>239</lpage>.<pub-id pub-id-type="pmid">27665535</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="bdi12556-cit-0078">
<string-name>
<surname>Naiberg</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Newton</surname>
<given-names>DF</given-names>
</string-name>, <string-name>
<surname>Collins</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Dickstein</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>Bowie</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>. <article-title>Elevated triglycerides are associated with decreased executive function among adolescents with bipolar disorder</article-title>. <source>Acta Psychiatr Scand</source>. <year>2016</year>;<volume>134</volume>:<fpage>241</fpage>&#x02010;<lpage>248</lpage>.<pub-id pub-id-type="pmid">27329743</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="bdi12556-cit-0079">
<string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>, <string-name>
<surname>Carnethon</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Matthews</surname>
<given-names>KA</given-names>
</string-name>, et&#x000a0;al. <article-title>Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a Scientific Statement From the American Heart Association</article-title>. <source>Circulation</source>. <year>2015</year>;<volume>132</volume>:<fpage>965</fpage>&#x02010;<lpage>986</lpage>.<pub-id pub-id-type="pmid">26260736</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="bdi12556-cit-0080">
<string-name>
<surname>Martin</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Woo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Timmins</surname>
<given-names>V</given-names>
</string-name>, et&#x000a0;al. <article-title>Binge eating and emotional eating behaviors among adolescents and young adults with bipolar disorder</article-title>. <source>J Affect Disord</source>. <year>2016</year>;<volume>195</volume>:<fpage>88</fpage>&#x02010;<lpage>95</lpage>.<pub-id pub-id-type="pmid">26890288</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0081"><label>81</label><mixed-citation publication-type="journal" id="bdi12556-cit-0081">
<string-name>
<surname>Jewell</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Abtan</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Scavone</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Timmins</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Swampillai</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>. <article-title>Preliminary evidence of disparities in physical activity among adolescents with bipolar disorder</article-title>. <source>Ment Health Phys Act</source>. <year>2015</year>;<volume>8</volume>:<fpage>62</fpage>&#x02010;<lpage>67</lpage>.</mixed-citation></ref><ref id="bdi12556-bib-0082"><label>82</label><mixed-citation publication-type="book" id="bdi12556-cit-0082">
<collab collab-type="authors">APA</collab>
. <source>Diagnostic and Statistical Manual of Mental Disorders</source>. <edition>5th edn</edition>
<publisher-loc>Arlington, VA</publisher-loc>: <publisher-name>American Psychiatric Publishing</publisher-name>; <year>2013</year>.</mixed-citation></ref><ref id="bdi12556-bib-0083"><label>83</label><mixed-citation publication-type="journal" id="bdi12556-cit-0083">
<string-name>
<surname>Axelson</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Fristad</surname>
<given-names>MA</given-names>
</string-name>, et&#x000a0;al. <article-title>Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study</article-title>. <source>J Clin Psychiatry</source>. <year>2012</year>;<volume>73</volume>:<fpage>1342</fpage>&#x02010;<lpage>1350</lpage>.<pub-id pub-id-type="pmid">23140653</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0084"><label>84</label><mixed-citation publication-type="journal" id="bdi12556-cit-0084">
<string-name>
<surname>Freeman</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>. <article-title>Disruptive mood dysregulation disorder in a community mental health clinic: prevalence, comorbidity and correlates</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2016</year>;<volume>26</volume>:<fpage>123</fpage>&#x02010;<lpage>130</lpage>.<pub-id pub-id-type="pmid">26745325</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0085"><label>85</label><mixed-citation publication-type="journal" id="bdi12556-cit-0085">
<string-name>
<surname>Copeland</surname>
<given-names>WE</given-names>
</string-name>, <string-name>
<surname>Shanahan</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Egger</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Angold</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Costello</surname>
<given-names>EJ</given-names>
</string-name>. <article-title>Adult diagnostic and functional outcomes of DSM&#x02010;5 disruptive mood dysregulation disorder</article-title>. <source>Am J Psychiatry</source>. <year>2014</year>;<volume>171</volume>:<fpage>668</fpage>&#x02010;<lpage>674</lpage>.<pub-id pub-id-type="pmid">24781389</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0086"><label>86</label><mixed-citation publication-type="journal" id="bdi12556-cit-0086">
<string-name>
<surname>Mayes</surname>
<given-names>SD</given-names>
</string-name>, <string-name>
<surname>Waxmonsky</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Calhoun</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Bixler</surname>
<given-names>EO</given-names>
</string-name>. <article-title>Disruptive mood dysregulation disorder symptoms and association with oppositional defiant and other disorders in a general population child sample</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2016</year>;<volume>26</volume>:<fpage>101</fpage>&#x02010;<lpage>106</lpage>.<pub-id pub-id-type="pmid">26745442</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0087"><label>87</label><mixed-citation publication-type="journal" id="bdi12556-cit-0087">
<string-name>
<surname>Birmaher</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Axelson</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Goldstein</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>Four&#x02010;year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study</article-title>. <source>Am J Psychiatry</source>. <year>2009</year>;<volume>166</volume>:<fpage>795</fpage>&#x02010;<lpage>804</lpage>.<pub-id pub-id-type="pmid">19448190</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0088"><label>88</label><mixed-citation publication-type="journal" id="bdi12556-cit-0088">
<string-name>
<surname>Shankman</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Lewinsohn</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>DN</given-names>
</string-name>, <string-name>
<surname>Small</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Seeley</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Altman</surname>
<given-names>SE</given-names>
</string-name>. <article-title>Subthreshold conditions as precursors for full syndrome disorders: a 15&#x02010;year longitudinal study of multiple diagnostic classes</article-title>. <source>J Child Psychol Psychiatry</source>. <year>2009</year>;<volume>50</volume>:<fpage>1485</fpage>&#x02010;<lpage>1494</lpage>.<pub-id pub-id-type="pmid">19573034</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0089"><label>89</label><mixed-citation publication-type="journal" id="bdi12556-cit-0089">
<string-name>
<surname>Wozniak</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Petty</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Schreck</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Moses</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</string-name>, <string-name>
<surname>Biederman</surname>
<given-names>J</given-names>
</string-name>. <article-title>High level of persistence of pediatric bipolar&#x02010;I disorder from childhood onto adolescent years: a four year prospective longitudinal follow&#x02010;up study</article-title>. <source>J Psychiatr Res</source>. <year>2011</year>;<volume>45</volume>:<fpage>1273</fpage>&#x02010;<lpage>1282</lpage>.<pub-id pub-id-type="pmid">21683960</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0090"><label>90</label><mixed-citation publication-type="journal" id="bdi12556-cit-0090">
<string-name>
<surname>Geller</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Tillman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bolhofner</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Zimerman</surname>
<given-names>B</given-names>
</string-name>. <article-title>Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8&#x02010;year outcome</article-title>. <source>Arch Gen Psychiatry</source>. <year>2008</year>;<volume>65</volume>:<fpage>1125</fpage>&#x02010;<lpage>1133</lpage>.<pub-id pub-id-type="pmid">18838629</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0091"><label>91</label><mixed-citation publication-type="journal" id="bdi12556-cit-0091">
<string-name>
<surname>Kowatch</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Danielyan</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>. <article-title>Review and meta&#x02010;analysis of the phenomenology and clinical characteristics of mania in children and adolescents</article-title>. <source>Bipolar Disord</source>. <year>2005</year>;<volume>7</volume>:<fpage>483</fpage>&#x02010;<lpage>496</lpage>.<pub-id pub-id-type="pmid">16403174</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0092"><label>92</label><mixed-citation publication-type="journal" id="bdi12556-cit-0092">
<string-name>
<surname>McClellan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kowatch</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>. <article-title>Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2007</year>;<volume>46</volume>:<fpage>107</fpage>&#x02010;<lpage>125</lpage>.<pub-id pub-id-type="pmid">17195735</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0093"><label>93</label><mixed-citation publication-type="journal" id="bdi12556-cit-0093">
<string-name>
<surname>Van Meter</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Burke</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Faedda</surname>
<given-names>GL</given-names>
</string-name>, <string-name>
<surname>Correll</surname>
<given-names>CU</given-names>
</string-name>. <article-title>The bipolar prodrome: meta&#x02010;analysis of symptom prevalence prior to initial or recurrent mood episodes</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2016</year>;<volume>55</volume>:<fpage>543</fpage>&#x02010;<lpage>555</lpage>.<pub-id pub-id-type="pmid">27343882</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0094"><label>94</label><mixed-citation publication-type="journal" id="bdi12556-cit-0094">
<string-name>
<surname>Tillman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Geller</surname>
<given-names>B</given-names>
</string-name>. <article-title>Controlled study of switching from attention&#x02010;deficit/hyperactivity disorder to a prepubertal and early adolescent bipolar I disorder phenotype during 6&#x02010;year prospective follow&#x02010;up: rate, risk, and predictors</article-title>. <source>Dev Psychopathol</source>. <year>2006</year>;<volume>18</volume>:<fpage>1037</fpage>&#x02010;<lpage>1053</lpage>.<pub-id pub-id-type="pmid">17064428</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0095"><label>95</label><mixed-citation publication-type="journal" id="bdi12556-cit-0095">
<string-name>
<surname>Biederman</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Petty</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Byrne</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wozniak</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</string-name>. <article-title>Risk for switch from unipolar to bipolar disorder in youth with ADHD: a long term prospective controlled study</article-title>. <source>J Affect Disord</source>. <year>2009</year>;<volume>119</volume>:<fpage>16</fpage>&#x02010;<lpage>21</lpage>.<pub-id pub-id-type="pmid">19324422</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0096"><label>96</label><mixed-citation publication-type="journal" id="bdi12556-cit-0096">
<string-name>
<surname>Molina</surname>
<given-names>BSG</given-names>
</string-name>, <string-name>
<surname>Hinshaw</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Swanson</surname>
<given-names>JM</given-names>
</string-name>, et&#x000a0;al. <article-title>The MTA at 8 Years</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2009</year>;<volume>48</volume>:<fpage>484</fpage>&#x02010;<lpage>500</lpage>.<pub-id pub-id-type="pmid">19318991</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0097"><label>97</label><mixed-citation publication-type="journal" id="bdi12556-cit-0097">
<string-name>
<surname>Evans</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Burke</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Roberts</surname>
<given-names>MC</given-names>
</string-name>, et&#x000a0;al. <article-title>Irritability in child and adolescent psychopathology: an integrative review for ICD&#x02010;11</article-title>. <source>Clin Psychol Rev</source>. <year>2017</year>;<volume>53</volume>:<fpage>29</fpage>&#x02010;<lpage>45</lpage>.<pub-id pub-id-type="pmid">28192774</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0098"><label>98</label><mixed-citation publication-type="journal" id="bdi12556-cit-0098">
<string-name>
<surname>Dickstein</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>Towbin</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Van Der Veen</surname>
<given-names>JW</given-names>
</string-name>, et&#x000a0;al. <article-title>Randomized double&#x02010;blind placebo&#x02010;controlled trial of lithium in youths with severe mood dysregulation</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2009</year>;<volume>19</volume>:<fpage>61</fpage>&#x02010;<lpage>73</lpage>.<pub-id pub-id-type="pmid">19232024</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0099"><label>99</label><mixed-citation publication-type="journal" id="bdi12556-cit-0099">
<string-name>
<surname>Cicero</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Epler</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Sher</surname>
<given-names>KJ</given-names>
</string-name>. <article-title>Are there developmentally limited forms of bipolar disorder?</article-title>
<source>J Abnorm Psychol</source>. <year>2009</year>;<volume>118</volume>:<fpage>431</fpage>&#x02010;<lpage>447</lpage>.<pub-id pub-id-type="pmid">19685942</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0100"><label>100</label><mixed-citation publication-type="journal" id="bdi12556-cit-0100">
<string-name>
<surname>Jensen&#x02010;Doss</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Feeny</surname>
<given-names>NC</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>. <article-title>Predictors and moderators of agreement between clinical and research diagnoses for children and adolescents</article-title>. <source>J Consult Clin Psychol</source>. <year>2014</year>;<volume>82</volume>:<fpage>1151</fpage>&#x02010;<lpage>1162</lpage>.<pub-id pub-id-type="pmid">24773574</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0101"><label>101</label><mixed-citation publication-type="journal" id="bdi12556-cit-0101">
<string-name>
<surname>Rettew</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Lynch</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Achenbach</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Dumenci</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ivanova</surname>
<given-names>MY</given-names>
</string-name>. <article-title>Meta&#x02010;analyses of agreement between diagnoses made from clinical evaluations and standardized diagnostic interviews</article-title>. <source>Int J Methods Psychiatr Res</source>. <year>2009</year>;<volume>18</volume>:<fpage>169</fpage>&#x02010;<lpage>184</lpage>.<pub-id pub-id-type="pmid">19701924</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0102"><label>102</label><mixed-citation publication-type="journal" id="bdi12556-cit-0102">
<string-name>
<surname>Jenkins</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Washburn</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>JK</given-names>
</string-name>. <article-title>Evidence&#x02010;based strategies improve assessment of pediatric bipolar disorder by community practitioners</article-title>. <source>Prof Psychol Res Pr</source>. <year>2011</year>;<volume>42</volume>:<fpage>121</fpage>&#x02010;<lpage>129</lpage>.<pub-id pub-id-type="pmid">21625392</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0103"><label>103</label><mixed-citation publication-type="journal" id="bdi12556-cit-0103">
<string-name>
<surname>Achenbach</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>McConaughy</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Howell</surname>
<given-names>CT</given-names>
</string-name>. <article-title>Child/Adolescent behavioral and emotional problems: implication of cross&#x02010;informant correlations for situational specificity</article-title>. <source>Psychol Bull</source>. <year>1987</year>;<volume>101</volume>:<fpage>213</fpage>&#x02010;<lpage>232</lpage>.<pub-id pub-id-type="pmid">3562706</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0104"><label>104</label><mixed-citation publication-type="journal" id="bdi12556-cit-0104">
<string-name>
<surname>Althoff</surname>
<given-names>RR</given-names>
</string-name>, <string-name>
<surname>Ayer</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Rettew</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Hudziak</surname>
<given-names>JJ</given-names>
</string-name>. <article-title>Assessment of dysregulated children using the Child Behavior Checklist: a receiver operating characteristic curve analysis</article-title>. <source>Psychol Assess</source>. <year>2010</year>;<volume>22</volume>:<fpage>609</fpage>&#x02010;<lpage>617</lpage>.<pub-id pub-id-type="pmid">20822273</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0105"><label>105</label><mixed-citation publication-type="journal" id="bdi12556-cit-0105">
<string-name>
<surname>Diler</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Birmaher</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Axelson</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>The Child Behavior Checklist (CBCL) and the CBCL&#x02010;bipolar phenotype are not useful in diagnosing pediatric bipolar disorder</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2009</year>;<volume>19</volume>:<fpage>23</fpage>&#x02010;<lpage>30</lpage>.<pub-id pub-id-type="pmid">19232020</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0106"><label>106</label><mixed-citation publication-type="journal" id="bdi12556-cit-0106">
<string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Danielson</surname>
<given-names>CK</given-names>
</string-name>, <string-name>
<surname>Calabrese</surname>
<given-names>JR</given-names>
</string-name>. <article-title>Discriminative validity of parent report of hypomanic and depressive symptoms on the General Behavior Inventory</article-title>. <source>Psychol Assess</source>. <year>2001</year>;<volume>13</volume>:<fpage>267</fpage>&#x02010;<lpage>276</lpage>.<pub-id pub-id-type="pmid">11433802</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0107"><label>107</label><mixed-citation publication-type="journal" id="bdi12556-cit-0107">
<string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Frazier</surname>
<given-names>TW</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Calabrese</surname>
<given-names>JR</given-names>
</string-name>. <article-title>Developing a ten item short form of the Parent General Behavior Inventory to assess for juvenile mania and hypomania</article-title>. <source>J Clin Psychiatry</source>. <year>2008</year>;<volume>69</volume>:<fpage>831</fpage>&#x02010;<lpage>839</lpage>.<pub-id pub-id-type="pmid">18452343</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0108"><label>108</label><mixed-citation publication-type="journal" id="bdi12556-cit-0108">
<string-name>
<surname>Pavuluri</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Henry</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Devineni</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Carbray</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Birmaher</surname>
<given-names>B</given-names>
</string-name>. <article-title>Child mania rating scale: development, reliability, and validity</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2006</year>;<volume>45</volume>:<fpage>550</fpage>&#x02010;<lpage>560</lpage>.<pub-id pub-id-type="pmid">16601399</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0109"><label>109</label><mixed-citation publication-type="journal" id="bdi12556-cit-0109">
<string-name>
<surname>Henry</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Pavuluri</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Birmaher</surname>
<given-names>B</given-names>
</string-name>. <article-title>Accuracy of brief and full forms of the Child Mania Rating Scale</article-title>. <source>J Clin Psychol</source>. <year>2008</year>;<volume>64</volume>:<fpage>368</fpage>&#x02010;<lpage>381</lpage>.<pub-id pub-id-type="pmid">18302291</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0110"><label>110</label><mixed-citation publication-type="journal" id="bdi12556-cit-0110">
<string-name>
<surname>Wagner</surname>
<given-names>KD</given-names>
</string-name>, <string-name>
<surname>Kowatch</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Emslie</surname>
<given-names>GJ</given-names>
</string-name>, et&#x000a0;al. <article-title>A double&#x02010;blind, randomized, placebo&#x02010;controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents</article-title>. <source>Am J Psychiatry</source>. <year>2006</year>;<volume>163</volume>:<fpage>1179</fpage>&#x02010;<lpage>1186</lpage>.<pub-id pub-id-type="pmid">16816222</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0111"><label>111</label><mixed-citation publication-type="book" id="bdi12556-cit-0111">
<string-name>
<surname>Straus</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Glasziou</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Richardson</surname>
<given-names>WS</given-names>
</string-name>, <string-name>
<surname>Haynes</surname>
<given-names>RB</given-names>
</string-name>. <source>Evidence&#x02010;based medicine: How to practice and teach EBM</source>, <edition>4th edn</edition>
<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Churchill Livingstone</publisher-name>; <year>2011</year>.</mixed-citation></ref><ref id="bdi12556-bib-0112"><label>112</label><mixed-citation publication-type="journal" id="bdi12556-cit-0112">
<string-name>
<surname>Jenkins</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Feeny</surname>
<given-names>NC</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>. <article-title>Generalizability of evidence&#x02010;based assessment recommendations for pediatric bipolar disorder</article-title>. <source>Psychol Assess</source>. <year>2012</year>;<volume>24</volume>:<fpage>269</fpage>&#x02010;<lpage>281</lpage>.<pub-id pub-id-type="pmid">22004538</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0113"><label>113</label><mixed-citation publication-type="journal" id="bdi12556-cit-0113">
<string-name>
<surname>West</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Celio</surname>
<given-names>CI</given-names>
</string-name>, <string-name>
<surname>Henry</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Pavuluri</surname>
<given-names>MN</given-names>
</string-name>. <article-title>Child Mania Rating Scale&#x02010;Parent Version: a valid measure of symptom change due to pharmacotherapy</article-title>. <source>J Affect Disord</source>. <year>2011</year>;<volume>128</volume>:<fpage>112</fpage>&#x02010;<lpage>119</lpage>.<pub-id pub-id-type="pmid">20858565</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0114"><label>114</label><mixed-citation publication-type="journal" id="bdi12556-cit-0114">
<string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mankoski</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorder</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2013</year>;<volume>23</volume>:<fpage>72</fpage>&#x02010;<lpage>79</lpage>.<pub-id pub-id-type="pmid">23480324</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0115"><label>115</label><mixed-citation publication-type="journal" id="bdi12556-cit-0115">
<string-name>
<surname>Geller</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Zimerman</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH&#x02010;U&#x02010;KSADS) mania and rapid cycling sections</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2001</year>;<volume>40</volume>:<fpage>450</fpage>&#x02010;<lpage>455</lpage>.<pub-id pub-id-type="pmid">11314571</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0116"><label>116</label><mixed-citation publication-type="journal" id="bdi12556-cit-0116">
<string-name>
<surname>Young</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Biggs</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Ziegler</surname>
<given-names>VE</given-names>
</string-name>, <string-name>
<surname>Meyer</surname>
<given-names>DA</given-names>
</string-name>. <article-title>A rating scale for mania: reliability, validity, and sensitivity</article-title>. <source>Br J Psychiatry</source>. <year>1978</year>;<volume>133</volume>:<fpage>429</fpage>&#x02010;<lpage>435</lpage>.<pub-id pub-id-type="pmid">728692</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0117"><label>117</label><mixed-citation publication-type="journal" id="bdi12556-cit-0117">
<string-name>
<surname>Poznanski</surname>
<given-names>EO</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Salguero</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kelsh</surname>
<given-names>RC</given-names>
</string-name>. <article-title>Preliminary studies of the reliability and validity of the Children's Depression Rating Scale</article-title>. <source>J Am Acad Child Psychiatry</source>. <year>1984</year>;<volume>23</volume>:<fpage>191</fpage>&#x02010;<lpage>197</lpage>.<pub-id pub-id-type="pmid">6715741</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0118"><label>118</label><mixed-citation publication-type="journal" id="bdi12556-cit-0118">
<string-name>
<surname>Axelson</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Birmaher</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Brent</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>A preliminary study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School&#x02010;Age Children mania rating scale for children and adolescents</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2003</year>;<volume>13</volume>:<fpage>463</fpage>&#x02010;<lpage>470</lpage>.<pub-id pub-id-type="pmid">14977459</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0119"><label>119</label><mixed-citation publication-type="journal" id="bdi12556-cit-0119">
<string-name>
<surname>Demeter</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Carlson</surname>
<given-names>GA</given-names>
</string-name>, et&#x000a0;al. <article-title>Age differences in the phenomenology of pediatric bipolar disorder</article-title>. <source>J Affect Disord</source>. <year>2013</year>;<volume>147</volume>:<fpage>295</fpage>&#x02010;<lpage>303</lpage>.<pub-id pub-id-type="pmid">23219057</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0120"><label>120</label><mixed-citation publication-type="journal" id="bdi12556-cit-0120">
<string-name>
<surname>Yee</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Algorta</surname>
<given-names>GP</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, et&#x000a0;al. <article-title>Unfiltered administration of the YMRS and CDRS&#x02010;R in a clinical sample of children</article-title>. <source>J Clin Child Adolesc Psychol</source>. <year>2015</year>;<volume>44</volume>:<fpage>992</fpage>&#x02010;<lpage>1007</lpage>.<pub-id pub-id-type="pmid">24885078</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0121"><label>121</label><mixed-citation publication-type="journal" id="bdi12556-cit-0121">
<string-name>
<surname>Suppiger</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>In&#x02010;Albon</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hendriksen</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hermann</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Margraf</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Schneider</surname>
<given-names>S</given-names>
</string-name>. <article-title>Acceptance of structured diagnostic interviews for mental disorders in clinical practice and research settings</article-title>. <source>Behav Ther</source>. <year>2009</year>;<volume>40</volume>:<fpage>272</fpage>&#x02010;<lpage>279</lpage>.<pub-id pub-id-type="pmid">19647528</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0122"><label>122</label><mixed-citation publication-type="journal" id="bdi12556-cit-0122">
<string-name>
<surname>Algorta</surname>
<given-names>GP</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Phelps</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jenkins</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>. <article-title>An inexpensive family index of risk for mood issues improves identification of pediatric bipolar disorder</article-title>. <source>Psychol Assess</source>. <year>2013</year>;<volume>25</volume>:<fpage>12</fpage>&#x02010;<lpage>22</lpage>.<pub-id pub-id-type="pmid">22800090</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0123"><label>123</label><mixed-citation publication-type="journal" id="bdi12556-cit-0123">
<string-name>
<surname>Miklowitz</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Axelson</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>George</surname>
<given-names>EL</given-names>
</string-name>, et&#x000a0;al. <article-title>Expressed emotion moderates the effects of family&#x02010;focused treatment for bipolar adolescents</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2009</year>;<volume>48</volume>:<fpage>643</fpage>&#x02010;<lpage>651</lpage>.<pub-id pub-id-type="pmid">19454920</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0124"><label>124</label><mixed-citation publication-type="journal" id="bdi12556-cit-0124">
<string-name>
<surname>Peruzzolo</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Tramontina</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rohde</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Zeni</surname>
<given-names>CP</given-names>
</string-name>. <article-title>Pharmacotherapy of bipolar disorder in children and adolescents: an update</article-title>. <source>Rev Bras Psiquiatr</source>. <year>2013</year>;<volume>35</volume>:<fpage>393</fpage>&#x02010;<lpage>405</lpage>.<pub-id pub-id-type="pmid">24402215</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0125"><label>125</label><mixed-citation publication-type="journal" id="bdi12556-cit-0125">
<string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>, <string-name>
<surname>Sassi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Diler</surname>
<given-names>RS</given-names>
</string-name>. <article-title>Pharmacological treatment of bipolar disorder in children and adolescents</article-title>. <source>Child Adolesc Psychiatr Clin N Am</source>. <year>2012</year>;<volume>21</volume>:<fpage>911</fpage>&#x02010;<lpage>939</lpage>.<pub-id pub-id-type="pmid">23040907</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0126"><label>126</label><mixed-citation publication-type="journal" id="bdi12556-cit-0126">
<string-name>
<surname>Singh</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Ketter</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>KD</given-names>
</string-name>. <article-title>Atypical antipsychotics for acute manic and mixed episodes in children and adolescents with bipolar disorder</article-title>. <source>Drugs</source>. <year>2010</year>;<volume>70</volume>:<fpage>433</fpage>&#x02010;<lpage>442</lpage>.<pub-id pub-id-type="pmid">20205485</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0127"><label>127</label><mixed-citation publication-type="book" id="bdi12556-cit-0127">
<string-name>
<surname>Kowatch</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Scheffer</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Stanford</surname>
<given-names>K</given-names>
</string-name>. <article-title>Placebo controlled trial of divalproex versus lithium for bipolar disorder</article-title>. <publisher-loc>Boston, MA</publisher-loc>: <publisher-name>American Academy of Child and Adolescent Psychiatry 54th Annual Meeting</publisher-name>; <year>2007</year>.</mixed-citation></ref><ref id="bdi12556-bib-0128"><label>128</label><mixed-citation publication-type="journal" id="bdi12556-cit-0128">
<string-name>
<surname>Correll</surname>
<given-names>CU</given-names>
</string-name>. <article-title>Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short&#x02010;term trials</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2007</year>;<volume>46</volume>:<fpage>687</fpage>&#x02010;<lpage>700</lpage>.<pub-id pub-id-type="pmid">17513981</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0129"><label>129</label><mixed-citation publication-type="journal" id="bdi12556-cit-0129">
<string-name>
<surname>Liu</surname>
<given-names>HY</given-names>
</string-name>, <string-name>
<surname>Potter</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Woodworth</surname>
<given-names>KY</given-names>
</string-name>, et&#x000a0;al. <article-title>Pharmacologic treatments for pediatric bipolar disorder: a review and meta&#x02010;analysis</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2011</year>;<volume>50</volume>:<fpage>749</fpage>&#x02010;<lpage>762</lpage>.<pub-id pub-id-type="pmid">21784295</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0130"><label>130</label><mixed-citation publication-type="journal" id="bdi12556-cit-0130">
<string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Robb</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>McNamara</surname>
<given-names>NK</given-names>
</string-name>, et&#x000a0;al. <article-title>Lithium in the acute treatment of bipolar I disorder: a double&#x02010;blind, placebo&#x02010;controlled study</article-title>. <source>Pediatrics</source>. <year>2015</year>;<volume>136</volume>:<fpage>885</fpage>&#x02010;<lpage>894</lpage>.<pub-id pub-id-type="pmid">26459650</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0131"><label>131</label><mixed-citation publication-type="journal" id="bdi12556-cit-0131">
<string-name>
<surname>Wagner</surname>
<given-names>KD</given-names>
</string-name>, <string-name>
<surname>Redden</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kowatch</surname>
<given-names>RA</given-names>
</string-name>, et&#x000a0;al. <article-title>A double&#x02010;blind, randomized, placebo&#x02010;controlled trial of divalproex extended&#x02010;release in the treatment of bipolar disorder in children and adolescents</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2009</year>;<volume>48</volume>:<fpage>519</fpage>&#x02010;<lpage>532</lpage>.<pub-id pub-id-type="pmid">19325497</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0132"><label>132</label><mixed-citation publication-type="journal" id="bdi12556-cit-0132">
<string-name>
<surname>Correll</surname>
<given-names>CU</given-names>
</string-name>, <string-name>
<surname>Sheridan</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>DelBello</surname>
<given-names>MP</given-names>
</string-name>. <article-title>Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo&#x02010;controlled trials</article-title>. <source>Bipolar Disord</source>. <year>2010</year>;<volume>12</volume>:<fpage>116</fpage>&#x02010;<lpage>141</lpage>.<pub-id pub-id-type="pmid">20402706</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0133"><label>133</label><mixed-citation publication-type="journal" id="bdi12556-cit-0133">
<string-name>
<surname>Delbello</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Kushner</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2005</year>;<volume>44</volume>:<fpage>539</fpage>&#x02010;<lpage>547</lpage>.<pub-id pub-id-type="pmid">15908836</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0134"><label>134</label><mixed-citation publication-type="journal" id="bdi12556-cit-0134">
<string-name>
<surname>Tramontina</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zeni</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Pheula</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rohde</surname>
<given-names>LA</given-names>
</string-name>. <article-title>Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: an open clinical trial</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2007</year>;<volume>17</volume>:<fpage>129</fpage>&#x02010;<lpage>134</lpage>.<pub-id pub-id-type="pmid">17343561</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0135"><label>135</label><mixed-citation publication-type="journal" id="bdi12556-cit-0135">
<string-name>
<surname>Geller</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Luby</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Joshi</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. <article-title>A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents</article-title>. <source>Arch Gen Psychiatry</source>. <year>2012</year>;<volume>69</volume>:<fpage>515</fpage>&#x02010;<lpage>528</lpage>.<pub-id pub-id-type="pmid">22213771</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0136"><label>136</label><mixed-citation publication-type="journal" id="bdi12556-cit-0136">
<string-name>
<surname>Vitiello</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Riddle</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Yenokyan</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2012</year>;<volume>51</volume>:<fpage>867</fpage>&#x02010;<lpage>878</lpage>.<pub-id pub-id-type="pmid">22917200</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0137"><label>137</label><mixed-citation publication-type="journal" id="bdi12556-cit-0137">
<string-name>
<surname>Stringaris</surname>
<given-names>A</given-names>
</string-name>. <article-title>What we can all learn from the Treatment of Early Age Mania (TEAM) trial</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2012</year>;<volume>51</volume>:<fpage>861</fpage>&#x02010;<lpage>863</lpage>.<pub-id pub-id-type="pmid">22917198</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0138"><label>138</label><mixed-citation publication-type="journal" id="bdi12556-cit-0138">
<string-name>
<surname>Detke</surname>
<given-names>HC</given-names>
</string-name>, <string-name>
<surname>DelBello</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Landry</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Usher</surname>
<given-names>RW</given-names>
</string-name>. <article-title>Olanzapine/fluoxetine combination in children and adolescents with bipolar i depression: a randomized, double&#x02010;blind, placebo&#x02010;controlled trial</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2015</year>;<volume>54</volume>:<fpage>217</fpage>&#x02010;<lpage>224</lpage>.<pub-id pub-id-type="pmid">25721187</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0139"><label>139</label><mixed-citation publication-type="miscellaneous" id="bdi12556-cit-0139">
<string-name>
<surname>Delbello</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Goldman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Phillips</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Deng</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Cucchiaro</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Loebel</surname>
<given-names>A</given-names>
</string-name>. <article-title>Efficacy and Safety of Lurasidone in Children and Adolescent Patients with Bipolar I Depression</article-title>. Presented at the annual meeting of the International Society for Bipolar Disorders, May 4&#x02013;7 <year>2017</year>, Washington DC.</mixed-citation></ref><ref id="bdi12556-bib-0140"><label>140</label><mixed-citation publication-type="journal" id="bdi12556-cit-0140">
<string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Pathak</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Earley</surname>
<given-names>WR</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>DelBello</surname>
<given-names>MP</given-names>
</string-name>. <article-title>Efficacy and safety of extended&#x02010;release quetiapine fumarate in youth with bipolar depression: an 8&#x000a0;week, double&#x02010;blind, placebo&#x02010;controlled trial</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2014d</year>;<volume>24</volume>:<fpage>325</fpage>&#x02010;<lpage>335</lpage>.<pub-id pub-id-type="pmid">24956042</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0141"><label>141</label><mixed-citation publication-type="journal" id="bdi12556-cit-0141">
<string-name>
<surname>DelBello</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Welge</surname>
<given-names>JA</given-names>
</string-name>, et&#x000a0;al. <article-title>A double&#x02010;blind, placebo&#x02010;controlled pilot study of quetiapine for depressed adolescents with bipolar disorder</article-title>. <source>Bipolar Disord</source>. <year>2009</year>;<volume>11</volume>:<fpage>483</fpage>&#x02010;<lpage>493</lpage>.<pub-id pub-id-type="pmid">19624387</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0142"><label>142</label><mixed-citation publication-type="journal" id="bdi12556-cit-0142">
<string-name>
<surname>Patel</surname>
<given-names>NC</given-names>
</string-name>, <string-name>
<surname>DelBello</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Bryan</surname>
<given-names>HS</given-names>
</string-name>, et&#x000a0;al. <article-title>Open&#x02010;label lithium for the treatment of adolescents with bipolar depression</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2006</year>;<volume>45</volume>:<fpage>289</fpage>&#x02010;<lpage>297</lpage>.<pub-id pub-id-type="pmid">16540813</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0143"><label>143</label><mixed-citation publication-type="journal" id="bdi12556-cit-0143">
<string-name>
<surname>Chang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Saxena</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Howe</surname>
<given-names>M</given-names>
</string-name>. <article-title>An open&#x02010;label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2006</year>;<volume>45</volume>:<fpage>298</fpage>&#x02010;<lpage>304</lpage>.<pub-id pub-id-type="pmid">16540814</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0144"><label>144</label><mixed-citation publication-type="journal" id="bdi12556-cit-0144">
<string-name>
<surname>Shon</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Joo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>HW</given-names>
</string-name>. <article-title>Lamotrigine treatment of adolescents with unipolar and bipolar depression: a retrospective chart review</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2014</year>;<volume>24</volume>:<fpage>285</fpage>&#x02010;<lpage>287</lpage>.<pub-id pub-id-type="pmid">24813210</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0145"><label>145</label><mixed-citation publication-type="journal" id="bdi12556-cit-0145">
<string-name>
<surname>Goldsmith</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>K</given-names>
</string-name>. <article-title>Antidepressants and psychostimulants in pediatric populations: is there an association with mania?</article-title>
<source>Paediatr Drugs</source>. <year>2011</year>;<volume>13</volume>:<fpage>225</fpage>&#x02010;<lpage>243</lpage>.<pub-id pub-id-type="pmid">21692547</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0146"><label>146</label><mixed-citation publication-type="journal" id="bdi12556-cit-0146">
<string-name>
<surname>Park</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Shon</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Joo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>HW</given-names>
</string-name>. <article-title>Antidepressant&#x02010;emergent mood switch in korean adolescents with mood disorder</article-title>. <source>Clin Neuropharmacol</source>. <year>2014</year>;<volume>37</volume>:<fpage>177</fpage>&#x02010;<lpage>185</lpage>.<pub-id pub-id-type="pmid">25384075</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0147"><label>147</label><mixed-citation publication-type="journal" id="bdi12556-cit-0147">
<string-name>
<surname>Bhowmik</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Aparasu</surname>
<given-names>RR</given-names>
</string-name>, <string-name>
<surname>Rajan</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Sherer</surname>
<given-names>JT</given-names>
</string-name>, <string-name>
<surname>Ochoa&#x02010;Perez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>H</given-names>
</string-name>. <article-title>Risk of manic switch associated with antidepressant therapy in pediatric bipolar depression</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2014</year>;<volume>24</volume>:<fpage>551</fpage>&#x02010;<lpage>561</lpage>.<pub-id pub-id-type="pmid">25470655</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0148"><label>148</label><mixed-citation publication-type="journal" id="bdi12556-cit-0148">
<string-name>
<surname>Strober</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Schmidt&#x02010;Lackner</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Freeman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bower</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lampert</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>DeAntonio</surname>
<given-names>M</given-names>
</string-name>. <article-title>Recovery and relapse in adolescents with bipolar affective illness: a five&#x02010;year naturalistic, prospective follow&#x02010;up</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>1995</year>;<volume>34</volume>:<fpage>724</fpage>&#x02010;<lpage>731</lpage>.<pub-id pub-id-type="pmid">7608045</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0149"><label>149</label><mixed-citation publication-type="journal" id="bdi12556-cit-0149">
<string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>McNamara</surname>
<given-names>NK</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, et&#x000a0;al. <article-title>Double&#x02010;blind 18&#x02010;month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2005</year>;<volume>44</volume>:<fpage>409</fpage>&#x02010;<lpage>417</lpage>.<pub-id pub-id-type="pmid">15843762</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0150"><label>150</label><mixed-citation publication-type="journal" id="bdi12556-cit-0150">
<string-name>
<surname>Redden</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>DelBello</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wagner</surname>
<given-names>KD</given-names>
</string-name>, et&#x000a0;al. <article-title>Long&#x02010;term safety of divalproex sodium extended&#x02010;release in children and adolescents with bipolar I disorder</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2009</year>;<volume>19</volume>:<fpage>83</fpage>&#x02010;<lpage>89</lpage>.<pub-id pub-id-type="pmid">19232026</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0151"><label>151</label><mixed-citation publication-type="journal" id="bdi12556-cit-0151">
<string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>McNamara</surname>
<given-names>NK</given-names>
</string-name>, et&#x000a0;al. <article-title>Double&#x02010;blind, randomized, placebo&#x02010;controlled long&#x02010;term maintenance study of aripiprazole in children with bipolar disorder</article-title>. <source>J Clin Psychiatry</source>. <year>2012</year>;<volume>73</volume>:<fpage>57</fpage>&#x02010;<lpage>63</lpage>.<pub-id pub-id-type="pmid">22152402</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0152"><label>152</label><mixed-citation publication-type="journal" id="bdi12556-cit-0152">
<string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Correll</surname>
<given-names>CU</given-names>
</string-name>, <string-name>
<surname>Nyilas</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Aripiprazole for the treatment of pediatric bipolar I disorder: a 30&#x02010;week, randomized, placebo&#x02010;controlled study</article-title>. <source>Bipolar Disord</source>. <year>2013</year>;<volume>15</volume>:<fpage>138</fpage>&#x02010;<lpage>149</lpage>.<pub-id pub-id-type="pmid">23437959</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0153"><label>153</label><mixed-citation publication-type="journal" id="bdi12556-cit-0153">
<string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Robb</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Adjunctive maintenance lamotrigine for pediatric bipolar I disorder: a placebo&#x02010;controlled, randomized withdrawal study</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2015</year>;<volume>54</volume>:<fpage>1020.e3</fpage>&#x02010;<lpage>1031.e3</lpage>.<pub-id pub-id-type="pmid">26598477</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0154"><label>154</label><mixed-citation publication-type="journal" id="bdi12556-cit-0154">
<string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Landbloom</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Mackle</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Long&#x02010;term safety of asenapine in pediatric patients diagnosed with bipolar I disorder: a 50&#x02010;week open&#x02010;label, flexible&#x02010;dose trial</article-title>. <source>Pediatr Drugs</source>. <year>2016</year>;<volume>18</volume>:<fpage>367</fpage>&#x02010;<lpage>378</lpage>.</mixed-citation></ref><ref id="bdi12556-bib-0155"><label>155</label><mixed-citation publication-type="journal" id="bdi12556-cit-0155">
<string-name>
<surname>Scheffer</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Kowatch</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Carmody</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Rush</surname>
<given-names>AJ</given-names>
</string-name>. <article-title>Randomized, placebo&#x02010;controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium</article-title>. <source>Am J Psychiatry</source>. <year>2005</year>;<volume>162</volume>:<fpage>58</fpage>&#x02010;<lpage>64</lpage>.<pub-id pub-id-type="pmid">15625202</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0156"><label>156</label><mixed-citation publication-type="journal" id="bdi12556-cit-0156">
<string-name>
<surname>Findling</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Short</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>McNamara</surname>
<given-names>NK</given-names>
</string-name>, et&#x000a0;al. <article-title>Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention&#x02010;deficit/hyperactivity disorder</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2007</year>;<volume>46</volume>:<fpage>1445</fpage>&#x02010;<lpage>1453</lpage>.<pub-id pub-id-type="pmid">18049294</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0157"><label>157</label><mixed-citation publication-type="journal" id="bdi12556-cit-0157">
<string-name>
<surname>Tramontina</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zeni</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Ketzer</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Pheula</surname>
<given-names>GF</given-names>
</string-name>, <string-name>
<surname>Narvaez</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Rohde</surname>
<given-names>LA</given-names>
</string-name>. <article-title>Aripiprazole in children and adolescents with bipolar disorder comorbid with attention&#x02010;deficit/hyperactivity disorder: a pilot randomized clinical trial</article-title>. <source>J Clin Psychiatry</source>. <year>2009</year>;<volume>70</volume>:<fpage>756</fpage>&#x02010;<lpage>764</lpage>.<pub-id pub-id-type="pmid">19389329</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0158"><label>158</label><mixed-citation publication-type="journal" id="bdi12556-cit-0158">
<string-name>
<surname>Hah</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>K</given-names>
</string-name>. <article-title>Atomoxetine for the treatment of attention&#x02010;deficit/hyperactivity disorder in children and adolescents with bipolar disorders</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2005</year>;<volume>15</volume>:<fpage>996</fpage>&#x02010;<lpage>1004</lpage>.<pub-id pub-id-type="pmid">16379520</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0159"><label>159</label><mixed-citation publication-type="journal" id="bdi12556-cit-0159">
<string-name>
<surname>Geller</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Cooper</surname>
<given-names>TB</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Double&#x02010;blind and placebo&#x02010;controlled study of lithium for adolescent bipolar disorders with secondary substance dependency</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>1998</year>;<volume>37</volume>:<fpage>171</fpage>&#x02010;<lpage>178</lpage>.<pub-id pub-id-type="pmid">9473913</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0160"><label>160</label><mixed-citation publication-type="journal" id="bdi12556-cit-0160">
<string-name>
<surname>Wozniak</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Biederman</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mick</surname>
<given-names>E</given-names>
</string-name>, et&#x000a0;al. <article-title>Omega&#x02010;3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open&#x02010;label trial</article-title>. <source>Eur Neuropsychopharmacol</source>. <year>2007</year>;<volume>17</volume>:<fpage>440</fpage>&#x02010;<lpage>447</lpage>.<pub-id pub-id-type="pmid">17258897</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0161"><label>161</label><mixed-citation publication-type="journal" id="bdi12556-cit-0161">
<string-name>
<surname>Frazier</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Fristad</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Arnold</surname>
<given-names>LE</given-names>
</string-name>. <article-title>Feasibility of a nutritional supplement as treatment for pediatric bipolar spectrum disorders</article-title>. <source>J Altern Complement Med</source>. <year>2012</year>;<volume>18</volume>:<fpage>678</fpage>&#x02010;<lpage>685</lpage>.<pub-id pub-id-type="pmid">22747095</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0162"><label>162</label><mixed-citation publication-type="journal" id="bdi12556-cit-0162">
<string-name>
<surname>Clayton</surname>
<given-names>EH</given-names>
</string-name>, <string-name>
<surname>Hanstock</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Hirneth</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Kable</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Garg</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Hazell</surname>
<given-names>PL</given-names>
</string-name>. <article-title>Reduced mania and depression in juvenile bipolar disorder associated with long&#x02010;chain [omega]&#x02010;3 polyunsaturated fatty acid supplementation</article-title>. <source>Eur J Clin Nutr</source>. <year>2009</year>;<volume>63</volume>:<fpage>1037</fpage>&#x02010;<lpage>1040</lpage>.<pub-id pub-id-type="pmid">19156158</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0163"><label>163</label><mixed-citation publication-type="journal" id="bdi12556-cit-0163">
<string-name>
<surname>Fristad</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Young</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Vesco</surname>
<given-names>AT</given-names>
</string-name>, et&#x000a0;al. <article-title>A randomized controlled trial of individual family psychoeducational psychotherapy and omega&#x02010;3 fatty acids in youth with subsyndromal bipolar disorder</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2015</year>;<volume>25</volume>:<fpage>764</fpage>&#x02010;<lpage>774</lpage>.<pub-id pub-id-type="pmid">26682997</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0164"><label>164</label><mixed-citation publication-type="journal" id="bdi12556-cit-0164">
<string-name>
<surname>Gracious</surname>
<given-names>BL</given-names>
</string-name>, <string-name>
<surname>Chirieac</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Costescu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Finucane</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Hibbeln</surname>
<given-names>JR</given-names>
</string-name>. <article-title>Randomized, placebo&#x02010;controlled trial of flax oil in pediatric bipolar disorder</article-title>. <source>Bipolar Disord</source>. <year>2010</year>;<volume>12</volume>:<fpage>142</fpage>&#x02010;<lpage>154</lpage>.<pub-id pub-id-type="pmid">20402707</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0165"><label>165</label><mixed-citation publication-type="journal" id="bdi12556-cit-0165">
<string-name>
<surname>Geddes</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Miklowitz</surname>
<given-names>DJ</given-names>
</string-name>. <article-title>Treatment of bipolar disorder</article-title>. <source>Lancet</source>. <year>2013</year>;<volume>381</volume>:<fpage>1672</fpage>&#x02010;<lpage>1682</lpage>.<pub-id pub-id-type="pmid">23663953</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0166"><label>166</label><mixed-citation publication-type="journal" id="bdi12556-cit-0166">
<string-name>
<surname>Colom</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Vieta</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Martinez&#x02010;Aran</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Reinares</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Goikolea</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Mart&#x000ed;nez&#x02010;Ar&#x000e1;n</surname>
<given-names>A</given-names>
</string-name>. <article-title>A randomized trial on the efficacy of group psychoeducation in the prophylaxis of bipolar disorder: a five year follow&#x02010;up</article-title>. <source>Br J Psychiatry</source>. <year>2009</year>;<volume>194</volume>:<fpage>260</fpage>&#x02010;<lpage>265</lpage>.<pub-id pub-id-type="pmid">19252157</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0167"><label>167</label><mixed-citation publication-type="journal" id="bdi12556-cit-0167">
<string-name>
<surname>Bauer</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>McBride</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Williford</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>Collaborative care for bipolar disorder: part II. Impact on clinical outcome, function, and costs</article-title>. <source>Psychiatr Serv</source>. <year>2006</year>;<volume>57</volume>:<fpage>937</fpage>&#x02010;<lpage>945</lpage>.<pub-id pub-id-type="pmid">16816277</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0168"><label>168</label><mixed-citation publication-type="journal" id="bdi12556-cit-0168">
<string-name>
<surname>Simon</surname>
<given-names>GE</given-names>
</string-name>, <string-name>
<surname>Ludman</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Bauer</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Unutzer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Operskalski</surname>
<given-names>B</given-names>
</string-name>. <article-title>Long&#x02010;term effectiveness and cost of a systematic care program for bipolar disorder</article-title>. <source>Arch Gen Psychiatry</source>. <year>2006</year>;<volume>63</volume>:<fpage>500</fpage>&#x02010;<lpage>508</lpage>.<pub-id pub-id-type="pmid">16651507</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0169"><label>169</label><mixed-citation publication-type="journal" id="bdi12556-cit-0169">
<string-name>
<surname>Frank</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kupfer</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Thase</surname>
<given-names>ME</given-names>
</string-name>, et&#x000a0;al. <article-title>Two&#x02010;year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder</article-title>. <source>Arch Gen Psychiatry</source>. <year>2005</year>;<volume>62</volume>:<fpage>996</fpage>&#x02010;<lpage>1004</lpage>.<pub-id pub-id-type="pmid">16143731</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0170"><label>170</label><mixed-citation publication-type="journal" id="bdi12556-cit-0170">
<string-name>
<surname>Fristad</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>MacPherson</surname>
<given-names>H</given-names>
</string-name>. <article-title>Evidence&#x02010;based psychosocial treatments for bipolar disorder in youth</article-title>. <source>J Clin Child Adolesc Psychol</source>. <year>2014</year>;<volume>43</volume>:<fpage>339</fpage>&#x02010;<lpage>355</lpage>.<pub-id pub-id-type="pmid">23927375</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0171"><label>171</label><mixed-citation publication-type="journal" id="bdi12556-cit-0171">
<string-name>
<surname>Goldstein</surname>
<given-names>TR</given-names>
</string-name>, <string-name>
<surname>Fersch&#x02010;Podrat</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Rivera</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Dialectical behavior therapy for adolescents with bipolar disorder: results from a pilot randomized trial</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2015</year>;<volume>25</volume>:<fpage>140</fpage>&#x02010;<lpage>149</lpage>.<pub-id pub-id-type="pmid">25010702</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0172"><label>172</label><mixed-citation publication-type="journal" id="bdi12556-cit-0172">
<string-name>
<surname>Miklowitz</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Schlosser</surname>
<given-names>DA</given-names>
</string-name>, et&#x000a0;al. <article-title>Family&#x02010;focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2014a</year>;<volume>53</volume>:<fpage>848</fpage>&#x02010;<lpage>858</lpage>.<pub-id pub-id-type="pmid">25062592</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0173"><label>173</label><mixed-citation publication-type="journal" id="bdi12556-cit-0173">
<string-name>
<surname>West</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Weinstein</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Peters</surname>
<given-names>AT</given-names>
</string-name>, et&#x000a0;al. <article-title>Child&#x02010;and family&#x02010;focused cognitive&#x02010;behavioral therapy for pediatric bipolar disorder: a randomized clinical trial</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2014</year>;<volume>53</volume>:<fpage>1168</fpage>&#x02010;<lpage>1178</lpage>.<pub-id pub-id-type="pmid">25440307</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0174"><label>174</label><mixed-citation publication-type="book" id="bdi12556-cit-0174">
<string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>, <string-name>
<surname>Goldstein</surname>
<given-names>TR</given-names>
</string-name>, <string-name>
<surname>Miklowitz</surname>
<given-names>DJ</given-names>
</string-name>, et&#x000a0;al. <source>Development of integrated family &#x02010;focused treatment (FFT) for adolescents with bipolar disorder and comorbid substance use disorders</source>. <publisher-loc>Phoenix, AZ</publisher-loc>: <publisher-name>NCDEU</publisher-name>; <year>2008</year>.</mixed-citation></ref><ref id="bdi12556-bib-0175"><label>175</label><mixed-citation publication-type="journal" id="bdi12556-cit-0175">
<string-name>
<surname>Miklowitz</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Schneck</surname>
<given-names>CD</given-names>
</string-name>, <string-name>
<surname>George</surname>
<given-names>EL</given-names>
</string-name>, et&#x000a0;al. <article-title>A 2&#x02010;year randomized trial of pharmacotherapy and family&#x02010;focused treatment for adolescents with bipolar I and II disorders</article-title>. <source>Am J Psychiatry</source>. <year>2014b</year>;<volume>171</volume>:<fpage>658</fpage>&#x02010;<lpage>667</lpage>.<pub-id pub-id-type="pmid">24626789</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0176"><label>176</label><mixed-citation publication-type="journal" id="bdi12556-cit-0176">
<string-name>
<surname>Fristad</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Evidence&#x02010;based psychotherapies and nutritional interventions for children with bipolar spectrum disorders and their families</article-title>. <source>J Clin Psychiatry</source>. <year>2016</year>;<volume>77</volume>:<fpage>e4</fpage>.<pub-id pub-id-type="pmid">27570930</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0177"><label>177</label><mixed-citation publication-type="journal" id="bdi12556-cit-0177">
<string-name>
<surname>Hlastala</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Kotler</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>McClellan</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>McCauley</surname>
<given-names>EA</given-names>
</string-name>. <article-title>Interpersonal and social rhythm therapy for adolescents with bipolar disorder: treatment development and results from an open trial</article-title>. <source>Depress Anxiety</source>. <year>2010</year>;<volume>27</volume>:<fpage>457</fpage>&#x02010;<lpage>464</lpage>.<pub-id pub-id-type="pmid">20186968</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0178"><label>178</label><mixed-citation publication-type="journal" id="bdi12556-cit-0178">
<string-name>
<surname>MacPherson</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Mackinaw&#x02010;Koons</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Leffler</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Fristad</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Pilot effectiveness evaluation of community&#x02010;based multi&#x02010;family psychoeducational psychotherapy for childhood mood disorders</article-title>. <source>Couple Family Psychol</source>. <year>2016</year>;<volume>5</volume>:<fpage>43</fpage>&#x02010;<lpage>59</lpage>.<pub-id pub-id-type="pmid">27057423</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0179"><label>179</label><mixed-citation publication-type="journal" id="bdi12556-cit-0179">
<string-name>
<surname>MacPherson</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Leffler</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Fristad</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Implementation of multi&#x02010;family psychoeducational psychotherapy for childhood mood disorders in an outpatient community setting</article-title>. <source>J Marital Fam Ther</source>. <year>2014</year>;<volume>40</volume>:<fpage>193</fpage>&#x02010;<lpage>211</lpage>.<pub-id pub-id-type="pmid">24749838</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0180"><label>180</label><mixed-citation publication-type="journal" id="bdi12556-cit-0180">
<string-name>
<surname>Mendenhall</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Fristad</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Early</surname>
<given-names>TJ</given-names>
</string-name>. <article-title>Factors influencing service utilization and mood symptom severity in children with mood disorders: effects of multifamily psychoeducation groups (MFPGs)</article-title>. <source>J Consult Clin Psychol</source>. <year>2009</year>;<volume>77</volume>:<fpage>463</fpage>.<pub-id pub-id-type="pmid">19485588</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0181"><label>181</label><mixed-citation publication-type="journal" id="bdi12556-cit-0181">
<string-name>
<surname>MacPherson</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Weinstein</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Henry</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>West</surname>
<given-names>AE</given-names>
</string-name>. <article-title>Mediators in the randomized trial of Child&#x02010; and Family&#x02010;Focused Cognitive&#x02010;Behavioral Therapy for pediatric bipolar disorder</article-title>. <source>Behav Res Ther</source>. <year>2016</year>;<volume>85</volume>:<fpage>60</fpage>&#x02010;<lpage>71</lpage>.<pub-id pub-id-type="pmid">27567973</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0182"><label>182</label><mixed-citation publication-type="journal" id="bdi12556-cit-0182">
<string-name>
<surname>MacPherson</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Algorta</surname>
<given-names>GP</given-names>
</string-name>, <string-name>
<surname>Mendenhall</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Fields</surname>
<given-names>BW</given-names>
</string-name>, <string-name>
<surname>Fristad</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Predictors and moderators in the randomized trial of multi&#x02010;family psychoeducational psychotherapy for childhood mood disorders</article-title>. <source>J Clin Child Adolesc Psychol</source>. <year>2014</year>;<volume>43</volume>:<fpage>459</fpage>&#x02010;<lpage>472</lpage>.<pub-id pub-id-type="pmid">23795823</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0183"><label>183</label><mixed-citation publication-type="journal" id="bdi12556-cit-0183">
<string-name>
<surname>Boylan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>MacPherson</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Fristad</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Examination of disruptive behavior outcomes and moderation in a randomized psychotherapy trial for mood disorders</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2013</year>;<volume>52</volume>:<fpage>699</fpage>&#x02010;<lpage>708</lpage>.<pub-id pub-id-type="pmid">23800483</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0184"><label>184</label><mixed-citation publication-type="journal" id="bdi12556-cit-0184">
<string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>, <string-name>
<surname>Goldstein</surname>
<given-names>TR</given-names>
</string-name>, <string-name>
<surname>Collinger</surname>
<given-names>KA</given-names>
</string-name>, et&#x000a0;al. <article-title>Treatment development and feasibility study of family&#x02010;focused treatment for adolescents with bipolar disorder and comorbid substance use disorders</article-title>. <source>J Psychiatr Pract</source>. <year>2014</year>;<volume>20</volume>:<fpage>237</fpage>&#x02010;<lpage>248</lpage>.<pub-id pub-id-type="pmid">24847999</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0185"><label>185</label><mixed-citation publication-type="journal" id="bdi12556-cit-0185">
<string-name>
<surname>Miklowitz</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Schneck</surname>
<given-names>CD</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>MK</given-names>
</string-name>, et&#x000a0;al. <article-title>Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family&#x02010;focused therapy</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2013</year>;<volume>52</volume>:<fpage>121</fpage>&#x02010;<lpage>131</lpage>.<pub-id pub-id-type="pmid">23357439</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0186"><label>186</label><mixed-citation publication-type="journal" id="bdi12556-cit-0186">
<string-name>
<surname>Nadkarni</surname>
<given-names>RB</given-names>
</string-name>, <string-name>
<surname>Fristad</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Clinical course of children with a depressive spectrum disorder and transient manic symptoms</article-title>. <source>Bipolar Disord</source>. <year>2010</year>;<volume>12</volume>:<fpage>494</fpage>&#x02010;<lpage>503</lpage>.<pub-id pub-id-type="pmid">20712750</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0187"><label>187</label><mixed-citation publication-type="journal" id="bdi12556-cit-0187">
<string-name>
<surname>Strakowski</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Adler</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Almeida</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>The functional neuroanatomy of bipolar disorder: a consensus model</article-title>. <source>Bipolar Disord</source>. <year>2012</year>;<volume>14</volume>:<fpage>313</fpage>&#x02010;<lpage>325</lpage>.<pub-id pub-id-type="pmid">22631617</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0188"><label>188</label><mixed-citation publication-type="book" id="bdi12556-cit-0188">
<string-name>
<surname>DelBello</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Kowatch</surname>
<given-names>RA</given-names>
</string-name>. <source>Neuroimaging in Pediatric Bipolar Disorder. Bipolar Disorder in Children and Early Adolescence</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Guilford Press</publisher-name>; <year>2003</year>:<fpage>158</fpage>&#x02010;<lpage>174</lpage>.</mixed-citation></ref><ref id="bdi12556-bib-0189"><label>189</label><mixed-citation publication-type="journal" id="bdi12556-cit-0189">
<string-name>
<surname>Schneider</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>DelBello</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>McNamara</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Strakowski</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Adler</surname>
<given-names>CM</given-names>
</string-name>. <article-title>Neuroprogression in bipolar disorder</article-title>. <source>Bipolar Disord</source>. <year>2012</year>;<volume>14</volume>:<fpage>356</fpage>&#x02010;<lpage>374</lpage>.<pub-id pub-id-type="pmid">22631620</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0190"><label>190</label><mixed-citation publication-type="journal" id="bdi12556-cit-0190">
<string-name>
<surname>Phillips</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Swartz</surname>
<given-names>HA</given-names>
</string-name>. <article-title>A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research</article-title>. <source>Am J Psychiatry</source>. <year>2014</year>;<volume>171</volume>:<fpage>829</fpage>&#x02010;<lpage>843</lpage>.<pub-id pub-id-type="pmid">24626773</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0191"><label>191</label><mixed-citation publication-type="journal" id="bdi12556-cit-0191">
<string-name>
<surname>Pfeifer</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Welge</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Strakowski</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Adler</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>DelBello</surname>
<given-names>MP</given-names>
</string-name>. <article-title>Meta&#x02010;analysis of amygdala volumes in children and adolescents with bipolar disorder</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2008</year>;<volume>47</volume>:<fpage>1289</fpage>&#x02010;<lpage>1298</lpage>.<pub-id pub-id-type="pmid">18827720</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0192"><label>192</label><mixed-citation publication-type="journal" id="bdi12556-cit-0192">
<string-name>
<surname>Usher</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Leucht</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Falkai</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Scherk</surname>
<given-names>H</given-names>
</string-name>. <article-title>Correlation between amygdala volume and age in bipolar disorder&#x02014;a systematic review and meta&#x02010;analysis of structural MRI studies</article-title>. <source>Psychiatry Res</source>. <year>2010</year>;<volume>182</volume>:<fpage>2010</fpage>.</mixed-citation></ref><ref id="bdi12556-bib-0193"><label>193</label><mixed-citation publication-type="journal" id="bdi12556-cit-0193">
<string-name>
<surname>Bitter</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Mills</surname>
<given-names>NP</given-names>
</string-name>, <string-name>
<surname>Adler</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Strakowski</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>DelBello</surname>
<given-names>MP</given-names>
</string-name>. <article-title>Progression of amygdala volumetric abnormalities in adolescents after their first manic episode</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2011</year>;<volume>50</volume>:<fpage>1017</fpage>&#x02010;<lpage>1026</lpage>.<pub-id pub-id-type="pmid">21961776</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0194"><label>194</label><mixed-citation publication-type="journal" id="bdi12556-cit-0194">
<string-name>
<surname>Adler</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Adams</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>DelBello</surname>
<given-names>MP</given-names>
</string-name>, et&#x000a0;al. <article-title>Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: a diffusion tensor imaging study</article-title>. <source>Am J Psychiatry</source>. <year>2006</year>;<volume>163</volume>:<fpage>322</fpage>&#x02010;<lpage>324</lpage>.<pub-id pub-id-type="pmid">16449490</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0195"><label>195</label><mixed-citation publication-type="journal" id="bdi12556-cit-0195">
<string-name>
<surname>Frazier</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Breeze</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Papadimitriou</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>White matter abnormalities in children with and at risk for bipolar disorder</article-title>. <source>Bipolar Disord</source>. <year>2007</year>;<volume>9</volume>:<fpage>799</fpage>&#x02010;<lpage>809</lpage>.<pub-id pub-id-type="pmid">18076529</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0196"><label>196</label><mixed-citation publication-type="journal" id="bdi12556-cit-0196">
<string-name>
<surname>Pavuluri</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kamineni</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Diffusion tensor imaging study of white matter fiber tracts in pediatric bipolar disorder and attention&#x02010;deficit/hyperactivity disorder</article-title>. <source>Biol Psychiat</source>. <year>2009</year>;<volume>65</volume>:<fpage>586</fpage>&#x02010;<lpage>593</lpage>.<pub-id pub-id-type="pmid">19027102</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0197"><label>197</label><mixed-citation publication-type="journal" id="bdi12556-cit-0197">
<string-name>
<surname>Kafantaris</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Kingsley</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ardekani</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>Lower orbital frontal white matter integrity in adolescents with bipolar I disorder</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2009</year>;<volume>48</volume>:<fpage>79</fpage>&#x02010;<lpage>86</lpage>.<pub-id pub-id-type="pmid">19050654</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0198"><label>198</label><mixed-citation publication-type="journal" id="bdi12556-cit-0198">
<string-name>
<surname>Saxena</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tamm</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Walley</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>A preliminary investigation of corpus callosum and anterior commissure aberrations in aggressive youth with bipolar disorders</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2012</year>;<volume>22</volume>:<fpage>112</fpage>&#x02010;<lpage>119</lpage>.<pub-id pub-id-type="pmid">22375854</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0199"><label>199</label><mixed-citation publication-type="journal" id="bdi12556-cit-0199">
<string-name>
<surname>Gao</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Jiao</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Qi</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>Combined analyses of gray matter voxel&#x02010;based morphometry and white matter tract&#x02010;based spatial statistics in pediatric bipolar mania</article-title>. <source>J Affect Disord</source>. <year>2013</year>;<volume>150</volume>:<fpage>70</fpage>&#x02010;<lpage>76</lpage>.<pub-id pub-id-type="pmid">23477846</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0200"><label>200</label><mixed-citation publication-type="journal" id="bdi12556-cit-0200">
<string-name>
<surname>James</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hough</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>James</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Structural brain and neuropsychometric changes associated with pediatric bipolar disorder with psychosis</article-title>. <source>Bipolar Disord</source>. <year>2011</year>;<volume>13</volume>:<fpage>16</fpage>&#x02010;<lpage>27</lpage>.<pub-id pub-id-type="pmid">21320249</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0201"><label>201</label><mixed-citation publication-type="journal" id="bdi12556-cit-0201">
<string-name>
<surname>Lu</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>XJ</given-names>
</string-name>, <string-name>
<surname>Fitzgerald</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Microstructural abnormalities of white matter differentiate pediatric and adult&#x02010;onset bipolar disorder</article-title>. <source>Bipolar Disord</source>. <year>2012</year>;<volume>14</volume>:<fpage>597</fpage>&#x02010;<lpage>606</lpage>.<pub-id pub-id-type="pmid">22882719</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0202"><label>202</label><mixed-citation publication-type="journal" id="bdi12556-cit-0202">
<string-name>
<surname>Wegbreit</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Cushman</surname>
<given-names>GK</given-names>
</string-name>, <string-name>
<surname>Puzia</surname>
<given-names>ME</given-names>
</string-name>, et&#x000a0;al. <article-title>Developmental meta&#x02010;analyses of the functional neural correlates of bipolar disorder</article-title>. <source>JAMA Psychiatry</source>. <year>2014</year>;<volume>71</volume>:<fpage>926</fpage>&#x02010;<lpage>935</lpage>.<pub-id pub-id-type="pmid">25100166</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0203"><label>203</label><mixed-citation publication-type="journal" id="bdi12556-cit-0203">
<string-name>
<surname>Lee</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Anumagalla</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Talluri</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Pavuluri</surname>
<given-names>MN</given-names>
</string-name>. <article-title>Meta&#x02010;analyses of developing brain function in high&#x02010;risk and emerged bipolar disorder</article-title>. <source>Front Psychiatry</source>. <year>2014</year>;<volume>5</volume>:<fpage>141</fpage>.<pub-id pub-id-type="pmid">25404919</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0204"><label>204</label><mixed-citation publication-type="journal" id="bdi12556-cit-0204">
<string-name>
<surname>Dickstein</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>Finger</surname>
<given-names>EC</given-names>
</string-name>, <string-name>
<surname>Skup</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pine</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Blair</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Leibenluft</surname>
<given-names>E</given-names>
</string-name>. <article-title>Altered neural function in pediatric bipolar disorder during reversal learning</article-title>. <source>Bipolar Disord</source>. <year>2010</year>;<volume>12</volume>:<fpage>707</fpage>&#x02010;<lpage>719</lpage>.<pub-id pub-id-type="pmid">21040288</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0205"><label>205</label><mixed-citation publication-type="journal" id="bdi12556-cit-0205">
<string-name>
<surname>Singh</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>KD</given-names>
</string-name>, <string-name>
<surname>Kelley</surname>
<given-names>RG</given-names>
</string-name>, et&#x000a0;al. <article-title>Reward processing in adolescents with bipolar I disorder</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2013</year>;<volume>52</volume>:<fpage>68</fpage>&#x02010;<lpage>83</lpage>.<pub-id pub-id-type="pmid">23265635</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0206"><label>206</label><mixed-citation publication-type="journal" id="bdi12556-cit-0206">
<string-name>
<surname>Urosevic</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Luciana</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jensen</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>KM</given-names>
</string-name>. <article-title>Age associations with neural processing of reward anticipation in adolescents with bipolar disorders</article-title>. <source>Neuroimage Clin</source>. <year>2016</year>;<volume>11</volume>:<fpage>476</fpage>&#x02010;<lpage>485</lpage>.<pub-id pub-id-type="pmid">27114896</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0207"><label>207</label><mixed-citation publication-type="journal" id="bdi12556-cit-0207">
<string-name>
<surname>Adler</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Delbello</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Mills</surname>
<given-names>NP</given-names>
</string-name>, <string-name>
<surname>Schmithorst</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Holland</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Strakowski</surname>
<given-names>SM</given-names>
</string-name>. <article-title>Comorbid ADHD is associated with altered patterns of neuronal activation in adolescents with bipolar disorder performing a simple attention task</article-title>. <source>Bipolar Disord</source>. <year>2005</year>;<volume>7</volume>:<fpage>577</fpage>&#x02010;<lpage>588</lpage>.<pub-id pub-id-type="pmid">16403183</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0208"><label>208</label><mixed-citation publication-type="journal" id="bdi12556-cit-0208">
<string-name>
<surname>Cerullo</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Adler</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Lamy</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Differential brain activation during response inhibition in bipolar and attention&#x02010;deficit hyperactivity disorders</article-title>. <source>Early Interv Psychiatry</source>. <year>2009</year>;<volume>3</volume>:<fpage>189</fpage>&#x02010;<lpage>197</lpage>.<pub-id pub-id-type="pmid">22640382</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0209"><label>209</label><mixed-citation publication-type="journal" id="bdi12556-cit-0209">
<string-name>
<surname>Leibenluft</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Rich</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Vinton</surname>
<given-names>DT</given-names>
</string-name>, et&#x000a0;al. <article-title>Neural circuitry engaged during unsuccessful motor inhibition in pediatric bipolar disorder</article-title>. <source>Am J Psychiatry</source>. <year>2007</year>;<volume>164</volume>:<fpage>52</fpage>&#x02010;<lpage>60</lpage>.<pub-id pub-id-type="pmid">17202544</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0210"><label>210</label><mixed-citation publication-type="journal" id="bdi12556-cit-0210">
<string-name>
<surname>Dickstein</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>Gorrostieta</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ombao</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Fronto&#x02010;temporal spontaneous resting state functional connectivity in pediatric bipolar disorder</article-title>. <source>Biol Psychiat</source>. <year>2010</year>;<volume>68</volume>:<fpage>839</fpage>&#x02010;<lpage>846</lpage>.<pub-id pub-id-type="pmid">20739018</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0211"><label>211</label><mixed-citation publication-type="journal" id="bdi12556-cit-0211">
<string-name>
<surname>Singh</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Kelley</surname>
<given-names>RG</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>KD</given-names>
</string-name>, <string-name>
<surname>Gotlib</surname>
<given-names>IH</given-names>
</string-name>. <article-title>Intrinsic amygdala functional connectivity in youth with bipolar I disorder</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2015</year>;<volume>54</volume>:<fpage>763</fpage>&#x02010;<lpage>770</lpage>.<pub-id pub-id-type="pmid">26299298</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0212"><label>212</label><mixed-citation publication-type="journal" id="bdi12556-cit-0212">
<string-name>
<surname>Xiao</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>Altered regional homogeneity in pediatric bipolar disorder during manic state: a resting&#x02010;state fMRI study</article-title>. <source>PLoS ONE</source>. <year>2013</year>;<volume>8</volume>:<fpage>e57978</fpage>.<pub-id pub-id-type="pmid">23526961</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0213"><label>213</label><mixed-citation publication-type="journal" id="bdi12556-cit-0213">
<string-name>
<surname>Gao</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Jiao</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Alterations of regional homogeneity in pediatric bipolar depression: a resting&#x02010;state fMRI study</article-title>. <source>BMC Psychiatry</source>. <year>2014</year>;<volume>14</volume>:<fpage>222</fpage>.<pub-id pub-id-type="pmid">25095790</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0214"><label>214</label><mixed-citation publication-type="journal" id="bdi12556-cit-0214">
<string-name>
<surname>Castillo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kwock</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Courvoisie</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hooper</surname>
<given-names>SR</given-names>
</string-name>. <article-title>Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations</article-title>. <source>AJNR Am J Neuroradiol</source>. <year>2000</year>;<volume>21</volume>:<fpage>832</fpage>&#x02010;<lpage>838</lpage>.<pub-id pub-id-type="pmid">10815657</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0215"><label>215</label><mixed-citation publication-type="journal" id="bdi12556-cit-0215">
<string-name>
<surname>Moore</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Frazier</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Glod</surname>
<given-names>CA</given-names>
</string-name>, et&#x000a0;al. <article-title>Glutamine and glutamate levels in children and adolescents with bipolar disorder: a 4.0&#x02010;T proton magnetic resonance spectroscopy study of the anterior cingulate cortex</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2007</year>;<volume>46</volume>:<fpage>524</fpage>&#x02010;<lpage>534</lpage>.<pub-id pub-id-type="pmid">17420688</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0216"><label>216</label><mixed-citation publication-type="journal" id="bdi12556-cit-0216">
<string-name>
<surname>Davanzo</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Yue</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Decreased anterior cingulate myo&#x02010;inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder</article-title>. <source>Neuropsychopharmacology</source>. <year>2001</year>;<volume>24</volume>:<fpage>359</fpage>&#x02010;<lpage>369</lpage>.<pub-id pub-id-type="pmid">11182531</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0217"><label>217</label><mixed-citation publication-type="journal" id="bdi12556-cit-0217">
<string-name>
<surname>Davanzo</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Yue</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>MA</given-names>
</string-name>, et&#x000a0;al. <article-title>Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents</article-title>. <source>Am J Psychiatry</source>. <year>2003</year>;<volume>160</volume>:<fpage>1442</fpage>&#x02010;<lpage>1452</lpage>.<pub-id pub-id-type="pmid">12900307</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0218"><label>218</label><mixed-citation publication-type="journal" id="bdi12556-cit-0218">
<string-name>
<surname>Cecil</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>DelBello</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Sellars</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Strakowski</surname>
<given-names>SM</given-names>
</string-name>. <article-title>Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2003</year>;<volume>13</volume>:<fpage>545</fpage>&#x02010;<lpage>555</lpage>.<pub-id pub-id-type="pmid">14977467</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0219"><label>219</label><mixed-citation publication-type="journal" id="bdi12556-cit-0219">
<string-name>
<surname>Chang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Adleman</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Dienes</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Barnea&#x02010;Goraly</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Reiss</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ketter</surname>
<given-names>T</given-names>
</string-name>. <article-title>Decreased N&#x02010;acetylaspartate in children with familial bipolar disorder</article-title>. <source>Biol Psychiatry</source>. <year>2003</year>;<volume>53</volume>:<fpage>1059</fpage>&#x02010;<lpage>1065</lpage>.<pub-id pub-id-type="pmid">12788251</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0220"><label>220</label><mixed-citation publication-type="journal" id="bdi12556-cit-0220">
<string-name>
<surname>Patel</surname>
<given-names>NC</given-names>
</string-name>, <string-name>
<surname>DelBello</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Cecil</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Stanford</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Adler</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Strakowski</surname>
<given-names>SM</given-names>
</string-name>. <article-title>Temporal change in N&#x02010;acetyl&#x02010;aspartate concentrations in adolescents with bipolar depression treated with lithium</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2008</year>;<volume>18</volume>:<fpage>132</fpage>&#x02010;<lpage>139</lpage>.<pub-id pub-id-type="pmid">18439111</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0221"><label>221</label><mixed-citation publication-type="journal" id="bdi12556-cit-0221">
<string-name>
<surname>Brambilla</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Stanley</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Nicoletti</surname>
<given-names>MA</given-names>
</string-name>, et&#x000a0;al. <article-title>1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients</article-title>. <source>J Affect Disord</source>. <year>2005</year>;<volume>86</volume>:<fpage>61</fpage>&#x02010;<lpage>67</lpage>.<pub-id pub-id-type="pmid">15820271</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0222"><label>222</label><mixed-citation publication-type="journal" id="bdi12556-cit-0222">
<string-name>
<surname>Caetano</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Olvera</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Hatch</surname>
<given-names>JP</given-names>
</string-name>, et&#x000a0;al. <article-title>Lower N&#x02010;acetyl&#x02010;aspartate levels in prefrontal cortices in pediatric bipolar disorder: a (1)H magnetic resonance spectroscopy study</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2011</year>;<volume>50</volume>:<fpage>85</fpage>&#x02010;<lpage>94</lpage>.<pub-id pub-id-type="pmid">21156273</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0223"><label>223</label><mixed-citation publication-type="journal" id="bdi12556-cit-0223">
<string-name>
<surname>Sassi</surname>
<given-names>RB</given-names>
</string-name>, <string-name>
<surname>Stanley</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Axelson</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients</article-title>. <source>Am J Psychiatry</source>. <year>2005</year>;<volume>162</volume>:<fpage>2109</fpage>&#x02010;<lpage>2115</lpage>.<pub-id pub-id-type="pmid">16263851</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0224"><label>224</label><mixed-citation publication-type="journal" id="bdi12556-cit-0224">
<string-name>
<surname>Olvera</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Caetano</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Fonseca</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Low levels of N&#x02010;acetyl aspartate in the left dorsolateral prefrontal cortex of pediatric bipolar patients</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2007</year>;<volume>17</volume>:<fpage>461</fpage>&#x02010;<lpage>473</lpage>.<pub-id pub-id-type="pmid">17822341</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0225"><label>225</label><mixed-citation publication-type="journal" id="bdi12556-cit-0225">
<string-name>
<surname>Strawn</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>NC</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>WJ</given-names>
</string-name>, et&#x000a0;al. <article-title>Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2012</year>;<volume>51</volume>:<fpage>642</fpage>&#x02010;<lpage>651</lpage>.<pub-id pub-id-type="pmid">22632623</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0226"><label>226</label><mixed-citation publication-type="journal" id="bdi12556-cit-0226">
<string-name>
<surname>DelBello</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Cecil</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Adler</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Daniels</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Strakowski</surname>
<given-names>SM</given-names>
</string-name>. <article-title>Neurochemical effects of olanzapaine in first&#x02010;hospitalization manic adolescents: a proton magnetic resonance spectroscopy study</article-title>. <source>Neuropsychopharmacology</source>. <year>2006</year>;<volume>31</volume>:<fpage>1264</fpage>&#x02010;<lpage>1273</lpage>.<pub-id pub-id-type="pmid">16292323</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0227"><label>227</label><mixed-citation publication-type="journal" id="bdi12556-cit-0227">
<string-name>
<surname>Diler</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Ladouceur</surname>
<given-names>CD</given-names>
</string-name>, <string-name>
<surname>Segreti</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Neural correlates of treatment response in depressed bipolar adolescents during emotion processing</article-title>. <source>Brain Imaging Behav</source>. <year>2013</year>;<volume>7</volume>:<fpage>227</fpage>&#x02010;<lpage>235</lpage>.<pub-id pub-id-type="pmid">23355265</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0228"><label>228</label><mixed-citation publication-type="journal" id="bdi12556-cit-0228">
<string-name>
<surname>Schneider</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Adler</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Whitsel</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>The effects of ziprasidone on prefrontal and amygdalar activation in manic youth with bipolar disorder</article-title>. <source>Isr J Psychiatry Relat Sci</source>. <year>2012</year>;<volume>49</volume>:<fpage>112</fpage>&#x02010;<lpage>120</lpage>.<pub-id pub-id-type="pmid">22801290</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0229"><label>229</label><mixed-citation publication-type="journal" id="bdi12556-cit-0229">
<string-name>
<surname>Schneider</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Weber</surname>
<given-names>W</given-names>
</string-name>, et&#x000a0;al. <article-title>The effects of carbamazepine on prefrontal activation in manic youth with bipolar disorder</article-title>. <source>Psychiatry Res</source>. <year>2014</year>;<volume>223</volume>:<fpage>268</fpage>&#x02010;<lpage>270</lpage>.<pub-id pub-id-type="pmid">25035298</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0230"><label>230</label><mixed-citation publication-type="journal" id="bdi12556-cit-0230">
<string-name>
<surname>Wegbreit</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ellis</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Nandam</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Amygdala functional connectivity predicts pharmacotherapy outcome in pediatric bipolar disorder</article-title>. <source>Brain Connect</source>. <year>2011</year>;<volume>1</volume>:<fpage>411</fpage>&#x02010;<lpage>422</lpage>.<pub-id pub-id-type="pmid">22432455</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0231"><label>231</label><mixed-citation publication-type="journal" id="bdi12556-cit-0231">
<string-name>
<surname>Garrett</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Miklowitz</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Howe</surname>
<given-names>ME</given-names>
</string-name>, et&#x000a0;al. <article-title>Changes in brain activation following psychotherapy for youth with mood dysregulation at familial risk for bipolar disorder</article-title>. <source>Prog Neuropsychopharmacol Biol Psychiatry</source>. <year>2015</year>;<volume>56</volume>:<fpage>215</fpage>&#x02010;<lpage>220</lpage>.<pub-id pub-id-type="pmid">25283342</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0232"><label>232</label><mixed-citation publication-type="journal" id="bdi12556-cit-0232">
<string-name>
<surname>Joseph</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Frazier</surname>
<given-names>TW</given-names>
</string-name>, <string-name>
<surname>Youngstrom</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Soares</surname>
<given-names>JC</given-names>
</string-name>. <article-title>A quantitative and qualitative review of neurocognitive performance in pediatric bipolar disorder&#x0201d;</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2008</year>;<volume>18</volume>:<fpage>595</fpage>&#x02010;<lpage>605</lpage>.<pub-id pub-id-type="pmid">19108664</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0233"><label>233</label><mixed-citation publication-type="journal" id="bdi12556-cit-0233">
<string-name>
<surname>Pavuluri</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>West</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hill</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Jindal</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Sweeney</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Neurocognitive function in pediatric bipolar disorder: 3&#x02010;year follow&#x02010;up shows cognitive development lagging behind healthy youths</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2009</year>;<volume>48</volume>:<fpage>299</fpage>&#x02010;<lpage>307</lpage>.<pub-id pub-id-type="pmid">19182689</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0234"><label>234</label><mixed-citation publication-type="journal" id="bdi12556-cit-0234">
<string-name>
<surname>Dickstein</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>Cushman</surname>
<given-names>GK</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>Weissman</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Wegbreit</surname>
<given-names>E</given-names>
</string-name>. <article-title>Cognitive remediation: potential novel brain&#x02010;based treatment for bipolar disorder in children and adolescents</article-title>. <source>CNS Spectr</source>. <year>2015</year>;<volume>20</volume>:<fpage>382</fpage>&#x02010;<lpage>390</lpage>.<pub-id pub-id-type="pmid">26135596</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0235"><label>235</label><mixed-citation publication-type="journal" id="bdi12556-cit-0235">
<string-name>
<surname>Munkholm</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bra&#x000fc;ner</surname>
<given-names>JV</given-names>
</string-name>, <string-name>
<surname>Kessing</surname>
<given-names>LV</given-names>
</string-name>, <string-name>
<surname>Vinberg</surname>
<given-names>M</given-names>
</string-name>. <article-title>Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta&#x02010;analysis</article-title>. <source>J Psychiatr Res</source>. <year>2013</year>;<volume>47</volume>:<fpage>1119</fpage>&#x02010;<lpage>1133</lpage>.<pub-id pub-id-type="pmid">23768870</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0236"><label>236</label><mixed-citation publication-type="journal" id="bdi12556-cit-0236">
<string-name>
<surname>Frey</surname>
<given-names>BN</given-names>
</string-name>, <string-name>
<surname>Andreazza</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Houenou</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force</article-title>. <source>Aust N Z J Psychiatry</source>. <year>2013</year>;<volume>47</volume>:<fpage>321</fpage>&#x02010;<lpage>332</lpage>.<pub-id pub-id-type="pmid">23411094</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0237"><label>237</label><mixed-citation publication-type="journal" id="bdi12556-cit-0237">
<string-name>
<surname>Berk</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kapczinski</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Andreazza</surname>
<given-names>AC</given-names>
</string-name>, et&#x000a0;al. <article-title>Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors</article-title>. <source>Neurosci Biobehav Rev</source>. <year>2011</year>;<volume>35</volume>:<fpage>804</fpage>&#x02010;<lpage>817</lpage>.<pub-id pub-id-type="pmid">20934453</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0238"><label>238</label><mixed-citation publication-type="journal" id="bdi12556-cit-0238">
<string-name>
<surname>Kapczinski</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Dias</surname>
<given-names>VV</given-names>
</string-name>, <string-name>
<surname>Kauer&#x02010;Sant'Anna</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>The potential use of biomarkers as an adjunctive tool for staging bipolar disorder</article-title>. <source>Prog Neuropsychopharmacol Biol Psychiatry</source>. <year>2009</year>;<volume>33</volume>:<fpage>1366</fpage>&#x02010;<lpage>1371</lpage>.<pub-id pub-id-type="pmid">19666076</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0239"><label>239</label><mixed-citation publication-type="journal" id="bdi12556-cit-0239">
<string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>, <string-name>
<surname>Collinger</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Lotrich</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>Preliminary findings regarding pro&#x02010;inflammatory markers and brain&#x02010;derived neurotrophic factor among adolescents with bipolar spectrum disorders</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2011</year>;<volume>21</volume>:<fpage>479</fpage>&#x02010;<lpage>484</lpage>.<pub-id pub-id-type="pmid">22040193</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0240"><label>240</label><mixed-citation publication-type="journal" id="bdi12556-cit-0240">
<string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>, <string-name>
<surname>Lotrich</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Axelson</surname>
<given-names>DA</given-names>
</string-name>, et&#x000a0;al. <article-title>Inflammatory markers among adolescents and young adults with bipolar spectrum disorders</article-title>. <source>J Clin Psychiatry</source>. <year>2015</year>;<volume>76</volume>:<fpage>1556</fpage>&#x02010;<lpage>1563</lpage>.<pub-id pub-id-type="pmid">26646032</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0241"><label>241</label><mixed-citation publication-type="journal" id="bdi12556-cit-0241">
<string-name>
<surname>Miklowitz</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Portnoff</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Armstrong</surname>
<given-names>CC</given-names>
</string-name>, et&#x000a0;al. <article-title>Inflammatory cytokines and nuclear factor&#x02010;kappa B activation in adolescents with bipolar and major depressive disorders</article-title>. <source>Psychiatry Res</source>. <year>2016</year>;<volume>241</volume>:<fpage>315</fpage>&#x02010;<lpage>322</lpage>.<pub-id pub-id-type="pmid">27227701</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0242"><label>242</label><mixed-citation publication-type="journal" id="bdi12556-cit-0242">
<string-name>
<surname>Hatch</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Scola</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Olowoyeye</surname>
<given-names>O</given-names>
</string-name>, et&#x000a0;al. <article-title>Inflammatory markers and brain&#x02010;derived neurotrophic factor as potential bridges linking bipolar disorder and cardiovascular risk among adolescents</article-title>. <source>J Clin Psychiatry</source>. <year>2017</year>;<volume>78</volume>:<fpage>e286</fpage>&#x02010;<lpage>e293</lpage>.<pub-id pub-id-type="pmid">28199074</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0243"><label>243</label><mixed-citation publication-type="journal" id="bdi12556-cit-0243">
<string-name>
<surname>Hatch</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Andreazza</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Olowoyeye</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Rezin</surname>
<given-names>GT</given-names>
</string-name>, <string-name>
<surname>Moody</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>. <article-title>Cardiovascular and psychiatric characteristics associated with oxidative stress markers among adolescents with bipolar disorder</article-title>. <source>J Psychosom Res</source>. <year>2015</year>;<volume>79</volume>:<fpage>222</fpage>&#x02010;<lpage>227</lpage>.<pub-id pub-id-type="pmid">25934154</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0244"><label>244</label><mixed-citation publication-type="journal" id="bdi12556-cit-0244">
<string-name>
<surname>Magalhaes</surname>
<given-names>PV</given-names>
</string-name>, <string-name>
<surname>Jansen</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Pinheiro</surname>
<given-names>RT</given-names>
</string-name>, et&#x000a0;al. <article-title>Peripheral oxidative damage in early&#x02010;stage mood disorders: a nested population&#x02010;based case&#x02010;control study</article-title>. <source>Int J Neuropsychopharmacol</source>. <year>2012</year>;<volume>15</volume>:<fpage>1043</fpage>&#x02010;<lpage>1050</lpage>.<pub-id pub-id-type="pmid">22008234</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0245"><label>245</label><mixed-citation publication-type="journal" id="bdi12556-cit-0245">
<string-name>
<surname>Scola</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>McNamara</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Croarkin</surname>
<given-names>PE</given-names>
</string-name>, et&#x000a0;al. <article-title>Lipid peroxidation biomarkers in adolescents with or at high&#x02010;risk for bipolar disorder</article-title>. <source>J Affect Disord</source>. <year>2016</year>;<volume>192</volume>:<fpage>176</fpage>&#x02010;<lpage>183</lpage>.<pub-id pub-id-type="pmid">26735329</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0246"><label>246</label><mixed-citation publication-type="journal" id="bdi12556-cit-0246">
<string-name>
<surname>Newton</surname>
<given-names>DF</given-names>
</string-name>, <string-name>
<surname>Naiberg</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Andreazza</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Scola</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Dickstein</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>. <article-title>Association of lipid peroxidation and brain&#x02010;derived neurotrophic factor with executive function in adolescent bipolar disorder</article-title>. <source>Psychopharmacology</source>. <year>2017</year>;<volume>234</volume>:<fpage>647</fpage>&#x02010;<lpage>656</lpage>.<pub-id pub-id-type="pmid">27957714</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0247"><label>247</label><mixed-citation publication-type="journal" id="bdi12556-cit-0247">
<string-name>
<surname>Pandey</surname>
<given-names>GN</given-names>
</string-name>, <string-name>
<surname>Rizavi</surname>
<given-names>HS</given-names>
</string-name>, <string-name>
<surname>Dwivedi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Pavuluri</surname>
<given-names>MN</given-names>
</string-name>. <article-title>Brain&#x02010;derived neurotrophic factor gene expression in pediatric bipolar disorder: effects of treatment and clinical response</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. <year>2008</year>;<volume>47</volume>:<fpage>1077</fpage>&#x02010;<lpage>1085</lpage>.<pub-id pub-id-type="pmid">18664999</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0248"><label>248</label><mixed-citation publication-type="journal" id="bdi12556-cit-0248">
<string-name>
<surname>Inal&#x02010;Emiroglu</surname>
<given-names>FN</given-names>
</string-name>, <string-name>
<surname>Karabay</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Resmi</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Correlations between amygdala volumes and serum levels of BDNF and NGF as a neurobiological markerin adolescents with bipolar disorder</article-title>. <source>J Affect Disord</source>. <year>2015</year>;<volume>182</volume>:<fpage>50</fpage>&#x02010;<lpage>56</lpage>.<pub-id pub-id-type="pmid">25973783</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0249"><label>249</label><mixed-citation publication-type="journal" id="bdi12556-cit-0249">
<string-name>
<surname>Inal&#x02010;Emiroglu</surname>
<given-names>FN</given-names>
</string-name>, <string-name>
<surname>Resmi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Karabay</surname>
<given-names>N</given-names>
</string-name>, et&#x000a0;al. <article-title>Decreased right hippocampal volumes and neuroprogression markers in adolescents with bipolar disorder</article-title>. <source>Neuropsychobiology</source>. <year>2015</year>;<volume>71</volume>:<fpage>140</fpage>&#x02010;<lpage>148</lpage>.<pub-id pub-id-type="pmid">25925781</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0250"><label>250</label><mixed-citation publication-type="journal" id="bdi12556-cit-0250">
<string-name>
<surname>Mick</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Wozniak</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wilens</surname>
<given-names>TE</given-names>
</string-name>, <string-name>
<surname>Biederman</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</string-name>. <article-title>Family&#x02010;based association study of the BDNF, COMT and serotonin transporter genes and DSM&#x02010;IV bipolar&#x02010;I disorder in children</article-title>. <source>BMC Psychiatry</source>. <year>2009</year>;<volume>9</volume>:<fpage>2</fpage>.<pub-id pub-id-type="pmid">19193231</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0251"><label>251</label><mixed-citation publication-type="journal" id="bdi12556-cit-0251">
<string-name>
<surname>Mick</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Biederman</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Family based association study of pediatric bipolar disorder and the dopamine transporter gene (SLC6A3)</article-title>. <source>Am J Med Genet B Neuropsychiatr Genet</source>. <year>2008</year>;<volume>147B</volume>:<fpage>1182</fpage>&#x02010;<lpage>1185</lpage>.<pub-id pub-id-type="pmid">18361424</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0252"><label>252</label><mixed-citation publication-type="journal" id="bdi12556-cit-0252">
<string-name>
<surname>Gallitano</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Tillman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Dinu</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Geller</surname>
<given-names>B</given-names>
</string-name>. <article-title>Family&#x02010;based association study of early growth response gene 3 with child bipolar I disorder</article-title>. <source>J Affect Disord</source>. <year>2012</year>;<volume>138</volume>:<fpage>387</fpage>&#x02010;<lpage>396</lpage>.<pub-id pub-id-type="pmid">22370066</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0253"><label>253</label><mixed-citation publication-type="journal" id="bdi12556-cit-0253">
<string-name>
<surname>Geller</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Tillman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bolhofner</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hennessy</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Cook</surname>
<given-names>EH</given-names>
</string-name>. <article-title>GAD1 single nucleotide polymorphism is in linkage disequilibrium with a child bipolar i disorder phenotype</article-title>. <source>J Child Adolesc Psychopharmacol</source>. <year>2007</year>;<volume>18</volume>:<fpage>25</fpage>&#x02010;<lpage>29</lpage>.</mixed-citation></ref><ref id="bdi12556-bib-0254"><label>254</label><mixed-citation publication-type="journal" id="bdi12556-cit-0254">
<string-name>
<surname>Geller</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Badner</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Tillman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Christian</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Bolhofner</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Cook</surname>
<given-names>EH</given-names>
</string-name>. <article-title>Linkage disequilibrium of the brain&#x02010;derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype</article-title>. <source>Am J Psychiatry</source>. <year>2004</year>;<volume>161</volume>:<fpage>1698</fpage>&#x02010;<lpage>1700</lpage>.<pub-id pub-id-type="pmid">15337662</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0255"><label>255</label><mixed-citation publication-type="journal" id="bdi12556-cit-0255">
<string-name>
<surname>Ferreira</surname>
<given-names>MAR</given-names>
</string-name>, <string-name>
<surname>O'Donovan</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Meng</surname>
<given-names>YA</given-names>
</string-name>, et&#x000a0;al. <article-title>Collaborative genome&#x02010;wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder</article-title>. <source>Nat Genet</source>. <year>2008</year>;<volume>40</volume>:<fpage>1056</fpage>&#x02010;<lpage>1058</lpage>.<pub-id pub-id-type="pmid">18711365</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0256"><label>256</label><mixed-citation publication-type="journal" id="bdi12556-cit-0256">
<string-name>
<surname>Croarkin</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Luby</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Cercy</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Genetic risk score analysis in early&#x02010;onset bipolar disorder</article-title>. <source>J Clin Psychiatry</source>. <year>2017</year>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4088/JCP.15m10314">https://doi.org/10.4088/JCP.15m10314</ext-link>
</mixed-citation></ref><ref id="bdi12556-bib-0257"><label>257</label><mixed-citation publication-type="book" id="bdi12556-cit-0257">
<string-name>
<surname>Kraepelin</surname>
<given-names>E</given-names>
</string-name>. <source>Manic&#x02010;Depressive Insanity and Paranoia</source>. <publisher-loc>Edinburgh</publisher-loc>: <publisher-name>E. &#x00026; S. Livingstone</publisher-name>; <year>1921</year>.</mixed-citation></ref><ref id="bdi12556-bib-0258"><label>258</label><mixed-citation publication-type="journal" id="bdi12556-cit-0258">
<string-name>
<surname>Parens</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Johnston</surname>
<given-names>J</given-names>
</string-name>. <article-title>Controversies concerning the diagnosis and treatment of bipolar disorder in children</article-title>. <source>Child Adolesc Psychiatry Ment Health</source>. <year>2010</year>;<volume>4</volume>:<fpage>9</fpage>.<pub-id pub-id-type="pmid">20219111</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0259"><label>259</label><mixed-citation publication-type="journal" id="bdi12556-cit-0259">
<string-name>
<surname>Mitchell</surname>
<given-names>PB</given-names>
</string-name>. <article-title>Bipolar disorder: the shift to overdiagnosis</article-title>. <source>Can J Psychiatry</source>. <year>2012</year>;<volume>57</volume>:<fpage>659</fpage>&#x02010;<lpage>665</lpage>.<pub-id pub-id-type="pmid">23149281</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0260"><label>260</label><mixed-citation publication-type="journal" id="bdi12556-cit-0260">
<string-name>
<surname>Subramaniapillai</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>, <string-name>
<surname>MacIntosh</surname>
<given-names>BJ</given-names>
</string-name>, et al. <article-title>Characterizing exercise&#x02010;induced feelings after one bout of exercise among adolescents with and without bipolar disorder</article-title>. <source>J Affect Disord</source>. <year>2016</year>;<volume>190</volume>:<fpage>467</fpage>&#x02010;<lpage>473</lpage>.<pub-id pub-id-type="pmid">26551406</pub-id></mixed-citation></ref><ref id="bdi12556-bib-0261"><label>261</label><mixed-citation publication-type="journal" id="bdi12556-cit-0261">
<string-name>
<surname>Metcalfe</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>MacIntosh</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Scavone</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ou</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Korczak</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Goldstein</surname>
<given-names>BI</given-names>
</string-name>. <article-title>Effects of acute aerobic exercise on neural correlates of attention and inhibition in adolescents with bipolar disorder</article-title>. <source>Transl Psychiatry</source>. <year>2016</year>;<volume>6</volume>:<fpage>e814</fpage>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/tp.2016.85">https://doi.org/10.1038/tp.2016.85</ext-link>.<pub-id pub-id-type="pmid">27187236</pub-id></mixed-citation></ref></ref-list></back></article>